id	sid	tid	token	lemma	pos
ghmj-1070	1	1	indonesian	indonesian	ADJ
ghmj-1070	1	2	scholars	scholars	PROPN
ghmj-1070	1	3	’	'	PUNCT
ghmj-1070	1	4	alliance	alliance	NOUN
ghmj-1070	1	5	ghmj	ghmj	NOUN
ghmj-1070	1	6	(	(	PUNCT
ghmj-1070	1	7	global	global	ADJ
ghmj-1070	1	8	health	health	PROPN
ghmj-1070	1	9	management	management	NOUN
ghmj-1070	1	10	journal	journal	PROPN
ghmj-1070	1	11	)	)	PUNCT
ghmj-1070	1	12	2024	2024	NUM
ghmj-1070	1	13	,	,	PUNCT
ghmj-1070	1	14	vol	vol	NOUN
ghmj-1070	1	15	.	.	PROPN
ghmj-1070	1	16	7	7	NUM
ghmj-1070	1	17	,	,	PUNCT
ghmj-1070	1	18	no	no	INTJ
ghmj-1070	1	19	.	.	NOUN
ghmj-1070	1	20	4	4	NUM
ghmj-1070	1	21	open	open	ADJ
ghmj-1070	1	22	access	access	NOUN
ghmj-1070	1	23	research	research	NOUN
ghmj-1070	1	24	article	article	NOUN
ghmj-1070	1	25	the	the	DET
ghmj-1070	1	26	1st	1st	ADJ
ghmj-1070	1	27	cirebon	cirebon	PROPN
ghmj-1070	1	28	international	international	PROPN
ghmj-1070	1	29	health	health	NOUN
ghmj-1070	1	30	symposium	symposium	NOUN
ghmj-1070	1	31	:	:	PUNCT
ghmj-1070	1	32	faculty	faculty	NOUN
ghmj-1070	1	33	of	of	ADP
ghmj-1070	1	34	medicine	medicine	NOUN
ghmj-1070	1	35	,	,	PUNCT
ghmj-1070	1	36	universitas	universita	NOUN
ghmj-1070	1	37	swadaya	swadaya	NOUN
ghmj-1070	1	38	gunung	gunung	NOUN
ghmj-1070	1	39	jati	jati	PROPN
ghmj-1070	1	40	update	update	NOUN
ghmj-1070	1	41	on	on	ADP
ghmj-1070	1	42	non	non	ADJ
ghmj-1070	1	43	-	-	ADJ
ghmj-1070	1	44	communicable	communicable	ADJ
ghmj-1070	1	45	diseases	disease	NOUN
ghmj-1070	1	46	:	:	PUNCT
ghmj-1070	1	47	global	global	ADJ
ghmj-1070	1	48	perspective	perspective	NOUN
ghmj-1070	1	49	on	on	ADP
ghmj-1070	1	50	health	health	NOUN
ghmj-1070	1	51	challenges	challenge	NOUN
ghmj-1070	1	52	and	and	CCONJ
ghmj-1070	1	53	innovation	innovation	NOUN
ghmj-1070	1	54	demographics	demographic	NOUN
ghmj-1070	1	55	and	and	CCONJ
ghmj-1070	1	56	histopathological	histopathological	ADJ
ghmj-1070	1	57	characteristics	characteristic	NOUN
ghmj-1070	1	58	of	of	ADP
ghmj-1070	1	59	lung	lung	NOUN
ghmj-1070	1	60	cancer	cancer	NOUN
ghmj-1070	1	61	patients	patient	NOUN
ghmj-1070	1	62	in	in	ADP
ghmj-1070	1	63	cirebon	cirebon	PROPN
ghmj-1070	1	64	district	district	PROPN
ghmj-1070	1	65	,	,	PUNCT
ghmj-1070	1	66	indonesia	indonesia	PROPN
ghmj-1070	1	67	(	(	PUNCT
ghmj-1070	1	68	2021	2021	NUM
ghmj-1070	1	69	-	-	SYM
ghmj-1070	1	70	2023	2023	NUM
ghmj-1070	1	71	)	)	PUNCT
ghmj-1070	1	72	syakira	syakira	NOUN
ghmj-1070	1	73	puteri	puteri	PROPN
ghmj-1070	1	74	sulaeman1	sulaeman1	PROPN
ghmj-1070	1	75	*	*	PUNCT
ghmj-1070	1	76	,	,	PUNCT
ghmj-1070	1	77	alya	alya	PROPN
ghmj-1070	1	78	amila	amila	PROPN
ghmj-1070	1	79	fitrie2	fitrie2	PROPN
ghmj-1070	1	80	,	,	PUNCT
ghmj-1070	1	81	sedayu3	sedayu3	NOUN
ghmj-1070	1	82	1	1	NUM
ghmj-1070	1	83	faculty	faculty	NOUN
ghmj-1070	1	84	of	of	ADP
ghmj-1070	1	85	medicine	medicine	NOUN
ghmj-1070	1	86	,	,	PUNCT
ghmj-1070	1	87	universitas	universita	NOUN
ghmj-1070	1	88	swadaya	swadaya	NOUN
ghmj-1070	1	89	gunung	gunung	PROPN
ghmj-1070	1	90	jati	jati	PROPN
ghmj-1070	1	91	,	,	PUNCT
ghmj-1070	1	92	indonesia	indonesia	PROPN
ghmj-1070	1	93	,	,	PUNCT
ghmj-1070	1	94	2	2	NUM
ghmj-1070	1	95	department	department	NOUN
ghmj-1070	1	96	of	of	ADP
ghmj-1070	1	97	anatomical	anatomical	ADJ
ghmj-1070	1	98	pathology	pathology	NOUN
ghmj-1070	1	99	,	,	PUNCT
ghmj-1070	1	100	universitas	universita	NOUN
ghmj-1070	1	101	swadaya	swadaya	NOUN
ghmj-1070	1	102	gunung	gunung	PROPN
ghmj-1070	1	103	jati	jati	PROPN
ghmj-1070	1	104	,	,	PUNCT
ghmj-1070	1	105	indonesia	indonesia	PROPN
ghmj-1070	1	106	,	,	PUNCT
ghmj-1070	1	107	3	3	NUM
ghmj-1070	1	108	department	department	NOUN
ghmj-1070	1	109	of	of	ADP
ghmj-1070	1	110	internal	internal	ADJ
ghmj-1070	1	111	medicine	medicine	NOUN
ghmj-1070	1	112	,	,	PUNCT
ghmj-1070	1	113	universitas	universita	NOUN
ghmj-1070	1	114	swadaya	swadaya	NOUN
ghmj-1070	1	115	gunung	gunung	PROPN
ghmj-1070	1	116	jati	jati	PROPN
ghmj-1070	1	117	,	,	PUNCT
ghmj-1070	1	118	indonesia	indonesia	PROPN
ghmj-1070	1	119	.	.	PUNCT
ghmj-1070	2	1	*	*	PUNCT
ghmj-1070	2	2	corresponding	correspond	VERB
ghmj-1070	2	3	author	author	NOUN
ghmj-1070	2	4	’s	’s	PART
ghmj-1070	2	5	e	e	NOUN
ghmj-1070	2	6	-	-	NOUN
ghmj-1070	2	7	mail	mail	NOUN
ghmj-1070	2	8	:	:	PUNCT
ghmj-1070	2	9	puterisulaeman2002@gmail.com	puterisulaeman2002@gmail.com	X
ghmj-1070	2	10	doi	doi	NOUN
ghmj-1070	2	11	:	:	PUNCT
ghmj-1070	2	12	10.35898	10.35898	NUM
ghmj-1070	2	13	/	/	SYM
ghmj-1070	2	14	ghmj-741070	ghmj-741070	ADJ
ghmj-1070	2	15	abstract	abstract	ADJ
ghmj-1070	2	16	background	background	NOUN
ghmj-1070	2	17	:	:	PUNCT
ghmj-1070	2	18	based	base	VERB
ghmj-1070	2	19	on	on	ADP
ghmj-1070	2	20	the	the	DET
ghmj-1070	2	21	global	global	ADJ
ghmj-1070	2	22	burden	burden	NOUN
ghmj-1070	2	23	of	of	ADP
ghmj-1070	2	24	cancer	cancer	NOUN
ghmj-1070	2	25	study	study	NOUN
ghmj-1070	2	26	(	(	PUNCT
ghmj-1070	2	27	globocan	globocan	PROPN
ghmj-1070	2	28	)	)	PUNCT
ghmj-1070	2	29	in	in	ADP
ghmj-1070	2	30	2020	2020	NUM
ghmj-1070	2	31	,	,	PUNCT
ghmj-1070	2	32	in	in	ADP
ghmj-1070	2	33	the	the	DET
ghmj-1070	2	34	world	world	NOUN
ghmj-1070	2	35	,	,	PUNCT
ghmj-1070	2	36	lung	lung	NOUN
ghmj-1070	2	37	cancer	cancer	NOUN
ghmj-1070	2	38	is	be	AUX
ghmj-1070	2	39	the	the	DET
ghmj-1070	2	40	first	first	ADJ
ghmj-1070	2	41	cause	cause	NOUN
ghmj-1070	2	42	of	of	ADP
ghmj-1070	2	43	death	death	NOUN
ghmj-1070	2	44	.	.	PUNCT
ghmj-1070	3	1	in	in	ADP
ghmj-1070	3	2	indonesia	indonesia	PROPN
ghmj-1070	3	3	,	,	PUNCT
ghmj-1070	3	4	lung	lung	NOUN
ghmj-1070	3	5	cancer	cancer	NOUN
ghmj-1070	3	6	is	be	AUX
ghmj-1070	3	7	the	the	DET
ghmj-1070	3	8	third	third	ADV
ghmj-1070	3	9	highest	high	ADJ
ghmj-1070	3	10	.	.	PUNCT
ghmj-1070	4	1	lung	lung	NOUN
ghmj-1070	4	2	cancer	cancer	NOUN
ghmj-1070	4	3	is	be	AUX
ghmj-1070	4	4	classified	classify	VERB
ghmj-1070	4	5	into	into	ADP
ghmj-1070	4	6	two	two	NUM
ghmj-1070	4	7	cell	cell	NOUN
ghmj-1070	4	8	types	type	NOUN
ghmj-1070	4	9	:	:	PUNCT
ghmj-1070	4	10	small	small	ADJ
ghmj-1070	4	11	cell	cell	NOUN
ghmj-1070	4	12	lung	lung	NOUN
ghmj-1070	4	13	cancer	cancer	NOUN
ghmj-1070	4	14	and	and	CCONJ
ghmj-1070	4	15	non	non	ADJ
ghmj-1070	4	16	-	-	ADJ
ghmj-1070	4	17	small	small	ADJ
ghmj-1070	4	18	cell	cell	NOUN
ghmj-1070	4	19	lung	lung	NOUN
ghmj-1070	4	20	cancer	cancer	NOUN
ghmj-1070	4	21	.	.	PUNCT
ghmj-1070	5	1	there	there	PRON
ghmj-1070	5	2	are	be	VERB
ghmj-1070	5	3	two	two	NUM
ghmj-1070	5	4	types	type	NOUN
ghmj-1070	5	5	of	of	ADP
ghmj-1070	5	6	non	non	ADJ
ghmj-1070	5	7	-	-	ADJ
ghmj-1070	5	8	small	small	ADJ
ghmj-1070	5	9	cell	cell	NOUN
ghmj-1070	5	10	lung	lung	NOUN
ghmj-1070	5	11	cancer	cancer	NOUN
ghmj-1070	5	12	:	:	PUNCT
ghmj-1070	5	13	squamous	squamous	ADJ
ghmj-1070	5	14	cell	cell	NOUN
ghmj-1070	5	15	carcinoma	carcinoma	NOUN
ghmj-1070	5	16	,	,	PUNCT
ghmj-1070	5	17	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	5	18	,	,	PUNCT
ghmj-1070	5	19	and	and	CCONJ
ghmj-1070	5	20	large	large	ADJ
ghmj-1070	5	21	cell	cell	NOUN
ghmj-1070	5	22	carcinoma	carcinoma	NOUN
ghmj-1070	5	23	.	.	PUNCT
ghmj-1070	6	1	aims	aim	NOUN
ghmj-1070	6	2	:	:	PUNCT
ghmj-1070	6	3	to	to	PART
ghmj-1070	6	4	determine	determine	VERB
ghmj-1070	6	5	the	the	DET
ghmj-1070	6	6	demographics	demographic	NOUN
ghmj-1070	6	7	and	and	CCONJ
ghmj-1070	6	8	histopathological	histopathological	ADJ
ghmj-1070	6	9	characteristics	characteristic	NOUN
ghmj-1070	6	10	of	of	ADP
ghmj-1070	6	11	lung	lung	NOUN
ghmj-1070	6	12	cancer	cancer	NOUN
ghmj-1070	6	13	patients	patient	NOUN
ghmj-1070	6	14	in	in	ADP
ghmj-1070	6	15	cirebon	cirebon	NOUN
ghmj-1070	6	16	district	district	NOUN
ghmj-1070	6	17	(	(	PUNCT
ghmj-1070	6	18	2021	2021	NUM
ghmj-1070	6	19	-	-	SYM
ghmj-1070	6	20	2023	2023	NUM
ghmj-1070	6	21	)	)	PUNCT
ghmj-1070	6	22	.	.	PUNCT
ghmj-1070	7	1	methods	method	NOUN
ghmj-1070	7	2	:	:	PUNCT
ghmj-1070	7	3	this	this	DET
ghmj-1070	7	4	research	research	NOUN
ghmj-1070	7	5	employed	employ	VERB
ghmj-1070	7	6	a	a	DET
ghmj-1070	7	7	descriptive	descriptive	ADJ
ghmj-1070	7	8	observational	observational	ADJ
ghmj-1070	7	9	method	method	NOUN
ghmj-1070	7	10	.	.	PUNCT
ghmj-1070	8	1	the	the	DET
ghmj-1070	8	2	data	datum	NOUN
ghmj-1070	8	3	were	be	AUX
ghmj-1070	8	4	collected	collect	VERB
ghmj-1070	8	5	from	from	ADP
ghmj-1070	8	6	general	general	ADJ
ghmj-1070	8	7	hospitals	hospital	NOUN
ghmj-1070	8	8	’	'	PUNCT
ghmj-1070	8	9	medical	medical	ADJ
ghmj-1070	8	10	records	record	NOUN
ghmj-1070	8	11	of	of	ADP
ghmj-1070	8	12	lung	lung	NOUN
ghmj-1070	8	13	cancer	cancer	NOUN
ghmj-1070	8	14	patients	patient	NOUN
ghmj-1070	8	15	at	at	ADP
ghmj-1070	8	16	rsud	rsud	PROPN
ghmj-1070	8	17	waled	wale	VERB
ghmj-1070	8	18	cirebon	cirebon	NOUN
ghmj-1070	8	19	and	and	CCONJ
ghmj-1070	8	20	rsud	rsud	VERB
ghmj-1070	8	21	arjawinangun	arjawinangun	NOUN
ghmj-1070	8	22	in	in	ADP
ghmj-1070	8	23	2021	2021	NUM
ghmj-1070	8	24	-	-	SYM
ghmj-1070	8	25	2023	2023	NUM
ghmj-1070	8	26	using	use	VERB
ghmj-1070	8	27	the	the	DET
ghmj-1070	8	28	total	total	ADJ
ghmj-1070	8	29	sampling	sample	VERB
ghmj-1070	8	30	technique	technique	NOUN
ghmj-1070	8	31	.	.	PUNCT
ghmj-1070	9	1	there	there	PRON
ghmj-1070	9	2	were	be	VERB
ghmj-1070	9	3	69	69	NUM
ghmj-1070	9	4	respondents	respondent	NOUN
ghmj-1070	9	5	met	meet	VERB
ghmj-1070	9	6	the	the	DET
ghmj-1070	9	7	inclusion	inclusion	NOUN
ghmj-1070	9	8	criteria	criterion	NOUN
ghmj-1070	9	9	for	for	ADP
ghmj-1070	9	10	this	this	DET
ghmj-1070	9	11	recent	recent	ADJ
ghmj-1070	9	12	study	study	NOUN
ghmj-1070	9	13	.	.	PUNCT
ghmj-1070	10	1	results	result	NOUN
ghmj-1070	10	2	:	:	PUNCT
ghmj-1070	10	3	in	in	ADP
ghmj-1070	10	4	this	this	DET
ghmj-1070	10	5	study	study	NOUN
ghmj-1070	10	6	,	,	PUNCT
ghmj-1070	10	7	there	there	PRON
ghmj-1070	10	8	were	be	VERB
ghmj-1070	10	9	68.1	68.1	NUM
ghmj-1070	10	10	%	%	NOUN
ghmj-1070	10	11	of	of	ADP
ghmj-1070	10	12	patients	patient	NOUN
ghmj-1070	10	13	aged	age	VERB
ghmj-1070	10	14	from	from	ADP
ghmj-1070	10	15	46	46	NUM
ghmj-1070	10	16	to	to	PART
ghmj-1070	10	17	70	70	NUM
ghmj-1070	10	18	years	year	NOUN
ghmj-1070	10	19	,	,	PUNCT
ghmj-1070	10	20	and	and	CCONJ
ghmj-1070	10	21	the	the	DET
ghmj-1070	10	22	majority	majority	NOUN
ghmj-1070	10	23	were	be	AUX
ghmj-1070	10	24	male	male	ADJ
ghmj-1070	10	25	(	(	PUNCT
ghmj-1070	10	26	66.7	66.7	NUM
ghmj-1070	10	27	%	%	NOUN
ghmj-1070	10	28	)	)	PUNCT
ghmj-1070	10	29	.	.	PUNCT
ghmj-1070	11	1	the	the	DET
ghmj-1070	11	2	most	most	ADV
ghmj-1070	11	3	common	common	ADJ
ghmj-1070	11	4	cancer	cancer	NOUN
ghmj-1070	11	5	cell	cell	NOUN
ghmj-1070	11	6	type	type	NOUN
ghmj-1070	11	7	was	be	AUX
ghmj-1070	11	8	adenocarcinoma	adenocarcinoma	ADJ
ghmj-1070	11	9	(	(	PUNCT
ghmj-1070	11	10	69.6	69.6	NUM
ghmj-1070	11	11	%	%	NOUN
ghmj-1070	11	12	)	)	PUNCT
ghmj-1070	11	13	.	.	PUNCT
ghmj-1070	12	1	most	most	ADJ
ghmj-1070	12	2	patients	patient	NOUN
ghmj-1070	12	3	did	do	AUX
ghmj-1070	12	4	not	not	PART
ghmj-1070	12	5	have	have	VERB
ghmj-1070	12	6	information	information	NOUN
ghmj-1070	12	7	regarding	regard	VERB
ghmj-1070	12	8	occupational	occupational	ADJ
ghmj-1070	12	9	data	datum	NOUN
ghmj-1070	12	10	(	(	PUNCT
ghmj-1070	12	11	68.1	68.1	NUM
ghmj-1070	12	12	%	%	NOUN
ghmj-1070	12	13	)	)	PUNCT
ghmj-1070	12	14	,	,	PUNCT
ghmj-1070	12	15	smoking	smoke	VERB
ghmj-1070	12	16	history	history	NOUN
ghmj-1070	12	17	(	(	PUNCT
ghmj-1070	12	18	98.6	98.6	NUM
ghmj-1070	12	19	%	%	NOUN
ghmj-1070	12	20	)	)	PUNCT
ghmj-1070	12	21	,	,	PUNCT
ghmj-1070	12	22	family	family	NOUN
ghmj-1070	12	23	history	history	NOUN
ghmj-1070	12	24	(	(	PUNCT
ghmj-1070	12	25	98.6	98.6	NUM
ghmj-1070	12	26	%	%	NOUN
ghmj-1070	12	27	)	)	PUNCT
ghmj-1070	12	28	,	,	PUNCT
ghmj-1070	12	29	and	and	CCONJ
ghmj-1070	12	30	staging	stage	VERB
ghmj-1070	12	31	(	(	PUNCT
ghmj-1070	12	32	89.9	89.9	NUM
ghmj-1070	12	33	%	%	NOUN
ghmj-1070	12	34	)	)	PUNCT
ghmj-1070	12	35	included	include	VERB
ghmj-1070	12	36	in	in	ADP
ghmj-1070	12	37	their	their	PRON
ghmj-1070	12	38	medical	medical	ADJ
ghmj-1070	12	39	records	record	NOUN
ghmj-1070	12	40	.	.	PUNCT
ghmj-1070	13	1	conclusion	conclusion	NOUN
ghmj-1070	13	2	:	:	PUNCT
ghmj-1070	13	3	the	the	DET
ghmj-1070	13	4	analysis	analysis	NOUN
ghmj-1070	13	5	showed	show	VERB
ghmj-1070	13	6	that	that	SCONJ
ghmj-1070	13	7	most	most	ADJ
ghmj-1070	13	8	lung	lung	NOUN
ghmj-1070	13	9	cancer	cancer	NOUN
ghmj-1070	13	10	patients	patient	NOUN
ghmj-1070	13	11	are	be	AUX
ghmj-1070	13	12	aged	age	VERB
ghmj-1070	13	13	46	46	NUM
ghmj-1070	13	14	-	-	SYM
ghmj-1070	13	15	70	70	NUM
ghmj-1070	13	16	years	year	NOUN
ghmj-1070	13	17	and	and	CCONJ
ghmj-1070	13	18	male	male	ADJ
ghmj-1070	13	19	incidences	incidence	NOUN
ghmj-1070	13	20	in	in	ADP
ghmj-1070	13	21	lung	lung	NOUN
ghmj-1070	13	22	cancer	cancer	NOUN
ghmj-1070	13	23	patients	patient	NOUN
ghmj-1070	13	24	were	be	AUX
ghmj-1070	13	25	higher	high	ADJ
ghmj-1070	13	26	.	.	PUNCT
ghmj-1070	14	1	the	the	DET
ghmj-1070	14	2	most	most	ADV
ghmj-1070	14	3	common	common	ADJ
ghmj-1070	14	4	type	type	NOUN
ghmj-1070	14	5	of	of	ADP
ghmj-1070	14	6	histopathological	histopathological	ADJ
ghmj-1070	14	7	is	be	AUX
ghmj-1070	14	8	adenocarcinoma	adenocarcinoma	ADJ
ghmj-1070	14	9	.	.	PUNCT
ghmj-1070	15	1	related	relate	VERB
ghmj-1070	15	2	to	to	ADP
ghmj-1070	15	3	occupational	occupational	ADJ
ghmj-1070	15	4	data	datum	NOUN
ghmj-1070	15	5	,	,	PUNCT
ghmj-1070	15	6	smoking	smoking	NOUN
ghmj-1070	15	7	history	history	NOUN
ghmj-1070	15	8	,	,	PUNCT
ghmj-1070	15	9	family	family	NOUN
ghmj-1070	15	10	history	history	NOUN
ghmj-1070	15	11	,	,	PUNCT
ghmj-1070	15	12	and	and	CCONJ
ghmj-1070	15	13	staging	staging	NOUN
ghmj-1070	15	14	could	could	AUX
ghmj-1070	15	15	not	not	PART
ghmj-1070	15	16	be	be	AUX
ghmj-1070	15	17	concluded	conclude	VERB
ghmj-1070	15	18	because	because	SCONJ
ghmj-1070	15	19	they	they	PRON
ghmj-1070	15	20	were	be	AUX
ghmj-1070	15	21	not	not	PART
ghmj-1070	15	22	included	include	VERB
ghmj-1070	15	23	in	in	ADP
ghmj-1070	15	24	the	the	DET
ghmj-1070	15	25	medical	medical	ADJ
ghmj-1070	15	26	record	record	NOUN
ghmj-1070	15	27	.	.	PUNCT
ghmj-1070	16	1	keywords	keyword	NOUN
ghmj-1070	16	2	:	:	PUNCT
ghmj-1070	16	3	lung	lung	NOUN
ghmj-1070	16	4	cancer	cancer	NOUN
ghmj-1070	16	5	;	;	PUNCT
ghmj-1070	16	6	demographic	demographic	ADJ
ghmj-1070	16	7	;	;	PUNCT
ghmj-1070	16	8	histopathology	histopathology	NOUN
ghmj-1070	16	9	;	;	PUNCT
ghmj-1070	16	10	staging	stage	VERB
ghmj-1070	16	11	.	.	PUNCT
ghmj-1070	16	12	received	receive	VERB
ghmj-1070	16	13	:	:	PUNCT
ghmj-1070	16	14	25	25	NUM
ghmj-1070	16	15	september	september	PROPN
ghmj-1070	16	16	2024	2024	NUM
ghmj-1070	16	17	reviewed	review	VERB
ghmj-1070	16	18	:	:	PUNCT
ghmj-1070	16	19	19	19	NUM
ghmj-1070	16	20	october	october	NOUN
ghmj-1070	16	21	2024	2024	NUM
ghmj-1070	16	22	revised	revise	VERB
ghmj-1070	16	23	:	:	PUNCT
ghmj-1070	16	24	30	30	NUM
ghmj-1070	16	25	november	november	NOUN
ghmj-1070	16	26	2024	2024	NUM
ghmj-1070	16	27	accepted	accept	VERB
ghmj-1070	16	28	:	:	PUNCT
ghmj-1070	16	29	12	12	NUM
ghmj-1070	16	30	december	december	PROPN
ghmj-1070	16	31	2024	2024	NUM
ghmj-1070	16	32	©	©	PROPN
ghmj-1070	16	33	yayasan	yayasan	PROPN
ghmj-1070	16	34	aliansi	aliansi	PROPN
ghmj-1070	16	35	cendekiawan	cendekiawan	PROPN
ghmj-1070	16	36	indonesia	indonesia	PROPN
ghmj-1070	16	37	thailand	thailand	PROPN
ghmj-1070	16	38	(	(	PUNCT
ghmj-1070	16	39	indonesian	indonesian	ADJ
ghmj-1070	16	40	scholars	scholar	NOUN
ghmj-1070	16	41	’	’	PART
ghmj-1070	16	42	alliance	alliance	NOUN
ghmj-1070	16	43	)	)	PUNCT
ghmj-1070	16	44	.	.	PUNCT
ghmj-1070	17	1	this	this	PRON
ghmj-1070	17	2	is	be	AUX
ghmj-1070	17	3	an	an	DET
ghmj-1070	17	4	open	open	ADJ
ghmj-1070	17	5	-	-	PUNCT
ghmj-1070	17	6	access	access	NOUN
ghmj-1070	17	7	following	follow	VERB
ghmj-1070	17	8	creative	creative	ADJ
ghmj-1070	17	9	commons	common	NOUN
ghmj-1070	17	10	license	license	NOUN
ghmj-1070	17	11	deed	deed	NOUN
ghmj-1070	17	12	attribution	attribution	NOUN
ghmj-1070	17	13	-	-	PUNCT
ghmj-1070	17	14	noncommercial	noncommercial	ADJ
ghmj-1070	17	15	-	-	PUNCT
ghmj-1070	17	16	sharealike	sharealike	ADJ
ghmj-1070	17	17	4.0	4.0	NUM
ghmj-1070	17	18	international	international	ADJ
ghmj-1070	17	19	(	(	PUNCT
ghmj-1070	17	20	cc	cc	NOUN
ghmj-1070	17	21	by	by	ADP
ghmj-1070	17	22	-	-	PUNCT
ghmj-1070	17	23	nc	nc	PROPN
ghmj-1070	17	24	-	-	PUNCT
ghmj-1070	17	25	sa	sa	PROPN
ghmj-1070	17	26	4.0	4.0	NUM
ghmj-1070	17	27	)	)	PUNCT
ghmj-1070	17	28	mailto:puterisulaeman2002@gmail.com	mailto:puterisulaeman2002@gmail.com	PROPN
ghmj-1070	17	29	https://doi.org/10.35898/ghmj-741070	https://doi.org/10.35898/ghmj-741070	PROPN
ghmj-1070	17	30	https://orcid.org/0009-0000-0717-6197	https://orcid.org/0009-0000-0717-6197	PROPN
ghmj-1070	17	31	https://orcid.org/0009-0001-4059-3731	https://orcid.org/0009-0001-4059-3731	NOUN
ghmj-1070	17	32	https://orcid.org/0009-0007-0259-8973	https://orcid.org/0009-0007-0259-8973	NOUN
ghmj-1070	17	33	sulaeman	sulaeman	NOUN
ghmj-1070	17	34	,	,	PUNCT
ghmj-1070	17	35	et	et	PROPN
ghmj-1070	17	36	.	.	PUNCT
ghmj-1070	18	1	al	al	PROPN
ghmj-1070	18	2	.	.	PROPN
ghmj-1070	18	3	ghmj	ghmj	PROPN
ghmj-1070	18	4	(	(	PUNCT
ghmj-1070	18	5	global	global	ADJ
ghmj-1070	18	6	health	health	PROPN
ghmj-1070	18	7	management	management	NOUN
ghmj-1070	18	8	journal	journal	PROPN
ghmj-1070	18	9	)	)	PUNCT
ghmj-1070	18	10	2024	2024	NUM
ghmj-1070	18	11	,	,	PUNCT
ghmj-1070	18	12	vol	vol	NOUN
ghmj-1070	18	13	.	.	PROPN
ghmj-1070	18	14	7	7	NUM
ghmj-1070	18	15	,	,	PUNCT
ghmj-1070	18	16	no	no	INTJ
ghmj-1070	18	17	.	.	NOUN
ghmj-1070	18	18	4	4	NUM
ghmj-1070	18	19	294	294	NUM
ghmj-1070	18	20	1	1	NUM
ghmj-1070	18	21	.	.	PUNCT
ghmj-1070	18	22	introduction	introduction	NOUN
ghmj-1070	18	23	the	the	DET
ghmj-1070	18	24	world	world	PROPN
ghmj-1070	18	25	health	health	NOUN
ghmj-1070	18	26	organization	organization	NOUN
ghmj-1070	18	27	,	,	PUNCT
ghmj-1070	18	28	or	or	CCONJ
ghmj-1070	18	29	who	who	PRON
ghmj-1070	18	30	,	,	PUNCT
ghmj-1070	18	31	defined	define	VERB
ghmj-1070	18	32	cancer	cancer	NOUN
ghmj-1070	18	33	as	as	ADP
ghmj-1070	18	34	a	a	DET
ghmj-1070	18	35	condition	condition	NOUN
ghmj-1070	18	36	in	in	ADP
ghmj-1070	18	37	which	which	PRON
ghmj-1070	18	38	abnormal	abnormal	ADJ
ghmj-1070	18	39	cells	cell	NOUN
ghmj-1070	18	40	proliferate	proliferate	VERB
ghmj-1070	18	41	uncontrollably	uncontrollably	ADV
ghmj-1070	18	42	and	and	CCONJ
ghmj-1070	18	43	spread	spread	VERB
ghmj-1070	18	44	to	to	ADP
ghmj-1070	18	45	other	other	ADJ
ghmj-1070	18	46	organs	organ	NOUN
ghmj-1070	18	47	.	.	PUNCT
ghmj-1070	19	1	the	the	DET
ghmj-1070	19	2	most	most	ADV
ghmj-1070	19	3	common	common	ADJ
ghmj-1070	19	4	cause	cause	NOUN
ghmj-1070	19	5	of	of	ADP
ghmj-1070	19	6	mortality	mortality	NOUN
ghmj-1070	19	7	from	from	ADP
ghmj-1070	19	8	cancer	cancer	NOUN
ghmj-1070	19	9	is	be	AUX
ghmj-1070	19	10	metastases	metastasis	NOUN
ghmj-1070	19	11	to	to	ADP
ghmj-1070	19	12	other	other	ADJ
ghmj-1070	19	13	organs	organ	NOUN
ghmj-1070	19	14	.	.	PUNCT
ghmj-1070	20	1	cancer	cancer	NOUN
ghmj-1070	20	2	is	be	AUX
ghmj-1070	20	3	a	a	DET
ghmj-1070	20	4	huge	huge	ADJ
ghmj-1070	20	5	public	public	ADJ
ghmj-1070	20	6	-	-	PUNCT
ghmj-1070	20	7	health	health	NOUN
ghmj-1070	20	8	issue	issue	NOUN
ghmj-1070	20	9	around	around	ADP
ghmj-1070	20	10	the	the	DET
ghmj-1070	20	11	world	world	NOUN
ghmj-1070	20	12	.	.	PUNCT
ghmj-1070	21	1	lung	lung	NOUN
ghmj-1070	21	2	cancer	cancer	NOUN
ghmj-1070	21	3	is	be	AUX
ghmj-1070	21	4	one	one	NUM
ghmj-1070	21	5	of	of	ADP
ghmj-1070	21	6	the	the	DET
ghmj-1070	21	7	most	most	ADV
ghmj-1070	21	8	common	common	ADJ
ghmj-1070	21	9	malignancies	malignancy	NOUN
ghmj-1070	21	10	in	in	ADP
ghmj-1070	21	11	the	the	DET
ghmj-1070	21	12	world	world	NOUN
ghmj-1070	21	13	that	that	PRON
ghmj-1070	21	14	comes	come	VERB
ghmj-1070	21	15	from	from	ADP
ghmj-1070	21	16	the	the	DET
ghmj-1070	21	17	lung	lung	NOUN
ghmj-1070	21	18	parenchyma	parenchyma	NOUN
ghmj-1070	21	19	or	or	CCONJ
ghmj-1070	21	20	bronchi	bronchi	NOUN
ghmj-1070	21	21	(	(	PUNCT
ghmj-1070	21	22	nicholson	nicholson	PROPN
ghmj-1070	21	23	et	et	PROPN
ghmj-1070	21	24	al	al	PROPN
ghmj-1070	21	25	.	.	PROPN
ghmj-1070	21	26	2022	2022	NUM
ghmj-1070	21	27	)	)	PUNCT
ghmj-1070	21	28	.	.	PUNCT
ghmj-1070	22	1	according	accord	VERB
ghmj-1070	22	2	to	to	ADP
ghmj-1070	22	3	global	global	ADJ
ghmj-1070	22	4	burden	burden	NOUN
ghmj-1070	22	5	of	of	ADP
ghmj-1070	22	6	cancer	cancer	NOUN
ghmj-1070	22	7	study	study	NOUN
ghmj-1070	22	8	(	(	PUNCT
ghmj-1070	22	9	globocan	globocan	PROPN
ghmj-1070	22	10	)	)	PUNCT
ghmj-1070	22	11	in	in	ADP
ghmj-1070	22	12	2020	2020	NUM
ghmj-1070	22	13	,	,	PUNCT
ghmj-1070	22	14	in	in	ADP
ghmj-1070	22	15	the	the	DET
ghmj-1070	22	16	world	world	NOUN
ghmj-1070	22	17	,	,	PUNCT
ghmj-1070	22	18	lung	lung	NOUN
ghmj-1070	22	19	cancer	cancer	NOUN
ghmj-1070	22	20	is	be	AUX
ghmj-1070	22	21	the	the	DET
ghmj-1070	22	22	first	first	ADJ
ghmj-1070	22	23	cause	cause	NOUN
ghmj-1070	22	24	of	of	ADP
ghmj-1070	22	25	deaths	death	NOUN
ghmj-1070	22	26	with	with	ADP
ghmj-1070	22	27	1.8	1.8	NUM
ghmj-1070	22	28	million	million	NUM
ghmj-1070	22	29	deaths	death	NOUN
ghmj-1070	22	30	and	and	CCONJ
ghmj-1070	22	31	the	the	DET
ghmj-1070	22	32	second	second	ADJ
ghmj-1070	22	33	highest	high	ADJ
ghmj-1070	22	34	of	of	ADP
ghmj-1070	22	35	new	new	ADJ
ghmj-1070	22	36	cases	case	NOUN
ghmj-1070	22	37	after	after	ADP
ghmj-1070	22	38	breast	breast	NOUN
ghmj-1070	22	39	cancer	cancer	NOUN
ghmj-1070	22	40	.	.	PUNCT
ghmj-1070	23	1	in	in	ADP
ghmj-1070	23	2	asia	asia	PROPN
ghmj-1070	23	3	,	,	PUNCT
ghmj-1070	23	4	the	the	DET
ghmj-1070	23	5	incidences	incidence	NOUN
ghmj-1070	23	6	of	of	ADP
ghmj-1070	23	7	lung	lung	NOUN
ghmj-1070	23	8	cancer	cancer	NOUN
ghmj-1070	23	9	were	be	AUX
ghmj-1070	23	10	higher	high	ADJ
ghmj-1070	23	11	with	with	ADP
ghmj-1070	23	12	an	an	DET
ghmj-1070	23	13	estimated	estimate	VERB
ghmj-1070	23	14	number	number	NOUN
ghmj-1070	23	15	of	of	ADP
ghmj-1070	23	16	1.3	1.3	NUM
ghmj-1070	23	17	million	million	NUM
ghmj-1070	23	18	new	new	ADJ
ghmj-1070	23	19	cases	case	NOUN
ghmj-1070	23	20	.	.	PUNCT
ghmj-1070	24	1	in	in	ADP
ghmj-1070	24	2	indonesia	indonesia	PROPN
ghmj-1070	24	3	,	,	PUNCT
ghmj-1070	24	4	lung	lung	NOUN
ghmj-1070	24	5	cancer	cancer	NOUN
ghmj-1070	24	6	is	be	AUX
ghmj-1070	24	7	the	the	DET
ghmj-1070	24	8	third	third	ADV
ghmj-1070	24	9	highest	high	ADJ
ghmj-1070	24	10	(	(	PUNCT
ghmj-1070	24	11	8.8	8.8	NUM
ghmj-1070	24	12	%	%	NOUN
ghmj-1070	24	13	)	)	PUNCT
ghmj-1070	24	14	after	after	ADP
ghmj-1070	24	15	breast	breast	NOUN
ghmj-1070	24	16	cancer	cancer	NOUN
ghmj-1070	24	17	(	(	PUNCT
ghmj-1070	24	18	16.6	16.6	NUM
ghmj-1070	24	19	%	%	NOUN
ghmj-1070	24	20	)	)	PUNCT
ghmj-1070	24	21	and	and	CCONJ
ghmj-1070	24	22	cervical	cervical	ADJ
ghmj-1070	24	23	cancer	cancer	NOUN
ghmj-1070	24	24	(	(	PUNCT
ghmj-1070	24	25	9.2	9.2	NUM
ghmj-1070	24	26	%	%	NOUN
ghmj-1070	24	27	)	)	PUNCT
ghmj-1070	24	28	.	.	PUNCT
ghmj-1070	25	1	in	in	ADP
ghmj-1070	25	2	2019	2019	NUM
ghmj-1070	25	3	,	,	PUNCT
ghmj-1070	25	4	there	there	PRON
ghmj-1070	25	5	were	be	VERB
ghmj-1070	25	6	five	five	NUM
ghmj-1070	25	7	provinces	province	NOUN
ghmj-1070	25	8	with	with	ADP
ghmj-1070	25	9	the	the	DET
ghmj-1070	25	10	highest	high	ADJ
ghmj-1070	25	11	number	number	NOUN
ghmj-1070	25	12	of	of	ADP
ghmj-1070	25	13	lung	lung	NOUN
ghmj-1070	25	14	cancer	cancer	NOUN
ghmj-1070	25	15	patients	patient	NOUN
ghmj-1070	25	16	,	,	PUNCT
ghmj-1070	25	17	namely	namely	ADV
ghmj-1070	25	18	east	east	PROPN
ghmj-1070	25	19	java	java	PROPN
ghmj-1070	25	20	,	,	PUNCT
ghmj-1070	25	21	jakarta	jakarta	PROPN
ghmj-1070	25	22	,	,	PUNCT
ghmj-1070	25	23	central	central	ADJ
ghmj-1070	25	24	java	java	PROPN
ghmj-1070	25	25	,	,	PUNCT
ghmj-1070	25	26	west	west	PROPN
ghmj-1070	25	27	java	java	PROPN
ghmj-1070	25	28	and	and	CCONJ
ghmj-1070	25	29	south	south	PROPN
ghmj-1070	25	30	sumatra	sumatra	PROPN
ghmj-1070	25	31	(	(	PUNCT
ghmj-1070	25	32	ferlay	ferlay	PROPN
ghmj-1070	25	33	,	,	PUNCT
ghmj-1070	25	34	et	et	NOUN
ghmj-1070	25	35	.	.	PUNCT
ghmj-1070	26	1	al	al	PROPN
ghmj-1070	26	2	.	.	PROPN
ghmj-1070	26	3	,	,	PUNCT
ghmj-1070	26	4	2024	2024	NUM
ghmj-1070	26	5	)	)	PUNCT
ghmj-1070	26	6	.	.	PUNCT
ghmj-1070	27	1	based	base	VERB
ghmj-1070	27	2	on	on	ADP
ghmj-1070	27	3	gender	gender	NOUN
ghmj-1070	27	4	,	,	PUNCT
ghmj-1070	27	5	lung	lung	NOUN
ghmj-1070	27	6	cancer	cancer	NOUN
ghmj-1070	27	7	is	be	AUX
ghmj-1070	27	8	mostly	mostly	ADV
ghmj-1070	27	9	found	find	VERB
ghmj-1070	27	10	in	in	ADP
ghmj-1070	27	11	male	male	NOUN
ghmj-1070	27	12	with	with	ADP
ghmj-1070	27	13	25,943	25,943	NUM
ghmj-1070	27	14	(	(	PUNCT
ghmj-1070	27	15	14.1	14.1	NUM
ghmj-1070	27	16	%	%	NOUN
ghmj-1070	27	17	)	)	PUNCT
ghmj-1070	27	18	new	new	ADJ
ghmj-1070	27	19	cases	case	NOUN
ghmj-1070	27	20	,	,	PUNCT
ghmj-1070	27	21	while	while	SCONJ
ghmj-1070	27	22	female	female	ADJ
ghmj-1070	27	23	has	have	VERB
ghmj-1070	27	24	a	a	DET
ghmj-1070	27	25	lower	low	ADJ
ghmj-1070	27	26	incidence	incidence	NOUN
ghmj-1070	27	27	than	than	ADP
ghmj-1070	27	28	male	male	ADJ
ghmj-1070	27	29	with	with	ADP
ghmj-1070	27	30	8,840	8,840	NUM
ghmj-1070	27	31	(	(	PUNCT
ghmj-1070	27	32	4.1	4.1	NUM
ghmj-1070	27	33	%	%	NOUN
ghmj-1070	27	34	)	)	PUNCT
ghmj-1070	27	35	cases	case	NOUN
ghmj-1070	27	36	in	in	ADP
ghmj-1070	27	37	2020	2020	NUM
ghmj-1070	27	38	(	(	PUNCT
ghmj-1070	27	39	ferlay	ferlay	NOUN
ghmj-1070	27	40	,	,	PUNCT
ghmj-1070	27	41	et	et	NOUN
ghmj-1070	27	42	.	.	PUNCT
ghmj-1070	28	1	al	al	PROPN
ghmj-1070	28	2	.	.	PROPN
ghmj-1070	28	3	,	,	PUNCT
ghmj-1070	28	4	2024	2024	NUM
ghmj-1070	28	5	)	)	PUNCT
ghmj-1070	28	6	.	.	PUNCT
ghmj-1070	29	1	smoking	smoking	NOUN
ghmj-1070	29	2	is	be	AUX
ghmj-1070	29	3	a	a	DET
ghmj-1070	29	4	primary	primary	ADJ
ghmj-1070	29	5	risk	risk	NOUN
ghmj-1070	29	6	factor	factor	NOUN
ghmj-1070	29	7	for	for	ADP
ghmj-1070	29	8	lung	lung	NOUN
ghmj-1070	29	9	cancer	cancer	NOUN
ghmj-1070	29	10	.	.	PUNCT
ghmj-1070	30	1	the	the	DET
ghmj-1070	30	2	highest	high	ADJ
ghmj-1070	30	3	risk	risk	NOUN
ghmj-1070	30	4	was	be	AUX
ghmj-1070	30	5	found	find	VERB
ghmj-1070	30	6	in	in	ADP
ghmj-1070	30	7	male	male	ADJ
ghmj-1070	30	8	smokers	smoker	NOUN
ghmj-1070	30	9	.	.	PUNCT
ghmj-1070	31	1	passive	passive	ADJ
ghmj-1070	31	2	smokers	smoker	NOUN
ghmj-1070	31	3	are	be	AUX
ghmj-1070	31	4	20	20	NUM
ghmj-1070	31	5	-	-	SYM
ghmj-1070	31	6	30	30	NUM
ghmj-1070	31	7	%	%	NOUN
ghmj-1070	31	8	more	more	ADV
ghmj-1070	31	9	susceptible	susceptible	ADJ
ghmj-1070	31	10	to	to	ADP
ghmj-1070	31	11	lung	lung	NOUN
ghmj-1070	31	12	cancer	cancer	NOUN
ghmj-1070	31	13	.	.	PUNCT
ghmj-1070	32	1	riskesda	riskesda	NOUN
ghmj-1070	32	2	in	in	ADP
ghmj-1070	32	3	2018	2018	NUM
ghmj-1070	32	4	reported	report	VERB
ghmj-1070	32	5	that	that	SCONJ
ghmj-1070	32	6	around	around	ADV
ghmj-1070	32	7	34	34	NUM
ghmj-1070	32	8	%	%	NOUN
ghmj-1070	32	9	of	of	ADP
ghmj-1070	32	10	the	the	DET
ghmj-1070	32	11	indonesian	indonesian	ADJ
ghmj-1070	32	12	population	population	NOUN
ghmj-1070	32	13	is	be	AUX
ghmj-1070	32	14	a	a	DET
ghmj-1070	32	15	smoker	smoker	NOUN
ghmj-1070	32	16	and	and	CCONJ
ghmj-1070	32	17	the	the	DET
ghmj-1070	32	18	country	country	NOUN
ghmj-1070	32	19	with	with	ADP
ghmj-1070	32	20	the	the	DET
ghmj-1070	32	21	most	most	ADJ
ghmj-1070	32	22	smokers	smoker	NOUN
ghmj-1070	32	23	in	in	ADP
ghmj-1070	32	24	the	the	DET
ghmj-1070	32	25	entire	entire	ADJ
ghmj-1070	32	26	globe	globe	NOUN
ghmj-1070	32	27	(	(	PUNCT
ghmj-1070	32	28	kementrian	kementrian	NOUN
ghmj-1070	32	29	kesehatan	kesehatan	PROPN
ghmj-1070	32	30	republik	republik	PROPN
ghmj-1070	32	31	indonesia	indonesia	PROPN
ghmj-1070	32	32	,	,	PUNCT
ghmj-1070	32	33	2019	2019	NUM
ghmj-1070	32	34	)	)	PUNCT
ghmj-1070	32	35	.	.	PUNCT
ghmj-1070	33	1	another	another	DET
ghmj-1070	33	2	risk	risk	NOUN
ghmj-1070	33	3	factor	factor	NOUN
ghmj-1070	33	4	is	be	AUX
ghmj-1070	33	5	exposure	exposure	NOUN
ghmj-1070	33	6	to	to	ADP
ghmj-1070	33	7	asbestos	asbestos	NOUN
ghmj-1070	33	8	and	and	CCONJ
ghmj-1070	33	9	radon	radon	NOUN
ghmj-1070	33	10	.	.	PUNCT
ghmj-1070	34	1	exposure	exposure	NOUN
ghmj-1070	34	2	to	to	ADP
ghmj-1070	34	3	asbestos	asbestos	NOUN
ghmj-1070	34	4	,	,	PUNCT
ghmj-1070	34	5	especially	especially	ADV
ghmj-1070	34	6	in	in	ADP
ghmj-1070	34	7	the	the	DET
ghmj-1070	34	8	workplace	workplace	NOUN
ghmj-1070	34	9	could	could	AUX
ghmj-1070	34	10	increase	increase	VERB
ghmj-1070	34	11	the	the	DET
ghmj-1070	34	12	risk	risk	NOUN
ghmj-1070	34	13	of	of	ADP
ghmj-1070	34	14	lung	lung	NOUN
ghmj-1070	34	15	cancer	cancer	NOUN
ghmj-1070	34	16	depending	depend	VERB
ghmj-1070	34	17	on	on	ADP
ghmj-1070	34	18	how	how	SCONJ
ghmj-1070	34	19	frequent	frequent	ADJ
ghmj-1070	34	20	the	the	DET
ghmj-1070	34	21	exposure	exposure	NOUN
ghmj-1070	34	22	is	be	AUX
ghmj-1070	34	23	(	(	PUNCT
ghmj-1070	34	24	buana	buana	PROPN
ghmj-1070	34	25	and	and	CCONJ
ghmj-1070	34	26	agustian	agustian	PROPN
ghmj-1070	34	27	harahap	harahap	PROPN
ghmj-1070	34	28	,	,	PUNCT
ghmj-1070	34	29	2022	2022	NUM
ghmj-1070	34	30	)	)	PUNCT
ghmj-1070	34	31	.	.	PUNCT
ghmj-1070	35	1	the	the	DET
ghmj-1070	35	2	probability	probability	NOUN
ghmj-1070	35	3	of	of	ADP
ghmj-1070	35	4	lung	lung	NOUN
ghmj-1070	35	5	cancer	cancer	NOUN
ghmj-1070	35	6	developed	develop	VERB
ghmj-1070	35	7	with	with	ADP
ghmj-1070	35	8	age	age	NOUN
ghmj-1070	35	9	,	,	PUNCT
ghmj-1070	35	10	as	as	SCONJ
ghmj-1070	35	11	the	the	DET
ghmj-1070	35	12	disease	disease	NOUN
ghmj-1070	35	13	progressed	progress	VERB
ghmj-1070	35	14	before	before	SCONJ
ghmj-1070	35	15	symptoms	symptom	NOUN
ghmj-1070	35	16	manifested	manifest	VERB
ghmj-1070	35	17	.	.	PUNCT
ghmj-1070	36	1	in	in	ADP
ghmj-1070	36	2	general	general	ADJ
ghmj-1070	36	3	,	,	PUNCT
ghmj-1070	36	4	83	83	NUM
ghmj-1070	36	5	%	%	NOUN
ghmj-1070	36	6	of	of	ADP
ghmj-1070	36	7	cases	case	NOUN
ghmj-1070	36	8	are	be	AUX
ghmj-1070	36	9	diagnosed	diagnose	VERB
ghmj-1070	36	10	at	at	ADP
ghmj-1070	36	11	age	age	NOUN
ghmj-1070	36	12	70	70	NUM
ghmj-1070	36	13	or	or	CCONJ
ghmj-1070	36	14	older	old	ADJ
ghmj-1070	36	15	.	.	PUNCT
ghmj-1070	37	1	nsclc	nsclc	PROPN
ghmj-1070	37	2	occurs	occur	VERB
ghmj-1070	37	3	most	most	ADV
ghmj-1070	37	4	frequently	frequently	ADV
ghmj-1070	37	5	in	in	ADP
ghmj-1070	37	6	male	male	NOUN
ghmj-1070	37	7	between	between	ADP
ghmj-1070	37	8	the	the	DET
ghmj-1070	37	9	ages	age	NOUN
ghmj-1070	37	10	of	of	ADP
ghmj-1070	37	11	80	80	NUM
ghmj-1070	37	12	-	-	SYM
ghmj-1070	37	13	84	84	NUM
ghmj-1070	37	14	years	year	NOUN
ghmj-1070	37	15	,	,	PUNCT
ghmj-1070	37	16	and	and	CCONJ
ghmj-1070	37	17	in	in	ADP
ghmj-1070	37	18	female	female	NOUN
ghmj-1070	37	19	between	between	ADP
ghmj-1070	37	20	the	the	DET
ghmj-1070	37	21	ages	age	NOUN
ghmj-1070	37	22	of	of	ADP
ghmj-1070	37	23	75	75	NUM
ghmj-1070	37	24	-	-	SYM
ghmj-1070	37	25	79	79	NUM
ghmj-1070	37	26	years	year	NOUN
ghmj-1070	37	27	.	.	PUNCT
ghmj-1070	38	1	sclc	sclc	PROPN
ghmj-1070	38	2	occurs	occur	VERB
ghmj-1070	38	3	most	most	ADV
ghmj-1070	38	4	commonly	commonly	ADV
ghmj-1070	38	5	in	in	ADP
ghmj-1070	38	6	male	male	ADJ
ghmj-1070	38	7	and	and	CCONJ
ghmj-1070	38	8	female	female	ADJ
ghmj-1070	38	9	between	between	ADP
ghmj-1070	38	10	the	the	DET
ghmj-1070	38	11	ages	age	NOUN
ghmj-1070	38	12	of	of	ADP
ghmj-1070	38	13	75	75	NUM
ghmj-1070	38	14	-	-	SYM
ghmj-1070	38	15	79	79	NUM
ghmj-1070	38	16	years	year	NOUN
ghmj-1070	38	17	.	.	PUNCT
ghmj-1070	39	1	there	there	PRON
ghmj-1070	39	2	are	be	VERB
ghmj-1070	39	3	two	two	NUM
ghmj-1070	39	4	categories	category	NOUN
ghmj-1070	39	5	of	of	ADP
ghmj-1070	39	6	lung	lung	NOUN
ghmj-1070	39	7	cancer	cancer	NOUN
ghmj-1070	39	8	:	:	PUNCT
ghmj-1070	39	9	14	14	NUM
ghmj-1070	39	10	%	%	NOUN
ghmj-1070	39	11	are	be	AUX
ghmj-1070	39	12	sclc	sclc	PROPN
ghmj-1070	39	13	and	and	CCONJ
ghmj-1070	39	14	81	81	NUM
ghmj-1070	39	15	%	%	NOUN
ghmj-1070	39	16	are	be	AUX
ghmj-1070	39	17	nsclc.(american	nsclc.(american	ADP
ghmj-1070	39	18	cancer	cancer	NOUN
ghmj-1070	39	19	society	society	NOUN
ghmj-1070	39	20	2023	2023	NUM
ghmj-1070	39	21	)	)	PUNCT
ghmj-1070	39	22	there	there	PRON
ghmj-1070	39	23	are	be	VERB
ghmj-1070	39	24	various	various	ADJ
ghmj-1070	39	25	kinds	kind	NOUN
ghmj-1070	39	26	of	of	ADP
ghmj-1070	39	27	nsclc	nsclc	NOUN
ghmj-1070	39	28	,	,	PUNCT
ghmj-1070	39	29	including	include	VERB
ghmj-1070	39	30	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	39	31	,	,	PUNCT
ghmj-1070	39	32	squamous	squamous	ADJ
ghmj-1070	39	33	cell	cell	NOUN
ghmj-1070	39	34	carcinoma	carcinoma	NOUN
ghmj-1070	39	35	(	(	PUNCT
ghmj-1070	39	36	scc	scc	NOUN
ghmj-1070	39	37	)	)	PUNCT
ghmj-1070	39	38	,	,	PUNCT
ghmj-1070	39	39	and	and	CCONJ
ghmj-1070	39	40	large	large	ADJ
ghmj-1070	39	41	cell	cell	NOUN
ghmj-1070	39	42	carcinoma	carcinoma	NOUN
ghmj-1070	39	43	(	(	PUNCT
ghmj-1070	39	44	lcc	lcc	PROPN
ghmj-1070	39	45	)	)	PUNCT
ghmj-1070	39	46	.	.	PUNCT
ghmj-1070	40	1	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	40	2	is	be	AUX
ghmj-1070	40	3	a	a	DET
ghmj-1070	40	4	malignant	malignant	ADJ
ghmj-1070	40	5	tumor	tumor	NOUN
ghmj-1070	40	6	that	that	PRON
ghmj-1070	40	7	has	have	VERB
ghmj-1070	40	8	glandular	glandular	ADJ
ghmj-1070	40	9	differentiation	differentiation	NOUN
ghmj-1070	40	10	.	.	PUNCT
ghmj-1070	41	1	a	a	DET
ghmj-1070	41	2	malignant	malignant	ADJ
ghmj-1070	41	3	epithelial	epithelial	ADJ
ghmj-1070	41	4	tumor	tumor	NOUN
ghmj-1070	41	5	that	that	PRON
ghmj-1070	41	6	has	have	VERB
ghmj-1070	41	7	keratinization	keratinization	NOUN
ghmj-1070	41	8	from	from	ADP
ghmj-1070	41	9	the	the	DET
ghmj-1070	41	10	bronchial	bronchial	ADJ
ghmj-1070	41	11	epithelium	epithelium	NOUN
ghmj-1070	41	12	is	be	AUX
ghmj-1070	41	13	called	call	VERB
ghmj-1070	41	14	squamous	squamous	ADJ
ghmj-1070	41	15	cell	cell	NOUN
ghmj-1070	41	16	carcinoma	carcinoma	NOUN
ghmj-1070	41	17	.	.	PUNCT
ghmj-1070	42	1	undifferentiated	undifferentiated	ADJ
ghmj-1070	42	2	carcinomas	carcinoma	NOUN
ghmj-1070	42	3	are	be	AUX
ghmj-1070	42	4	large	large	ADJ
ghmj-1070	42	5	cell	cell	NOUN
ghmj-1070	42	6	carcinomas	carcinoma	NOUN
ghmj-1070	42	7	(	(	PUNCT
ghmj-1070	42	8	travis	travis	PROPN
ghmj-1070	42	9	,	,	PUNCT
ghmj-1070	42	10	brambilla	brambilla	NOUN
ghmj-1070	42	11	,	,	PUNCT
ghmj-1070	42	12	and	and	CCONJ
ghmj-1070	42	13	mullerhermelink	mullerhermelink	ADJ
ghmj-1070	42	14	,	,	PUNCT
ghmj-1070	42	15	2005	2005	NUM
ghmj-1070	42	16	)	)	PUNCT
ghmj-1070	42	17	.	.	PUNCT
ghmj-1070	43	1	this	this	DET
ghmj-1070	43	2	research	research	NOUN
ghmj-1070	43	3	aimed	aim	VERB
ghmj-1070	43	4	to	to	PART
ghmj-1070	43	5	determine	determine	VERB
ghmj-1070	43	6	the	the	DET
ghmj-1070	43	7	demographics	demographic	NOUN
ghmj-1070	43	8	and	and	CCONJ
ghmj-1070	43	9	histopathological	histopathological	ADJ
ghmj-1070	43	10	characteristics	characteristic	NOUN
ghmj-1070	43	11	of	of	ADP
ghmj-1070	43	12	lung	lung	NOUN
ghmj-1070	43	13	cancer	cancer	NOUN
ghmj-1070	43	14	in	in	ADP
ghmj-1070	43	15	cirebon	cirebon	NOUN
ghmj-1070	43	16	district	district	NOUN
ghmj-1070	43	17	from	from	ADP
ghmj-1070	43	18	2021	2021	NUM
ghmj-1070	43	19	to	to	ADP
ghmj-1070	43	20	2023	2023	NUM
ghmj-1070	43	21	.	.	PUNCT
ghmj-1070	44	1	2	2	X
ghmj-1070	44	2	.	.	X
ghmj-1070	44	3	methods	method	NOUN
ghmj-1070	44	4	study	study	NOUN
ghmj-1070	44	5	design	design	VERB
ghmj-1070	44	6	this	this	DET
ghmj-1070	44	7	research	research	NOUN
ghmj-1070	44	8	employed	employ	VERB
ghmj-1070	44	9	a	a	DET
ghmj-1070	44	10	descriptive	descriptive	ADJ
ghmj-1070	44	11	observational	observational	ADJ
ghmj-1070	44	12	method	method	NOUN
ghmj-1070	44	13	.	.	PUNCT
ghmj-1070	45	1	this	this	DET
ghmj-1070	45	2	research	research	NOUN
ghmj-1070	45	3	is	be	AUX
ghmj-1070	45	4	a	a	DET
ghmj-1070	45	5	cross	cross	ADJ
ghmj-1070	45	6	-	-	ADJ
ghmj-1070	45	7	sectional	sectional	ADJ
ghmj-1070	45	8	study	study	NOUN
ghmj-1070	45	9	conducted	conduct	VERB
ghmj-1070	45	10	at	at	ADP
ghmj-1070	45	11	rsud	rsud	PROPN
ghmj-1070	45	12	waled	wale	VERB
ghmj-1070	45	13	cirebon	cirebon	NOUN
ghmj-1070	45	14	and	and	CCONJ
ghmj-1070	45	15	rsud	rsud	VERB
ghmj-1070	45	16	arjawinangun	arjawinangun	NOUN
ghmj-1070	45	17	.	.	PUNCT
ghmj-1070	46	1	this	this	DET
ghmj-1070	46	2	research	research	NOUN
ghmj-1070	46	3	has	have	AUX
ghmj-1070	46	4	been	be	AUX
ghmj-1070	46	5	approved	approve	VERB
ghmj-1070	46	6	by	by	ADP
ghmj-1070	46	7	the	the	DET
ghmj-1070	46	8	health	health	NOUN
ghmj-1070	46	9	research	research	NOUN
ghmj-1070	46	10	and	and	CCONJ
ghmj-1070	46	11	development	development	NOUN
ghmj-1070	46	12	ethics	ethic	NOUN
ghmj-1070	46	13	committee	committee	PROPN
ghmj-1070	46	14	of	of	ADP
ghmj-1070	46	15	rsud	rsud	PROPN
ghmj-1070	46	16	arjawinangun	arjawinangun	PROPN
ghmj-1070	46	17	(	(	PUNCT
ghmj-1070	46	18	ethical	ethical	ADJ
ghmj-1070	46	19	approval	approval	NOUN
ghmj-1070	46	20	427.9	427.9	NUM
ghmj-1070	46	21	/	/	SYM
ghmj-1070	46	22	kkepk.24	kkepk.24	NOUN
ghmj-1070	46	23	/	/	SYM
ghmj-1070	46	24	vi	vi	NOUN
ghmj-1070	46	25	/	/	SYM
ghmj-1070	46	26	rsud	rsud	X
ghmj-1070	46	27	awn/2024	awn/2024	NOUN
ghmj-1070	46	28	)	)	PUNCT
ghmj-1070	46	29	.	.	PUNCT
ghmj-1070	47	1	research	research	NOUN
ghmj-1070	47	2	license	license	NOUN
ghmj-1070	47	3	has	have	AUX
ghmj-1070	47	4	also	also	ADV
ghmj-1070	47	5	been	be	AUX
ghmj-1070	47	6	obtained	obtain	VERB
ghmj-1070	47	7	by	by	ADP
ghmj-1070	47	8	rsud	rsud	PROPN
ghmj-1070	47	9	waled	wale	VERB
ghmj-1070	47	10	cirebon	cirebon	NOUN
ghmj-1070	47	11	(	(	PUNCT
ghmj-1070	47	12	number	number	NOUN
ghmj-1070	47	13	:	:	PUNCT
ghmj-1070	47	14	800.2.2.1/1297	800.2.2.1/1297	NOUN
ghmj-1070	47	15	-	-	PUNCT
ghmj-1070	47	16	diklit/2024	diklit/2024	NOUN
ghmj-1070	47	17	)	)	PUNCT
ghmj-1070	47	18	and	and	CCONJ
ghmj-1070	47	19	rsud	rsud	VERB
ghmj-1070	47	20	arjawinangun	arjawinangun	NOUN
ghmj-1070	47	21	(	(	PUNCT
ghmj-1070	47	22	number	number	NOUN
ghmj-1070	47	23	:	:	PUNCT
ghmj-1070	47	24	447.26/7506	447.26/7506	NUM
ghmj-1070	47	25	/	/	SYM
ghmj-1070	47	26	rsudawn	rsudawn	NOUN
ghmj-1070	47	27	)	)	PUNCT
ghmj-1070	47	28	.	.	PUNCT
ghmj-1070	48	1	population	population	NOUN
ghmj-1070	48	2	and	and	CCONJ
ghmj-1070	48	3	sample	sample	VERB
ghmj-1070	48	4	the	the	DET
ghmj-1070	48	5	population	population	NOUN
ghmj-1070	48	6	in	in	ADP
ghmj-1070	48	7	this	this	DET
ghmj-1070	48	8	study	study	NOUN
ghmj-1070	48	9	were	be	AUX
ghmj-1070	48	10	all	all	PRON
ghmj-1070	48	11	patients	patient	NOUN
ghmj-1070	48	12	who	who	PRON
ghmj-1070	48	13	diagnosed	diagnose	VERB
ghmj-1070	48	14	with	with	ADP
ghmj-1070	48	15	lung	lung	NOUN
ghmj-1070	48	16	cancer	cancer	NOUN
ghmj-1070	48	17	by	by	ADP
ghmj-1070	48	18	cytology	cytology	NOUN
ghmj-1070	48	19	and/or	and/or	CCONJ
ghmj-1070	48	20	histopathology	histopathology	NOUN
ghmj-1070	48	21	in	in	ADP
ghmj-1070	48	22	2021	2021	NUM
ghmj-1070	48	23	to	to	ADP
ghmj-1070	48	24	2023	2023	NUM
ghmj-1070	48	25	.	.	PUNCT
ghmj-1070	49	1	data	datum	NOUN
ghmj-1070	49	2	were	be	AUX
ghmj-1070	49	3	acquired	acquire	VERB
ghmj-1070	49	4	from	from	ADP
ghmj-1070	49	5	medical	medical	ADJ
ghmj-1070	49	6	records	record	NOUN
ghmj-1070	49	7	of	of	ADP
ghmj-1070	49	8	lung	lung	NOUN
ghmj-1070	49	9	cancer	cancer	NOUN
ghmj-1070	49	10	patients	patient	NOUN
ghmj-1070	49	11	at	at	ADP
ghmj-1070	49	12	rsud	rsud	PROPN
ghmj-1070	49	13	waled	wale	VERB
ghmj-1070	49	14	cirebon	cirebon	NOUN
ghmj-1070	49	15	and	and	CCONJ
ghmj-1070	49	16	rsud	rsud	VERB
ghmj-1070	49	17	arjawinangun	arjawinangun	NOUN
ghmj-1070	49	18	in	in	ADP
ghmj-1070	49	19	2021	2021	NUM
ghmj-1070	49	20	-	-	SYM
ghmj-1070	49	21	2023	2023	NUM
ghmj-1070	49	22	using	use	VERB
ghmj-1070	49	23	the	the	DET
ghmj-1070	49	24	total	total	ADJ
ghmj-1070	49	25	sampling	sample	VERB
ghmj-1070	49	26	technique	technique	NOUN
ghmj-1070	49	27	.	.	PUNCT
ghmj-1070	50	1	inclusion	inclusion	NOUN
ghmj-1070	50	2	criteria	criterion	NOUN
ghmj-1070	50	3	;	;	PUNCT
ghmj-1070	50	4	patients	patient	NOUN
ghmj-1070	50	5	diagnosed	diagnose	VERB
ghmj-1070	50	6	with	with	ADP
ghmj-1070	50	7	lung	lung	NOUN
ghmj-1070	50	8	cancer	cancer	NOUN
ghmj-1070	50	9	by	by	ADP
ghmj-1070	50	10	cytology	cytology	NOUN
ghmj-1070	50	11	and/or	and/or	CCONJ
ghmj-1070	50	12	histopathology	histopathology	NOUN
ghmj-1070	50	13	when	when	SCONJ
ghmj-1070	50	14	admitted	admit	VERB
ghmj-1070	50	15	to	to	PART
ghmj-1070	50	16	rsud	rsud	VERB
ghmj-1070	50	17	waled	wale	VERB
ghmj-1070	50	18	cirebon	cirebon	NOUN
ghmj-1070	50	19	and	and	CCONJ
ghmj-1070	50	20	rsud	rsud	VERB
ghmj-1070	50	21	arjawinangun	arjawinangun	NOUN
ghmj-1070	50	22	in	in	ADP
ghmj-1070	50	23	2021	2021	NUM
ghmj-1070	50	24	-	-	SYM
ghmj-1070	50	25	2023	2023	NUM
ghmj-1070	50	26	and	and	CCONJ
ghmj-1070	50	27	patient	patient	NOUN
ghmj-1070	50	28	’s	’s	PART
ghmj-1070	50	29	medical	medical	ADJ
ghmj-1070	50	30	records	record	NOUN
ghmj-1070	50	31	contained	contain	VERB
ghmj-1070	50	32	main	main	ADJ
ghmj-1070	50	33	data	datum	NOUN
ghmj-1070	50	34	regarding	regard	VERB
ghmj-1070	50	35	age	age	NOUN
ghmj-1070	50	36	,	,	PUNCT
ghmj-1070	50	37	gender	gender	NOUN
ghmj-1070	50	38	and	and	CCONJ
ghmj-1070	50	39	histopathological	histopathological	ADJ
ghmj-1070	50	40	features	feature	NOUN
ghmj-1070	50	41	as	as	ADV
ghmj-1070	50	42	well	well	ADV
ghmj-1070	50	43	as	as	ADP
ghmj-1070	50	44	additional	additional	ADJ
ghmj-1070	50	45	data	datum	NOUN
ghmj-1070	50	46	such	such	ADJ
ghmj-1070	50	47	as	as	ADP
ghmj-1070	50	48	smoking	smoking	NOUN
ghmj-1070	50	49	history	history	NOUN
ghmj-1070	50	50	,	,	PUNCT
ghmj-1070	50	51	family	family	NOUN
ghmj-1070	50	52	history	history	NOUN
ghmj-1070	50	53	,	,	PUNCT
ghmj-1070	50	54	occupational	occupational	ADJ
ghmj-1070	50	55	data	datum	NOUN
ghmj-1070	50	56	and	and	CCONJ
ghmj-1070	50	57	staging	staging	NOUN
ghmj-1070	50	58	.	.	PUNCT
ghmj-1070	51	1	exclusion	exclusion	NOUN
ghmj-1070	51	2	criteria	criterion	NOUN
ghmj-1070	51	3	,	,	PUNCT
ghmj-1070	51	4	related	relate	VERB
ghmj-1070	51	5	to	to	ADP
ghmj-1070	51	6	the	the	DET
ghmj-1070	51	7	main	main	ADJ
ghmj-1070	51	8	data	datum	NOUN
ghmj-1070	51	9	including	include	VERB
ghmj-1070	51	10	age	age	NOUN
ghmj-1070	51	11	,	,	PUNCT
ghmj-1070	51	12	gender	gender	NOUN
ghmj-1070	51	13	,	,	PUNCT
ghmj-1070	51	14	and	and	CCONJ
ghmj-1070	51	15	histopathological	histopathological	ADJ
ghmj-1070	51	16	features	feature	NOUN
ghmj-1070	51	17	are	be	AUX
ghmj-1070	51	18	not	not	PART
ghmj-1070	51	19	sulaeman	sulaeman	NOUN
ghmj-1070	51	20	,	,	PUNCT
ghmj-1070	51	21	et	et	NOUN
ghmj-1070	51	22	.	.	PUNCT
ghmj-1070	52	1	al	al	PROPN
ghmj-1070	52	2	.	.	PROPN
ghmj-1070	52	3	ghmj	ghmj	PROPN
ghmj-1070	52	4	(	(	PUNCT
ghmj-1070	52	5	global	global	ADJ
ghmj-1070	52	6	health	health	PROPN
ghmj-1070	52	7	management	management	NOUN
ghmj-1070	52	8	journal	journal	PROPN
ghmj-1070	52	9	)	)	PUNCT
ghmj-1070	52	10	2024	2024	NUM
ghmj-1070	52	11	,	,	PUNCT
ghmj-1070	52	12	vol	vol	NOUN
ghmj-1070	52	13	.	.	PROPN
ghmj-1070	52	14	7	7	NUM
ghmj-1070	52	15	,	,	PUNCT
ghmj-1070	52	16	no	no	INTJ
ghmj-1070	52	17	.	.	NOUN
ghmj-1070	52	18	4	4	NUM
ghmj-1070	52	19	295	295	NUM
ghmj-1070	52	20	contained	contain	VERB
ghmj-1070	52	21	in	in	ADP
ghmj-1070	52	22	the	the	DET
ghmj-1070	52	23	patient	patient	NOUN
ghmj-1070	52	24	's	's	PART
ghmj-1070	52	25	medical	medical	ADJ
ghmj-1070	52	26	record	record	NOUN
ghmj-1070	52	27	.	.	PUNCT
ghmj-1070	53	1	this	this	DET
ghmj-1070	53	2	study	study	NOUN
ghmj-1070	53	3	had	have	VERB
ghmj-1070	53	4	a	a	DET
ghmj-1070	53	5	total	total	ADJ
ghmj-1070	53	6	population	population	NOUN
ghmj-1070	53	7	of	of	ADP
ghmj-1070	53	8	121	121	NUM
ghmj-1070	53	9	patients	patient	NOUN
ghmj-1070	53	10	,	,	PUNCT
ghmj-1070	53	11	with	with	ADP
ghmj-1070	53	12	69	69	NUM
ghmj-1070	53	13	of	of	ADP
ghmj-1070	53	14	them	they	PRON
ghmj-1070	53	15	meeting	meet	VERB
ghmj-1070	53	16	the	the	DET
ghmj-1070	53	17	inclusion	inclusion	NOUN
ghmj-1070	53	18	criteria	criterion	NOUN
ghmj-1070	53	19	.	.	PUNCT
ghmj-1070	54	1	this	this	DET
ghmj-1070	54	2	research	research	NOUN
ghmj-1070	54	3	was	be	AUX
ghmj-1070	54	4	conducted	conduct	VERB
ghmj-1070	54	5	in	in	ADP
ghmj-1070	54	6	may	may	PROPN
ghmj-1070	54	7	2024	2024	NUM
ghmj-1070	54	8	at	at	ADP
ghmj-1070	54	9	rsud	rsud	PROPN
ghmj-1070	54	10	waled	wale	VERB
ghmj-1070	54	11	cirebon	cirebon	NOUN
ghmj-1070	54	12	and	and	CCONJ
ghmj-1070	54	13	rsud	rsud	VERB
ghmj-1070	54	14	arjawinangun	arjawinangun	NOUN
ghmj-1070	54	15	.	.	PUNCT
ghmj-1070	55	1	measurements	measurement	VERB
ghmj-1070	55	2	the	the	DET
ghmj-1070	55	3	research	research	NOUN
ghmj-1070	55	4	variables	variable	NOUN
ghmj-1070	55	5	include	include	VERB
ghmj-1070	55	6	lung	lung	NOUN
ghmj-1070	55	7	cancer	cancer	NOUN
ghmj-1070	55	8	patients	patient	NOUN
ghmj-1070	55	9	demographics	demographic	NOUN
ghmj-1070	55	10	,	,	PUNCT
ghmj-1070	55	11	such	such	ADJ
ghmj-1070	55	12	as	as	ADP
ghmj-1070	55	13	age	age	NOUN
ghmj-1070	55	14	,	,	PUNCT
ghmj-1070	55	15	gender	gender	NOUN
ghmj-1070	55	16	,	,	PUNCT
ghmj-1070	55	17	occupation	occupation	NOUN
ghmj-1070	55	18	,	,	PUNCT
ghmj-1070	55	19	smoking	smoking	NOUN
ghmj-1070	55	20	history	history	NOUN
ghmj-1070	55	21	and	and	CCONJ
ghmj-1070	55	22	family	family	NOUN
ghmj-1070	55	23	history	history	NOUN
ghmj-1070	55	24	as	as	ADV
ghmj-1070	55	25	well	well	ADV
ghmj-1070	55	26	as	as	ADP
ghmj-1070	55	27	histopathological	histopathological	ADJ
ghmj-1070	55	28	characteristics	characteristic	NOUN
ghmj-1070	55	29	,	,	PUNCT
ghmj-1070	55	30	such	such	ADJ
ghmj-1070	55	31	small	small	ADJ
ghmj-1070	55	32	cell	cell	NOUN
ghmj-1070	55	33	lung	lung	NOUN
ghmj-1070	55	34	cancer	cancer	NOUN
ghmj-1070	55	35	,	,	PUNCT
ghmj-1070	55	36	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	55	37	,	,	PUNCT
ghmj-1070	55	38	squamous	squamous	ADJ
ghmj-1070	55	39	cell	cell	NOUN
ghmj-1070	55	40	carcinoma	carcinoma	NOUN
ghmj-1070	55	41	(	(	PUNCT
ghmj-1070	55	42	scc	scc	NOUN
ghmj-1070	55	43	)	)	PUNCT
ghmj-1070	55	44	,	,	PUNCT
ghmj-1070	56	1	large	large	ADJ
ghmj-1070	56	2	cell	cell	NOUN
ghmj-1070	56	3	carcinoma	carcinoma	NOUN
ghmj-1070	56	4	(	(	PUNCT
ghmj-1070	56	5	lcc	lcc	PROPN
ghmj-1070	56	6	)	)	PUNCT
ghmj-1070	56	7	,	,	PUNCT
ghmj-1070	56	8	and	and	CCONJ
ghmj-1070	56	9	staging	staging	NOUN
ghmj-1070	56	10	.	.	PUNCT
ghmj-1070	57	1	tnm	tnm	PROPN
ghmj-1070	57	2	staging	staging	NOUN
ghmj-1070	57	3	was	be	AUX
ghmj-1070	57	4	used	use	VERB
ghmj-1070	57	5	to	to	PART
ghmj-1070	57	6	identify	identify	VERB
ghmj-1070	57	7	the	the	DET
ghmj-1070	57	8	stage	stage	NOUN
ghmj-1070	57	9	of	of	ADP
ghmj-1070	57	10	lung	lung	NOUN
ghmj-1070	57	11	cancer	cancer	NOUN
ghmj-1070	57	12	.	.	PUNCT
ghmj-1070	58	1	data	datum	NOUN
ghmj-1070	58	2	were	be	AUX
ghmj-1070	58	3	acquired	acquire	VERB
ghmj-1070	58	4	from	from	ADP
ghmj-1070	58	5	medical	medical	ADJ
ghmj-1070	58	6	records	record	NOUN
ghmj-1070	58	7	of	of	ADP
ghmj-1070	58	8	lung	lung	NOUN
ghmj-1070	58	9	cancer	cancer	NOUN
ghmj-1070	58	10	patients	patient	NOUN
ghmj-1070	58	11	at	at	ADP
ghmj-1070	58	12	rsud	rsud	PROPN
ghmj-1070	58	13	waled	wale	VERB
ghmj-1070	58	14	cirebon	cirebon	NOUN
ghmj-1070	58	15	and	and	CCONJ
ghmj-1070	58	16	rsud	rsud	VERB
ghmj-1070	58	17	arjawinangun	arjawinangun	NOUN
ghmj-1070	58	18	in	in	ADP
ghmj-1070	58	19	2021	2021	NUM
ghmj-1070	58	20	-	-	SYM
ghmj-1070	58	21	2023	2023	NUM
ghmj-1070	58	22	.	.	PUNCT
ghmj-1070	59	1	data	datum	NOUN
ghmj-1070	59	2	analysis	analysis	NOUN
ghmj-1070	59	3	the	the	DET
ghmj-1070	59	4	collected	collect	VERB
ghmj-1070	59	5	data	datum	NOUN
ghmj-1070	59	6	were	be	AUX
ghmj-1070	59	7	analyzed	analyze	VERB
ghmj-1070	59	8	using	use	VERB
ghmj-1070	59	9	univariate	univariate	ADJ
ghmj-1070	59	10	analysis	analysis	NOUN
ghmj-1070	59	11	.	.	PUNCT
ghmj-1070	60	1	univariate	univariate	ADJ
ghmj-1070	60	2	analysis	analysis	NOUN
ghmj-1070	60	3	describes	describe	VERB
ghmj-1070	60	4	the	the	DET
ghmj-1070	60	5	characteristics	characteristic	NOUN
ghmj-1070	60	6	of	of	ADP
ghmj-1070	60	7	the	the	DET
ghmj-1070	60	8	demographics	demographic	NOUN
ghmj-1070	60	9	and	and	CCONJ
ghmj-1070	60	10	histopathological	histopathological	ADJ
ghmj-1070	60	11	using	use	VERB
ghmj-1070	60	12	frequency	frequency	NOUN
ghmj-1070	60	13	distribution	distribution	NOUN
ghmj-1070	60	14	and	and	CCONJ
ghmj-1070	60	15	percentage	percentage	NOUN
ghmj-1070	60	16	.	.	PUNCT
ghmj-1070	61	1	data	datum	NOUN
ghmj-1070	61	2	were	be	AUX
ghmj-1070	61	3	processed	process	VERB
ghmj-1070	61	4	using	use	VERB
ghmj-1070	61	5	spss	spss	PROPN
ghmj-1070	61	6	27	27	NUM
ghmj-1070	61	7	software	software	NOUN
ghmj-1070	61	8	.	.	PUNCT
ghmj-1070	62	1	3	3	X
ghmj-1070	62	2	.	.	X
ghmj-1070	62	3	results	result	VERB
ghmj-1070	62	4	the	the	DET
ghmj-1070	62	5	data	datum	NOUN
ghmj-1070	62	6	were	be	AUX
ghmj-1070	62	7	acquired	acquire	VERB
ghmj-1070	62	8	from	from	ADP
ghmj-1070	62	9	medical	medical	ADJ
ghmj-1070	62	10	records	record	NOUN
ghmj-1070	62	11	of	of	ADP
ghmj-1070	62	12	lung	lung	NOUN
ghmj-1070	62	13	cancer	cancer	NOUN
ghmj-1070	62	14	patients	patient	NOUN
ghmj-1070	62	15	at	at	ADP
ghmj-1070	62	16	rsud	rsud	PROPN
ghmj-1070	62	17	waled	wale	VERB
ghmj-1070	62	18	cirebon	cirebon	NOUN
ghmj-1070	62	19	and	and	CCONJ
ghmj-1070	62	20	rsud	rsud	VERB
ghmj-1070	62	21	arjawinangun	arjawinangun	NOUN
ghmj-1070	62	22	in	in	ADP
ghmj-1070	62	23	2021	2021	NUM
ghmj-1070	62	24	-	-	SYM
ghmj-1070	62	25	2023	2023	NUM
ghmj-1070	62	26	using	use	VERB
ghmj-1070	62	27	the	the	DET
ghmj-1070	62	28	total	total	ADJ
ghmj-1070	62	29	sampling	sample	VERB
ghmj-1070	62	30	technique	technique	NOUN
ghmj-1070	62	31	,	,	PUNCT
ghmj-1070	62	32	69	69	NUM
ghmj-1070	62	33	patients	patient	NOUN
ghmj-1070	62	34	who	who	PRON
ghmj-1070	62	35	met	meet	VERB
ghmj-1070	62	36	the	the	DET
ghmj-1070	62	37	inclusion	inclusion	NOUN
ghmj-1070	62	38	criteria	criterion	NOUN
ghmj-1070	62	39	and	and	CCONJ
ghmj-1070	62	40	exclusion	exclusion	NOUN
ghmj-1070	62	41	criteria	criterion	NOUN
ghmj-1070	62	42	were	be	AUX
ghmj-1070	62	43	included	include	VERB
ghmj-1070	62	44	in	in	ADP
ghmj-1070	62	45	this	this	DET
ghmj-1070	62	46	study	study	NOUN
ghmj-1070	62	47	.	.	PUNCT
ghmj-1070	63	1	age	age	NOUN
ghmj-1070	63	2	,	,	PUNCT
ghmj-1070	63	3	sex	sex	NOUN
ghmj-1070	63	4	,	,	PUNCT
ghmj-1070	63	5	occupation	occupation	NOUN
ghmj-1070	63	6	,	,	PUNCT
ghmj-1070	63	7	smoking	smoking	NOUN
ghmj-1070	63	8	history	history	NOUN
ghmj-1070	63	9	,	,	PUNCT
ghmj-1070	63	10	and	and	CCONJ
ghmj-1070	63	11	family	family	NOUN
ghmj-1070	63	12	history	history	NOUN
ghmj-1070	63	13	were	be	AUX
ghmj-1070	63	14	used	use	VERB
ghmj-1070	63	15	to	to	PART
ghmj-1070	63	16	describe	describe	VERB
ghmj-1070	63	17	demographic	demographic	ADJ
ghmj-1070	63	18	characteristics	characteristic	NOUN
ghmj-1070	63	19	.	.	PUNCT
ghmj-1070	64	1	histopathological	histopathological	ADJ
ghmj-1070	64	2	findings	finding	NOUN
ghmj-1070	64	3	and	and	CCONJ
ghmj-1070	64	4	staging	staging	NOUN
ghmj-1070	64	5	were	be	AUX
ghmj-1070	64	6	used	use	VERB
ghmj-1070	64	7	to	to	PART
ghmj-1070	64	8	describe	describe	VERB
ghmj-1070	64	9	the	the	DET
ghmj-1070	64	10	histopathological	histopathological	ADJ
ghmj-1070	64	11	characteristics	characteristic	NOUN
ghmj-1070	64	12	of	of	ADP
ghmj-1070	64	13	lung	lung	NOUN
ghmj-1070	64	14	cancer	cancer	NOUN
ghmj-1070	64	15	.	.	PUNCT
ghmj-1070	65	1	as	as	SCONJ
ghmj-1070	65	2	shown	show	VERB
ghmj-1070	65	3	in	in	ADP
ghmj-1070	65	4	table	table	NOUN
ghmj-1070	65	5	1	1	NUM
ghmj-1070	65	6	,	,	PUNCT
ghmj-1070	65	7	the	the	DET
ghmj-1070	65	8	majority	majority	NOUN
ghmj-1070	65	9	of	of	ADP
ghmj-1070	65	10	patients	patient	NOUN
ghmj-1070	65	11	were	be	AUX
ghmj-1070	65	12	aged	age	VERB
ghmj-1070	65	13	46	46	NUM
ghmj-1070	65	14	-	-	SYM
ghmj-1070	65	15	70	70	NUM
ghmj-1070	65	16	years	year	NOUN
ghmj-1070	65	17	(	(	PUNCT
ghmj-1070	65	18	68.1	68.1	NUM
ghmj-1070	65	19	%	%	NOUN
ghmj-1070	65	20	)	)	PUNCT
ghmj-1070	65	21	.	.	PUNCT
ghmj-1070	66	1	there	there	PRON
ghmj-1070	66	2	were	be	VERB
ghmj-1070	66	3	more	more	ADJ
ghmj-1070	66	4	male	male	ADJ
ghmj-1070	66	5	patients	patient	NOUN
ghmj-1070	66	6	than	than	ADP
ghmj-1070	66	7	female	female	ADJ
ghmj-1070	66	8	patients	patient	NOUN
ghmj-1070	66	9	,	,	PUNCT
ghmj-1070	66	10	with	with	ADP
ghmj-1070	66	11	46	46	NUM
ghmj-1070	66	12	male	male	ADJ
ghmj-1070	66	13	patients	patient	NOUN
ghmj-1070	66	14	(	(	PUNCT
ghmj-1070	66	15	66.7	66.7	NUM
ghmj-1070	66	16	%	%	NOUN
ghmj-1070	66	17	)	)	PUNCT
ghmj-1070	66	18	and	and	CCONJ
ghmj-1070	66	19	23	23	NUM
ghmj-1070	66	20	female	female	ADJ
ghmj-1070	66	21	patients	patient	NOUN
ghmj-1070	66	22	(	(	PUNCT
ghmj-1070	66	23	33.3	33.3	NUM
ghmj-1070	66	24	%	%	NOUN
ghmj-1070	66	25	)	)	PUNCT
ghmj-1070	66	26	.	.	PUNCT
ghmj-1070	67	1	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	67	2	was	be	AUX
ghmj-1070	67	3	the	the	DET
ghmj-1070	67	4	most	most	ADV
ghmj-1070	67	5	common	common	ADJ
ghmj-1070	67	6	histopathological	histopathological	ADJ
ghmj-1070	67	7	finding	finding	NOUN
ghmj-1070	67	8	(	(	PUNCT
ghmj-1070	67	9	69.6	69.6	NUM
ghmj-1070	67	10	%	%	NOUN
ghmj-1070	67	11	)	)	PUNCT
ghmj-1070	67	12	.	.	PUNCT
ghmj-1070	68	1	related	relate	VERB
ghmj-1070	68	2	to	to	ADP
ghmj-1070	68	3	occupational	occupational	ADJ
ghmj-1070	68	4	data	datum	NOUN
ghmj-1070	68	5	(	(	PUNCT
ghmj-1070	68	6	69.6	69.6	NUM
ghmj-1070	68	7	%	%	NOUN
ghmj-1070	68	8	)	)	PUNCT
ghmj-1070	68	9	,	,	PUNCT
ghmj-1070	68	10	smoking	smoke	VERB
ghmj-1070	68	11	history	history	NOUN
ghmj-1070	68	12	(	(	PUNCT
ghmj-1070	68	13	98.6	98.6	NUM
ghmj-1070	68	14	%	%	NOUN
ghmj-1070	68	15	)	)	PUNCT
ghmj-1070	68	16	,	,	PUNCT
ghmj-1070	68	17	family	family	NOUN
ghmj-1070	68	18	history	history	NOUN
ghmj-1070	68	19	(	(	PUNCT
ghmj-1070	68	20	98.6	98.6	NUM
ghmj-1070	68	21	%	%	NOUN
ghmj-1070	68	22	)	)	PUNCT
ghmj-1070	68	23	,	,	PUNCT
ghmj-1070	68	24	and	and	CCONJ
ghmj-1070	68	25	staging	stage	VERB
ghmj-1070	68	26	(	(	PUNCT
ghmj-1070	68	27	89.9	89.9	NUM
ghmj-1070	68	28	%	%	NOUN
ghmj-1070	68	29	)	)	PUNCT
ghmj-1070	69	1	the	the	DET
ghmj-1070	69	2	majority	majority	NOUN
ghmj-1070	69	3	had	have	VERB
ghmj-1070	69	4	no	no	DET
ghmj-1070	69	5	information	information	NOUN
ghmj-1070	69	6	on	on	ADP
ghmj-1070	69	7	their	their	PRON
ghmj-1070	69	8	medical	medical	ADJ
ghmj-1070	69	9	reports	report	NOUN
ghmj-1070	69	10	table	table	NOUN
ghmj-1070	69	11	2	2	NUM
ghmj-1070	69	12	shows	show	VERB
ghmj-1070	69	13	the	the	DET
ghmj-1070	69	14	variation	variation	NOUN
ghmj-1070	69	15	in	in	ADP
ghmj-1070	69	16	the	the	DET
ghmj-1070	69	17	distribution	distribution	NOUN
ghmj-1070	69	18	of	of	ADP
ghmj-1070	69	19	histopathological	histopathological	ADJ
ghmj-1070	69	20	characteristics	characteristic	NOUN
ghmj-1070	69	21	by	by	ADP
ghmj-1070	69	22	age	age	NOUN
ghmj-1070	69	23	in	in	ADP
ghmj-1070	69	24	lung	lung	NOUN
ghmj-1070	69	25	cancer	cancer	NOUN
ghmj-1070	69	26	patients	patient	NOUN
ghmj-1070	69	27	in	in	ADP
ghmj-1070	69	28	cirebon	cirebon	NOUN
ghmj-1070	69	29	districts	district	NOUN
ghmj-1070	69	30	in	in	ADP
ghmj-1070	69	31	2021	2021	NUM
ghmj-1070	69	32	to	to	ADP
ghmj-1070	69	33	2023	2023	NUM
ghmj-1070	69	34	.	.	PUNCT
ghmj-1070	70	1	of	of	ADP
ghmj-1070	70	2	the	the	DET
ghmj-1070	70	3	69	69	NUM
ghmj-1070	70	4	lung	lung	NOUN
ghmj-1070	70	5	cancer	cancer	NOUN
ghmj-1070	70	6	patients	patient	NOUN
ghmj-1070	70	7	,	,	PUNCT
ghmj-1070	70	8	68.1	68.1	NUM
ghmj-1070	70	9	%	%	NOUN
ghmj-1070	70	10	or	or	CCONJ
ghmj-1070	70	11	47	47	NUM
ghmj-1070	70	12	patients	patient	NOUN
ghmj-1070	70	13	were	be	AUX
ghmj-1070	70	14	aged	age	VERB
ghmj-1070	70	15	4670	4670	NUM
ghmj-1070	70	16	years	year	NOUN
ghmj-1070	70	17	with	with	ADP
ghmj-1070	70	18	sclc	sclc	PROPN
ghmj-1070	70	19	type	type	NOUN
ghmj-1070	70	20	and	and	CCONJ
ghmj-1070	70	21	squamous	squamous	ADJ
ghmj-1070	70	22	cell	cell	NOUN
ghmj-1070	70	23	carcinoma	carcinoma	NOUN
ghmj-1070	70	24	totalling	total	VERB
ghmj-1070	70	25	7	7	NUM
ghmj-1070	70	26	patients	patient	NOUN
ghmj-1070	70	27	(	(	PUNCT
ghmj-1070	70	28	10.1	10.1	NUM
ghmj-1070	70	29	%	%	NOUN
ghmj-1070	70	30	)	)	PUNCT
ghmj-1070	70	31	,	,	PUNCT
ghmj-1070	70	32	nsclc	nsclc	NOUN
ghmj-1070	70	33	totalling	total	VERB
ghmj-1070	70	34	1	1	NUM
ghmj-1070	70	35	patients	patient	NOUN
ghmj-1070	70	36	(	(	PUNCT
ghmj-1070	70	37	1.4	1.4	NUM
ghmj-1070	70	38	%	%	NOUN
ghmj-1070	70	39	)	)	PUNCT
ghmj-1070	70	40	,	,	PUNCT
ghmj-1070	70	41	and	and	CCONJ
ghmj-1070	70	42	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	70	43	totalling	total	VERB
ghmj-1070	70	44	32	32	NUM
ghmj-1070	70	45	patients	patient	NOUN
ghmj-1070	70	46	(	(	PUNCT
ghmj-1070	70	47	46.3	46.3	NUM
ghmj-1070	70	48	%	%	NOUN
ghmj-1070	70	49	)	)	PUNCT
ghmj-1070	70	50	.	.	PUNCT
ghmj-1070	71	1	there	there	PRON
ghmj-1070	71	2	were	be	VERB
ghmj-1070	71	3	2	2	NUM
ghmj-1070	71	4	(	(	PUNCT
ghmj-1070	71	5	2.9	2.9	NUM
ghmj-1070	71	6	%	%	NOUN
ghmj-1070	71	7	)	)	PUNCT
ghmj-1070	71	8	patients	patient	NOUN
ghmj-1070	71	9	<	<	X
ghmj-1070	71	10	46	46	NUM
ghmj-1070	71	11	years	year	NOUN
ghmj-1070	71	12	old	old	ADJ
ghmj-1070	71	13	with	with	ADP
ghmj-1070	71	14	squamous	squamous	ADJ
ghmj-1070	71	15	cell	cell	NOUN
ghmj-1070	71	16	carcinoma	carcinoma	NOUN
ghmj-1070	71	17	and	and	CCONJ
ghmj-1070	71	18	7	7	NUM
ghmj-1070	71	19	(	(	PUNCT
ghmj-1070	71	20	10.1	10.1	NUM
ghmj-1070	71	21	%	%	NOUN
ghmj-1070	71	22	)	)	PUNCT
ghmj-1070	71	23	with	with	ADP
ghmj-1070	71	24	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	71	25	.	.	PUNCT
ghmj-1070	72	1	there	there	PRON
ghmj-1070	72	2	were	be	VERB
ghmj-1070	72	3	4	4	NUM
ghmj-1070	72	4	patients	patient	NOUN
ghmj-1070	72	5	(	(	PUNCT
ghmj-1070	72	6	5.8	5.8	NUM
ghmj-1070	72	7	%	%	NOUN
ghmj-1070	72	8	)	)	PUNCT
ghmj-1070	72	9	with	with	ADP
ghmj-1070	72	10	squamous	squamous	ADJ
ghmj-1070	72	11	cell	cell	NOUN
ghmj-1070	72	12	carcinoma	carcinoma	NOUN
ghmj-1070	72	13	and	and	CCONJ
ghmj-1070	72	14	9	9	NUM
ghmj-1070	72	15	patients	patient	NOUN
ghmj-1070	72	16	(	(	PUNCT
ghmj-1070	72	17	3	3	NUM
ghmj-1070	72	18	%	%	NOUN
ghmj-1070	72	19	)	)	PUNCT
ghmj-1070	72	20	with	with	ADP
ghmj-1070	72	21	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	72	22	aged	aged	ADJ
ghmj-1070	72	23	>	>	SYM
ghmj-1070	72	24	70	70	NUM
ghmj-1070	72	25	years	year	NOUN
ghmj-1070	72	26	old	old	ADJ
ghmj-1070	72	27	.	.	PUNCT
ghmj-1070	73	1	as	as	SCONJ
ghmj-1070	73	2	shown	show	VERB
ghmj-1070	73	3	in	in	ADP
ghmj-1070	73	4	table	table	NOUN
ghmj-1070	73	5	3	3	NUM
ghmj-1070	73	6	,	,	PUNCT
ghmj-1070	73	7	the	the	DET
ghmj-1070	73	8	histopathological	histopathological	ADJ
ghmj-1070	73	9	characteristics	characteristic	NOUN
ghmj-1070	73	10	of	of	ADP
ghmj-1070	73	11	lung	lung	NOUN
ghmj-1070	73	12	cancer	cancer	NOUN
ghmj-1070	73	13	patients	patient	NOUN
ghmj-1070	73	14	in	in	ADP
ghmj-1070	73	15	cirebon	cirebon	NOUN
ghmj-1070	73	16	district	district	NOUN
ghmj-1070	73	17	in	in	ADP
ghmj-1070	73	18	2021	2021	NUM
ghmj-1070	73	19	to	to	ADP
ghmj-1070	73	20	2023	2023	NUM
ghmj-1070	73	21	by	by	ADP
ghmj-1070	73	22	gender	gender	NOUN
ghmj-1070	73	23	.	.	PUNCT
ghmj-1070	74	1	in	in	ADP
ghmj-1070	74	2	male	male	NOUN
ghmj-1070	74	3	,	,	PUNCT
ghmj-1070	74	4	6	6	NUM
ghmj-1070	74	5	patients	patient	NOUN
ghmj-1070	74	6	(	(	PUNCT
ghmj-1070	74	7	8.7	8.7	NUM
ghmj-1070	74	8	%	%	NOUN
ghmj-1070	74	9	)	)	PUNCT
ghmj-1070	74	10	had	have	AUX
ghmj-1070	74	11	sclc	sclc	PROPN
ghmj-1070	74	12	,	,	PUNCT
ghmj-1070	74	13	11	11	NUM
ghmj-1070	74	14	patients	patient	NOUN
ghmj-1070	74	15	(	(	PUNCT
ghmj-1070	74	16	15.9	15.9	NUM
ghmj-1070	74	17	%	%	NOUN
ghmj-1070	74	18	)	)	PUNCT
ghmj-1070	74	19	had	have	VERB
ghmj-1070	74	20	squamous	squamous	ADJ
ghmj-1070	74	21	cell	cell	NOUN
ghmj-1070	74	22	carcinoma	carcinoma	NOUN
ghmj-1070	74	23	,	,	PUNCT
ghmj-1070	74	24	and	and	CCONJ
ghmj-1070	74	25	29	29	NUM
ghmj-1070	74	26	patients	patient	NOUN
ghmj-1070	74	27	(	(	PUNCT
ghmj-1070	74	28	42	42	NUM
ghmj-1070	74	29	%	%	NOUN
ghmj-1070	74	30	)	)	PUNCT
ghmj-1070	74	31	had	have	VERB
ghmj-1070	74	32	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	74	33	,	,	PUNCT
ghmj-1070	74	34	while	while	SCONJ
ghmj-1070	74	35	in	in	ADP
ghmj-1070	74	36	female	female	ADJ
ghmj-1070	74	37	,	,	PUNCT
ghmj-1070	74	38	1	1	NUM
ghmj-1070	74	39	patient	patient	NOUN
ghmj-1070	74	40	each	each	PRON
ghmj-1070	74	41	(	(	PUNCT
ghmj-1070	74	42	1.4	1.4	NUM
ghmj-1070	74	43	%	%	NOUN
ghmj-1070	74	44	)	)	PUNCT
ghmj-1070	74	45	had	have	VERB
ghmj-1070	74	46	sclc	sclc	PROPN
ghmj-1070	74	47	and	and	CCONJ
ghmj-1070	74	48	nsclc	nsclc	NOUN
ghmj-1070	74	49	,	,	PUNCT
ghmj-1070	74	50	2	2	NUM
ghmj-1070	74	51	patients	patient	NOUN
ghmj-1070	74	52	(	(	PUNCT
ghmj-1070	74	53	2.9	2.9	NUM
ghmj-1070	74	54	%	%	NOUN
ghmj-1070	74	55	)	)	PUNCT
ghmj-1070	74	56	had	have	VERB
ghmj-1070	74	57	squamous	squamous	ADJ
ghmj-1070	74	58	cell	cell	NOUN
ghmj-1070	74	59	carcinoma	carcinoma	NOUN
ghmj-1070	74	60	,	,	PUNCT
ghmj-1070	74	61	and	and	CCONJ
ghmj-1070	74	62	19	19	NUM
ghmj-1070	74	63	patients	patient	NOUN
ghmj-1070	74	64	(	(	PUNCT
ghmj-1070	74	65	27.5	27.5	NUM
ghmj-1070	74	66	%	%	NOUN
ghmj-1070	74	67	)	)	PUNCT
ghmj-1070	74	68	had	have	VERB
ghmj-1070	74	69	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	74	70	.	.	PUNCT
ghmj-1070	75	1	the	the	DET
ghmj-1070	75	2	ratio	ratio	NOUN
ghmj-1070	75	3	of	of	ADP
ghmj-1070	75	4	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	75	5	to	to	ADP
ghmj-1070	75	6	squamous	squamous	ADJ
ghmj-1070	75	7	cell	cell	NOUN
ghmj-1070	75	8	carcinoma	carcinoma	NOUN
ghmj-1070	75	9	in	in	ADP
ghmj-1070	75	10	males	male	NOUN
ghmj-1070	75	11	was	be	AUX
ghmj-1070	75	12	29:11	29:11	NUM
ghmj-1070	75	13	and	and	CCONJ
ghmj-1070	75	14	19:2	19:2	NUM
ghmj-1070	75	15	in	in	ADP
ghmj-1070	75	16	females	female	NOUN
ghmj-1070	75	17	.	.	PUNCT
ghmj-1070	76	1	in	in	ADP
ghmj-1070	76	2	this	this	DET
ghmj-1070	76	3	study	study	NOUN
ghmj-1070	76	4	,	,	PUNCT
ghmj-1070	76	5	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	76	6	was	be	AUX
ghmj-1070	76	7	the	the	DET
ghmj-1070	76	8	most	most	ADV
ghmj-1070	76	9	common	common	ADJ
ghmj-1070	76	10	type	type	NOUN
ghmj-1070	76	11	of	of	ADP
ghmj-1070	76	12	cancer	cancer	NOUN
ghmj-1070	76	13	cell	cell	NOUN
ghmj-1070	76	14	found	find	VERB
ghmj-1070	76	15	in	in	ADP
ghmj-1070	76	16	both	both	DET
ghmj-1070	76	17	males	male	NOUN
ghmj-1070	76	18	and	and	CCONJ
ghmj-1070	76	19	females	female	NOUN
ghmj-1070	76	20	.	.	PUNCT
ghmj-1070	77	1	the	the	DET
ghmj-1070	77	2	ratio	ratio	NOUN
ghmj-1070	77	3	of	of	ADP
ghmj-1070	77	4	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	77	5	patients	patient	NOUN
ghmj-1070	77	6	in	in	ADP
ghmj-1070	77	7	males	male	NOUN
ghmj-1070	77	8	and	and	CCONJ
ghmj-1070	77	9	females	female	NOUN
ghmj-1070	77	10	was	be	AUX
ghmj-1070	77	11	29:19	29:19	NUM
ghmj-1070	77	12	.	.	PUNCT
ghmj-1070	78	1	this	this	PRON
ghmj-1070	78	2	means	mean	VERB
ghmj-1070	78	3	that	that	SCONJ
ghmj-1070	78	4	in	in	ADP
ghmj-1070	78	5	this	this	DET
ghmj-1070	78	6	study	study	NOUN
ghmj-1070	78	7	,	,	PUNCT
ghmj-1070	78	8	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	78	9	was	be	AUX
ghmj-1070	78	10	found	find	VERB
ghmj-1070	78	11	more	more	ADV
ghmj-1070	78	12	in	in	ADP
ghmj-1070	78	13	male	male	NOUN
ghmj-1070	78	14	than	than	ADP
ghmj-1070	78	15	female	female	NOUN
ghmj-1070	78	16	.	.	PUNCT
ghmj-1070	79	1	sulaeman	sulaeman	PROPN
ghmj-1070	79	2	,	,	PUNCT
ghmj-1070	79	3	et	et	PROPN
ghmj-1070	79	4	.	.	PUNCT
ghmj-1070	80	1	al	al	PROPN
ghmj-1070	80	2	.	.	PROPN
ghmj-1070	80	3	ghmj	ghmj	PROPN
ghmj-1070	80	4	(	(	PUNCT
ghmj-1070	80	5	global	global	ADJ
ghmj-1070	80	6	health	health	PROPN
ghmj-1070	80	7	management	management	NOUN
ghmj-1070	80	8	journal	journal	PROPN
ghmj-1070	80	9	)	)	PUNCT
ghmj-1070	80	10	2024	2024	NUM
ghmj-1070	80	11	,	,	PUNCT
ghmj-1070	80	12	vol	vol	NOUN
ghmj-1070	80	13	.	.	PROPN
ghmj-1070	80	14	7	7	NUM
ghmj-1070	80	15	,	,	PUNCT
ghmj-1070	80	16	no	no	INTJ
ghmj-1070	80	17	.	.	NOUN
ghmj-1070	80	18	4	4	NUM
ghmj-1070	80	19	296	296	NUM
ghmj-1070	80	20	table	table	NOUN
ghmj-1070	80	21	1	1	NUM
ghmj-1070	80	22	.	.	PUNCT
ghmj-1070	81	1	patient	patient	PROPN
ghmj-1070	81	2	’s	’s	PART
ghmj-1070	81	3	characteristics	characteristic	NOUN
ghmj-1070	81	4	variables	variable	NOUN
ghmj-1070	81	5	frequency	frequency	NOUN
ghmj-1070	81	6	(	(	PUNCT
ghmj-1070	81	7	n	n	CCONJ
ghmj-1070	81	8	)	)	PUNCT
ghmj-1070	81	9	percentage	percentage	NOUN
ghmj-1070	81	10	(	(	PUNCT
ghmj-1070	81	11	%	%	NOUN
ghmj-1070	81	12	)	)	PUNCT
ghmj-1070	81	13	age	age	NOUN
ghmj-1070	81	14	<	<	NOUN
ghmj-1070	81	15	46	46	NUM
ghmj-1070	81	16	years	year	NOUN
ghmj-1070	81	17	9	9	NUM
ghmj-1070	81	18	13	13	NUM
ghmj-1070	81	19	46	46	NUM
ghmj-1070	81	20	-	-	SYM
ghmj-1070	81	21	70	70	NUM
ghmj-1070	81	22	years	year	NOUN
ghmj-1070	81	23	47	47	NUM
ghmj-1070	81	24	68.1	68.1	NUM
ghmj-1070	81	25	>	>	SYM
ghmj-1070	81	26	70	70	NUM
ghmj-1070	81	27	years	year	NOUN
ghmj-1070	81	28	13	13	NUM
ghmj-1070	81	29	18.8	18.8	NUM
ghmj-1070	81	30	gender	gender	NOUN
ghmj-1070	81	31	male	male	NOUN
ghmj-1070	81	32	46	46	NUM
ghmj-1070	81	33	66.7	66.7	NUM
ghmj-1070	81	34	female	female	ADJ
ghmj-1070	81	35	23	23	NUM
ghmj-1070	81	36	33.3	33.3	NUM
ghmj-1070	81	37	occupation	occupation	NOUN
ghmj-1070	81	38	labor	labor	NOUN
ghmj-1070	81	39	2	2	NUM
ghmj-1070	81	40	2.9	2.9	NUM
ghmj-1070	81	41	housewife	housewife	NOUN
ghmj-1070	81	42	6	6	NUM
ghmj-1070	81	43	8.7	8.7	NUM
ghmj-1070	81	44	farmer	farmer	NOUN
ghmj-1070	81	45	1	1	NUM
ghmj-1070	81	46	1.4	1.4	NUM
ghmj-1070	81	47	entrepreneur	entrepreneur	NOUN
ghmj-1070	81	48	6	6	NUM
ghmj-1070	81	49	8.7	8.7	NUM
ghmj-1070	81	50	not	not	PART
ghmj-1070	81	51	working	work	VERB
ghmj-1070	81	52	7	7	NUM
ghmj-1070	81	53	10.1	10.1	NUM
ghmj-1070	81	54	no	no	DET
ghmj-1070	81	55	information	information	NOUN
ghmj-1070	81	56	47	47	NUM
ghmj-1070	81	57	68.1	68.1	NUM
ghmj-1070	81	58	smoking	smoking	NOUN
ghmj-1070	81	59	history	history	NOUN
ghmj-1070	81	60	smoking	smoke	VERB
ghmj-1070	81	61	0	0	NUM
ghmj-1070	81	62	0	0	NUM
ghmj-1070	82	1	no	no	DET
ghmj-1070	82	2	smoking	smoking	NOUN
ghmj-1070	82	3	1	1	NUM
ghmj-1070	82	4	1.4	1.4	NUM
ghmj-1070	82	5	no	no	DET
ghmj-1070	82	6	information	information	NOUN
ghmj-1070	82	7	68	68	NUM
ghmj-1070	82	8	98.6	98.6	NUM
ghmj-1070	82	9	family	family	NOUN
ghmj-1070	82	10	history	history	NOUN
ghmj-1070	82	11	yes	yes	INTJ
ghmj-1070	82	12	0	0	NUM
ghmj-1070	82	13	0	0	NUM
ghmj-1070	83	1	no	no	DET
ghmj-1070	83	2	1	1	NUM
ghmj-1070	83	3	1.4	1.4	NUM
ghmj-1070	83	4	no	no	DET
ghmj-1070	83	5	information	information	NOUN
ghmj-1070	83	6	68	68	NUM
ghmj-1070	83	7	98.6	98.6	NUM
ghmj-1070	83	8	histopathology	histopathology	NOUN
ghmj-1070	83	9	sclc	sclc	PROPN
ghmj-1070	83	10	7	7	NUM
ghmj-1070	83	11	10.1	10.1	NUM
ghmj-1070	83	12	nsclc	nsclc	NOUN
ghmj-1070	83	13	1	1	NUM
ghmj-1070	83	14	1.4	1.4	NUM
ghmj-1070	83	15	squamous	squamous	ADJ
ghmj-1070	83	16	cell	cell	NOUN
ghmj-1070	83	17	carcinoma	carcinoma	NOUN
ghmj-1070	83	18	(	(	PUNCT
ghmj-1070	83	19	scc	scc	NOUN
ghmj-1070	83	20	)	)	PUNCT
ghmj-1070	83	21	13	13	NUM
ghmj-1070	83	22	18.8	18.8	NUM
ghmj-1070	83	23	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	83	24	48	48	NUM
ghmj-1070	83	25	69.6	69.6	NUM
ghmj-1070	83	26	large	large	ADJ
ghmj-1070	83	27	cell	cell	NOUN
ghmj-1070	83	28	carcinoma	carcinoma	NOUN
ghmj-1070	83	29	(	(	PUNCT
ghmj-1070	83	30	lcc	lcc	PROPN
ghmj-1070	83	31	)	)	PUNCT
ghmj-1070	83	32	0	0	NUM
ghmj-1070	83	33	0	0	NUM
ghmj-1070	83	34	lung	lung	NOUN
ghmj-1070	83	35	cancer	cancer	NOUN
ghmj-1070	83	36	staging	stage	VERB
ghmj-1070	83	37	ia	ia	PROPN
ghmj-1070	83	38	0	0	NUM
ghmj-1070	83	39	0	0	NUM
ghmj-1070	83	40	ib	ib	NOUN
ghmj-1070	83	41	0	0	NUM
ghmj-1070	83	42	0	0	NUM
ghmj-1070	83	43	iia	iia	VERB
ghmj-1070	83	44	0	0	NUM
ghmj-1070	83	45	0	0	NUM
ghmj-1070	83	46	iib	iib	NOUN
ghmj-1070	83	47	0	0	NUM
ghmj-1070	83	48	0	0	PUNCT
ghmj-1070	83	49	iiia	iiia	ADP
ghmj-1070	83	50	0	0	NUM
ghmj-1070	83	51	0	0	NUM
ghmj-1070	83	52	iiib	iiib	NOUN
ghmj-1070	83	53	1	1	NUM
ghmj-1070	83	54	1.4	1.4	NUM
ghmj-1070	83	55	iiic	iiic	PROPN
ghmj-1070	83	56	0	0	NUM
ghmj-1070	83	57	0	0	NUM
ghmj-1070	83	58	iv	iv	NUM
ghmj-1070	83	59	4	4	NUM
ghmj-1070	83	60	5.8	5.8	NUM
ghmj-1070	83	61	iva	iva	NOUN
ghmj-1070	83	62	1	1	NUM
ghmj-1070	83	63	1.4	1.4	NUM
ghmj-1070	83	64	ivb	ivb	NOUN
ghmj-1070	83	65	1	1	NUM
ghmj-1070	83	66	1.4	1.4	NUM
ghmj-1070	83	67	no	no	DET
ghmj-1070	83	68	information	information	NOUN
ghmj-1070	83	69	62	62	NUM
ghmj-1070	83	70	89.9	89.9	NUM
ghmj-1070	83	71	table	table	NOUN
ghmj-1070	83	72	2	2	NUM
ghmj-1070	83	73	.	.	PUNCT
ghmj-1070	83	74	histopathological	histopathological	ADJ
ghmj-1070	83	75	characteristics	characteristic	NOUN
ghmj-1070	83	76	by	by	ADP
ghmj-1070	83	77	age	age	NOUN
ghmj-1070	83	78	histopathology	histopathology	NOUN
ghmj-1070	83	79	age	age	NOUN
ghmj-1070	83	80	total	total	NOUN
ghmj-1070	83	81	<	<	NOUN
ghmj-1070	83	82	46	46	NUM
ghmj-1070	83	83	years	year	NOUN
ghmj-1070	83	84	46	46	NUM
ghmj-1070	83	85	-	-	SYM
ghmj-1070	83	86	70	70	NUM
ghmj-1070	83	87	years	year	NOUN
ghmj-1070	83	88	>	>	SYM
ghmj-1070	83	89	70	70	NUM
ghmj-1070	83	90	years	year	NOUN
ghmj-1070	83	91	sclc	sclc	PROPN
ghmj-1070	83	92	0	0	NUM
ghmj-1070	83	93	(	(	PUNCT
ghmj-1070	83	94	0	0	NUM
ghmj-1070	83	95	%	%	NOUN
ghmj-1070	83	96	)	)	PUNCT
ghmj-1070	83	97	7	7	NUM
ghmj-1070	83	98	(	(	PUNCT
ghmj-1070	83	99	10.1	10.1	NUM
ghmj-1070	83	100	%	%	NOUN
ghmj-1070	83	101	)	)	PUNCT
ghmj-1070	83	102	0	0	NUM
ghmj-1070	84	1	(	(	PUNCT
ghmj-1070	84	2	0	0	NUM
ghmj-1070	84	3	%	%	NOUN
ghmj-1070	84	4	)	)	PUNCT
ghmj-1070	84	5	7	7	NUM
ghmj-1070	84	6	(	(	PUNCT
ghmj-1070	84	7	10.1	10.1	NUM
ghmj-1070	84	8	%	%	NOUN
ghmj-1070	84	9	)	)	PUNCT
ghmj-1070	84	10	nsclc	nsclc	NOUN
ghmj-1070	84	11	0	0	NUM
ghmj-1070	85	1	(	(	PUNCT
ghmj-1070	85	2	0	0	NUM
ghmj-1070	85	3	%	%	NOUN
ghmj-1070	85	4	)	)	PUNCT
ghmj-1070	85	5	1	1	NUM
ghmj-1070	85	6	(	(	PUNCT
ghmj-1070	85	7	1.4	1.4	NUM
ghmj-1070	85	8	%	%	NOUN
ghmj-1070	85	9	)	)	PUNCT
ghmj-1070	85	10	0	0	NUM
ghmj-1070	86	1	(	(	PUNCT
ghmj-1070	86	2	0	0	NUM
ghmj-1070	86	3	%	%	NOUN
ghmj-1070	86	4	)	)	PUNCT
ghmj-1070	86	5	1	1	NUM
ghmj-1070	86	6	(	(	PUNCT
ghmj-1070	86	7	1.4	1.4	NUM
ghmj-1070	86	8	%	%	NOUN
ghmj-1070	86	9	)	)	PUNCT
ghmj-1070	86	10	squamous	squamous	ADJ
ghmj-1070	86	11	cell	cell	NOUN
ghmj-1070	86	12	carcinoma	carcinoma	NOUN
ghmj-1070	86	13	2	2	NUM
ghmj-1070	86	14	(	(	PUNCT
ghmj-1070	86	15	2.9	2.9	NUM
ghmj-1070	86	16	%	%	NOUN
ghmj-1070	86	17	)	)	PUNCT
ghmj-1070	86	18	7	7	NUM
ghmj-1070	86	19	(	(	PUNCT
ghmj-1070	86	20	10.1	10.1	NUM
ghmj-1070	86	21	%	%	NOUN
ghmj-1070	86	22	)	)	PUNCT
ghmj-1070	86	23	4	4	NUM
ghmj-1070	86	24	(	(	PUNCT
ghmj-1070	86	25	5.8	5.8	NUM
ghmj-1070	86	26	%	%	NOUN
ghmj-1070	86	27	)	)	PUNCT
ghmj-1070	86	28	13	13	NUM
ghmj-1070	86	29	(	(	PUNCT
ghmj-1070	86	30	18.8	18.8	NUM
ghmj-1070	86	31	%	%	NOUN
ghmj-1070	86	32	)	)	PUNCT
ghmj-1070	86	33	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	86	34	7	7	NUM
ghmj-1070	86	35	(	(	PUNCT
ghmj-1070	86	36	10.1	10.1	NUM
ghmj-1070	86	37	%	%	NOUN
ghmj-1070	86	38	)	)	PUNCT
ghmj-1070	86	39	32	32	NUM
ghmj-1070	86	40	(	(	PUNCT
ghmj-1070	86	41	46.3	46.3	NUM
ghmj-1070	86	42	%	%	NOUN
ghmj-1070	86	43	)	)	PUNCT
ghmj-1070	86	44	9	9	NUM
ghmj-1070	86	45	(	(	PUNCT
ghmj-1070	86	46	3	3	NUM
ghmj-1070	86	47	%	%	NOUN
ghmj-1070	86	48	)	)	PUNCT
ghmj-1070	86	49	48	48	NUM
ghmj-1070	86	50	(	(	PUNCT
ghmj-1070	86	51	69.5	69.5	NUM
ghmj-1070	86	52	%	%	NOUN
ghmj-1070	86	53	)	)	PUNCT
ghmj-1070	86	54	large	large	ADJ
ghmj-1070	86	55	cell	cell	NOUN
ghmj-1070	86	56	carcinoma	carcinoma	NOUN
ghmj-1070	86	57	0	0	NUM
ghmj-1070	87	1	(	(	PUNCT
ghmj-1070	87	2	0	0	NUM
ghmj-1070	87	3	%	%	NOUN
ghmj-1070	87	4	)	)	PUNCT
ghmj-1070	87	5	0	0	NUM
ghmj-1070	88	1	(	(	PUNCT
ghmj-1070	88	2	0	0	NUM
ghmj-1070	88	3	%	%	NOUN
ghmj-1070	88	4	)	)	PUNCT
ghmj-1070	88	5	0	0	NUM
ghmj-1070	89	1	(	(	PUNCT
ghmj-1070	89	2	0	0	NUM
ghmj-1070	89	3	%	%	NOUN
ghmj-1070	89	4	)	)	PUNCT
ghmj-1070	89	5	0	0	NUM
ghmj-1070	90	1	(	(	PUNCT
ghmj-1070	90	2	0	0	NUM
ghmj-1070	90	3	%	%	NOUN
ghmj-1070	90	4	)	)	PUNCT
ghmj-1070	90	5	total	total	NOUN
ghmj-1070	90	6	9	9	NUM
ghmj-1070	90	7	(	(	PUNCT
ghmj-1070	90	8	13	13	NUM
ghmj-1070	90	9	%	%	NOUN
ghmj-1070	90	10	)	)	PUNCT
ghmj-1070	90	11	47	47	NUM
ghmj-1070	90	12	(	(	PUNCT
ghmj-1070	90	13	68.1	68.1	NUM
ghmj-1070	90	14	%	%	NOUN
ghmj-1070	90	15	)	)	PUNCT
ghmj-1070	90	16	13	13	NUM
ghmj-1070	90	17	(	(	PUNCT
ghmj-1070	90	18	18.8	18.8	NUM
ghmj-1070	90	19	%	%	NOUN
ghmj-1070	90	20	)	)	PUNCT
ghmj-1070	90	21	69	69	NUM
ghmj-1070	90	22	(	(	PUNCT
ghmj-1070	90	23	100	100	NUM
ghmj-1070	90	24	%	%	NOUN
ghmj-1070	90	25	)	)	PUNCT
ghmj-1070	90	26	sulaeman	sulaeman	PROPN
ghmj-1070	90	27	,	,	PUNCT
ghmj-1070	90	28	et	et	PROPN
ghmj-1070	90	29	.	.	PUNCT
ghmj-1070	91	1	al	al	PROPN
ghmj-1070	91	2	.	.	PROPN
ghmj-1070	91	3	ghmj	ghmj	PROPN
ghmj-1070	91	4	(	(	PUNCT
ghmj-1070	91	5	global	global	ADJ
ghmj-1070	91	6	health	health	PROPN
ghmj-1070	91	7	management	management	NOUN
ghmj-1070	91	8	journal	journal	PROPN
ghmj-1070	91	9	)	)	PUNCT
ghmj-1070	91	10	2024	2024	NUM
ghmj-1070	91	11	,	,	PUNCT
ghmj-1070	91	12	vol	vol	NOUN
ghmj-1070	91	13	.	.	PROPN
ghmj-1070	91	14	7	7	NUM
ghmj-1070	91	15	,	,	PUNCT
ghmj-1070	91	16	no	no	INTJ
ghmj-1070	91	17	.	.	NOUN
ghmj-1070	91	18	4	4	NUM
ghmj-1070	91	19	297	297	NUM
ghmj-1070	91	20	table	table	NOUN
ghmj-1070	91	21	3	3	NUM
ghmj-1070	91	22	.	.	PUNCT
ghmj-1070	91	23	histopathological	histopathological	ADJ
ghmj-1070	91	24	characteristics	characteristic	NOUN
ghmj-1070	91	25	by	by	ADP
ghmj-1070	91	26	gender	gender	NOUN
ghmj-1070	91	27	histopathology	histopathology	NOUN
ghmj-1070	91	28	gender	gender	NOUN
ghmj-1070	91	29	total	total	ADJ
ghmj-1070	91	30	male	male	ADJ
ghmj-1070	91	31	female	female	ADJ
ghmj-1070	91	32	sclc	sclc	NOUN
ghmj-1070	91	33	6	6	NUM
ghmj-1070	91	34	(	(	PUNCT
ghmj-1070	91	35	8.7	8.7	NUM
ghmj-1070	91	36	%	%	NOUN
ghmj-1070	91	37	)	)	PUNCT
ghmj-1070	91	38	1	1	NUM
ghmj-1070	91	39	(	(	PUNCT
ghmj-1070	91	40	1.4	1.4	NUM
ghmj-1070	91	41	%	%	NOUN
ghmj-1070	91	42	)	)	PUNCT
ghmj-1070	91	43	7	7	NUM
ghmj-1070	91	44	(	(	PUNCT
ghmj-1070	91	45	10.1	10.1	NUM
ghmj-1070	91	46	%	%	NOUN
ghmj-1070	91	47	)	)	PUNCT
ghmj-1070	91	48	nsclc	nsclc	NOUN
ghmj-1070	91	49	0	0	NUM
ghmj-1070	92	1	(	(	PUNCT
ghmj-1070	92	2	0	0	NUM
ghmj-1070	92	3	%	%	NOUN
ghmj-1070	92	4	)	)	PUNCT
ghmj-1070	92	5	1	1	NUM
ghmj-1070	92	6	(	(	PUNCT
ghmj-1070	92	7	1.4	1.4	NUM
ghmj-1070	92	8	%	%	NOUN
ghmj-1070	92	9	)	)	PUNCT
ghmj-1070	92	10	1	1	NUM
ghmj-1070	92	11	(	(	PUNCT
ghmj-1070	92	12	1.4	1.4	NUM
ghmj-1070	92	13	%	%	NOUN
ghmj-1070	92	14	)	)	PUNCT
ghmj-1070	92	15	squamous	squamous	ADJ
ghmj-1070	92	16	cell	cell	NOUN
ghmj-1070	92	17	carcinoma	carcinoma	NOUN
ghmj-1070	92	18	11	11	NUM
ghmj-1070	92	19	(	(	PUNCT
ghmj-1070	92	20	15.9	15.9	NUM
ghmj-1070	92	21	%	%	NOUN
ghmj-1070	92	22	)	)	PUNCT
ghmj-1070	92	23	2	2	NUM
ghmj-1070	92	24	(	(	PUNCT
ghmj-1070	92	25	2.9	2.9	NUM
ghmj-1070	92	26	%	%	NOUN
ghmj-1070	92	27	)	)	PUNCT
ghmj-1070	92	28	13	13	NUM
ghmj-1070	92	29	(	(	PUNCT
ghmj-1070	92	30	18.8	18.8	NUM
ghmj-1070	92	31	%	%	NOUN
ghmj-1070	92	32	)	)	PUNCT
ghmj-1070	92	33	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	92	34	29	29	NUM
ghmj-1070	92	35	(	(	PUNCT
ghmj-1070	92	36	42	42	NUM
ghmj-1070	92	37	%	%	NOUN
ghmj-1070	92	38	)	)	PUNCT
ghmj-1070	92	39	19	19	NUM
ghmj-1070	92	40	(	(	PUNCT
ghmj-1070	92	41	27.5	27.5	NUM
ghmj-1070	92	42	%	%	NOUN
ghmj-1070	92	43	)	)	PUNCT
ghmj-1070	92	44	48	48	NUM
ghmj-1070	92	45	(	(	PUNCT
ghmj-1070	92	46	69.5	69.5	NUM
ghmj-1070	92	47	%	%	NOUN
ghmj-1070	92	48	)	)	PUNCT
ghmj-1070	92	49	large	large	ADJ
ghmj-1070	92	50	cell	cell	NOUN
ghmj-1070	92	51	carcinoma	carcinoma	NOUN
ghmj-1070	92	52	0	0	NUM
ghmj-1070	93	1	(	(	PUNCT
ghmj-1070	93	2	0	0	NUM
ghmj-1070	93	3	%	%	NOUN
ghmj-1070	93	4	)	)	PUNCT
ghmj-1070	93	5	0	0	NUM
ghmj-1070	94	1	(	(	PUNCT
ghmj-1070	94	2	0	0	NUM
ghmj-1070	94	3	%	%	NOUN
ghmj-1070	94	4	)	)	PUNCT
ghmj-1070	94	5	0	0	NUM
ghmj-1070	95	1	(	(	PUNCT
ghmj-1070	95	2	0	0	NUM
ghmj-1070	95	3	%	%	NOUN
ghmj-1070	95	4	)	)	PUNCT
ghmj-1070	95	5	total	total	NOUN
ghmj-1070	95	6	46	46	NUM
ghmj-1070	95	7	(	(	PUNCT
ghmj-1070	95	8	66.7	66.7	NUM
ghmj-1070	95	9	%	%	NOUN
ghmj-1070	95	10	)	)	PUNCT
ghmj-1070	95	11	23	23	NUM
ghmj-1070	95	12	(	(	PUNCT
ghmj-1070	95	13	33.3	33.3	NUM
ghmj-1070	95	14	%	%	NOUN
ghmj-1070	95	15	)	)	PUNCT
ghmj-1070	95	16	69	69	NUM
ghmj-1070	95	17	(	(	PUNCT
ghmj-1070	95	18	100	100	NUM
ghmj-1070	95	19	%	%	NOUN
ghmj-1070	95	20	)	)	PUNCT
ghmj-1070	95	21	4	4	NUM
ghmj-1070	95	22	.	.	X
ghmj-1070	96	1	discussion	discussion	NOUN
ghmj-1070	96	2	the	the	DET
ghmj-1070	96	3	findings	finding	NOUN
ghmj-1070	96	4	in	in	ADP
ghmj-1070	96	5	this	this	DET
ghmj-1070	96	6	study	study	NOUN
ghmj-1070	96	7	show	show	VERB
ghmj-1070	96	8	that	that	SCONJ
ghmj-1070	96	9	lung	lung	NOUN
ghmj-1070	96	10	cancer	cancer	NOUN
ghmj-1070	96	11	patients	patient	NOUN
ghmj-1070	96	12	in	in	ADP
ghmj-1070	96	13	cirebon	cirebon	NOUN
ghmj-1070	96	14	district	district	NOUN
ghmj-1070	96	15	in	in	ADP
ghmj-1070	96	16	2021	2021	NUM
ghmj-1070	96	17	to	to	ADP
ghmj-1070	96	18	2023	2023	NUM
ghmj-1070	96	19	are	be	AUX
ghmj-1070	96	20	mostly	mostly	ADV
ghmj-1070	96	21	aged	age	VERB
ghmj-1070	96	22	46	46	NUM
ghmj-1070	96	23	-	-	SYM
ghmj-1070	96	24	70	70	NUM
ghmj-1070	96	25	years	year	NOUN
ghmj-1070	96	26	(	(	PUNCT
ghmj-1070	96	27	68.1	68.1	NUM
ghmj-1070	96	28	%	%	NOUN
ghmj-1070	96	29	)	)	PUNCT
ghmj-1070	96	30	and	and	CCONJ
ghmj-1070	96	31	based	base	VERB
ghmj-1070	96	32	on	on	ADP
ghmj-1070	96	33	the	the	DET
ghmj-1070	96	34	type	type	NOUN
ghmj-1070	96	35	of	of	ADP
ghmj-1070	96	36	cancer	cancer	NOUN
ghmj-1070	96	37	cells	cell	NOUN
ghmj-1070	96	38	,	,	PUNCT
ghmj-1070	96	39	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	96	40	is	be	AUX
ghmj-1070	96	41	the	the	DET
ghmj-1070	96	42	most	most	ADV
ghmj-1070	96	43	common	common	ADJ
ghmj-1070	96	44	(	(	PUNCT
ghmj-1070	96	45	46.3	46.3	NUM
ghmj-1070	96	46	%	%	NOUN
ghmj-1070	96	47	)	)	PUNCT
ghmj-1070	96	48	.	.	PUNCT
ghmj-1070	97	1	the	the	DET
ghmj-1070	97	2	findings	finding	NOUN
ghmj-1070	97	3	of	of	ADP
ghmj-1070	97	4	this	this	DET
ghmj-1070	97	5	study	study	NOUN
ghmj-1070	97	6	is	be	AUX
ghmj-1070	97	7	in	in	ADP
ghmj-1070	97	8	line	line	NOUN
ghmj-1070	97	9	with	with	ADP
ghmj-1070	97	10	those	those	PRON
ghmj-1070	97	11	of	of	ADP
ghmj-1070	97	12	study	study	NOUN
ghmj-1070	97	13	by	by	ADP
ghmj-1070	97	14	aini	aini	PROPN
ghmj-1070	97	15	et	et	PROPN
ghmj-1070	97	16	al	al	PROPN
ghmj-1070	97	17	.	.	PROPN
ghmj-1070	98	1	(	(	PUNCT
ghmj-1070	98	2	2019	2019	NUM
ghmj-1070	98	3	)	)	PUNCT
ghmj-1070	98	4	where	where	SCONJ
ghmj-1070	98	5	78.3	78.3	NUM
ghmj-1070	98	6	%	%	NOUN
ghmj-1070	98	7	of	of	ADP
ghmj-1070	98	8	patients	patient	NOUN
ghmj-1070	98	9	were	be	AUX
ghmj-1070	98	10	aged	age	VERB
ghmj-1070	98	11	46	46	NUM
ghmj-1070	98	12	-	-	SYM
ghmj-1070	98	13	70	70	NUM
ghmj-1070	98	14	years	year	NOUN
ghmj-1070	98	15	and	and	CCONJ
ghmj-1070	98	16	the	the	DET
ghmj-1070	98	17	most	most	ADV
ghmj-1070	98	18	common	common	ADJ
ghmj-1070	98	19	type	type	NOUN
ghmj-1070	98	20	of	of	ADP
ghmj-1070	98	21	cancer	cancer	NOUN
ghmj-1070	98	22	cell	cell	NOUN
ghmj-1070	98	23	found	find	VERB
ghmj-1070	98	24	was	be	AUX
ghmj-1070	98	25	adenocarcinoma	adenocarcinoma	ADJ
ghmj-1070	98	26	(	(	PUNCT
ghmj-1070	98	27	75	75	NUM
ghmj-1070	98	28	%	%	NOUN
ghmj-1070	98	29	)	)	PUNCT
ghmj-1070	98	30	.	.	PUNCT
ghmj-1070	99	1	this	this	PRON
ghmj-1070	99	2	happened	happen	VERB
ghmj-1070	99	3	because	because	SCONJ
ghmj-1070	99	4	the	the	DET
ghmj-1070	99	5	risk	risk	NOUN
ghmj-1070	99	6	of	of	ADP
ghmj-1070	99	7	lung	lung	NOUN
ghmj-1070	99	8	cancer	cancer	NOUN
ghmj-1070	99	9	tends	tend	VERB
ghmj-1070	99	10	to	to	PART
ghmj-1070	99	11	increase	increase	VERB
ghmj-1070	99	12	at	at	ADP
ghmj-1070	99	13	the	the	DET
ghmj-1070	99	14	age	age	NOUN
ghmj-1070	99	15	of	of	ADP
ghmj-1070	99	16	over	over	ADP
ghmj-1070	99	17	40	40	NUM
ghmj-1070	99	18	years	year	NOUN
ghmj-1070	99	19	and	and	CCONJ
ghmj-1070	99	20	over	over	ADP
ghmj-1070	99	21	50	50	NUM
ghmj-1070	99	22	years	year	NOUN
ghmj-1070	99	23	.	.	PUNCT
ghmj-1070	100	1	according	accord	VERB
ghmj-1070	100	2	to	to	ADP
ghmj-1070	100	3	balzer	balzer	PROPN
ghmj-1070	100	4	et	et	PROPN
ghmj-1070	100	5	al	al	PROPN
ghmj-1070	100	6	.	.	PROPN
ghmj-1070	101	1	(	(	PUNCT
ghmj-1070	101	2	2018	2018	NUM
ghmj-1070	101	3	)	)	PUNCT
ghmj-1070	101	4	,	,	PUNCT
ghmj-1070	101	5	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	101	6	typically	typically	ADV
ghmj-1070	101	7	develops	develop	VERB
ghmj-1070	101	8	between	between	ADP
ghmj-1070	101	9	the	the	DET
ghmj-1070	101	10	ages	age	NOUN
ghmj-1070	101	11	of	of	ADP
ghmj-1070	101	12	26	26	NUM
ghmj-1070	101	13	and	and	CCONJ
ghmj-1070	101	14	40	40	NUM
ghmj-1070	101	15	,	,	PUNCT
ghmj-1070	101	16	whereas	whereas	SCONJ
ghmj-1070	101	17	squamous	squamous	ADJ
ghmj-1070	101	18	cell	cell	NOUN
ghmj-1070	101	19	carcinoma	carcinoma	NOUN
ghmj-1070	101	20	develops	develop	VERB
ghmj-1070	101	21	after	after	ADP
ghmj-1070	101	22	the	the	DET
ghmj-1070	101	23	age	age	NOUN
ghmj-1070	101	24	of	of	ADP
ghmj-1070	101	25	50	50	NUM
ghmj-1070	101	26	.	.	PUNCT
ghmj-1070	102	1	this	this	PRON
ghmj-1070	102	2	is	be	AUX
ghmj-1070	102	3	in	in	ADP
ghmj-1070	102	4	line	line	NOUN
ghmj-1070	102	5	with	with	ADP
ghmj-1070	102	6	this	this	DET
ghmj-1070	102	7	study	study	NOUN
ghmj-1070	102	8	,	,	PUNCT
ghmj-1070	102	9	which	which	PRON
ghmj-1070	102	10	showed	show	VERB
ghmj-1070	102	11	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	102	12	among	among	ADP
ghmj-1070	102	13	patients	patient	NOUN
ghmj-1070	102	14	under	under	ADP
ghmj-1070	102	15	the	the	DET
ghmj-1070	102	16	age	age	NOUN
ghmj-1070	102	17	of	of	ADP
ghmj-1070	102	18	46	46	NUM
ghmj-1070	102	19	(	(	PUNCT
ghmj-1070	102	20	10.1	10.1	NUM
ghmj-1070	102	21	%	%	NOUN
ghmj-1070	102	22	)	)	PUNCT
ghmj-1070	102	23	and	and	CCONJ
ghmj-1070	102	24	squamous	squamous	ADJ
ghmj-1070	102	25	cell	cell	NOUN
ghmj-1070	102	26	carcinoma	carcinoma	NOUN
ghmj-1070	102	27	was	be	AUX
ghmj-1070	102	28	more	more	ADV
ghmj-1070	102	29	common	common	ADJ
ghmj-1070	102	30	among	among	ADP
ghmj-1070	102	31	patients	patient	NOUN
ghmj-1070	102	32	aged	age	VERB
ghmj-1070	102	33	46	46	NUM
ghmj-1070	102	34	-	-	SYM
ghmj-1070	102	35	70	70	NUM
ghmj-1070	102	36	(	(	PUNCT
ghmj-1070	102	37	10.1	10.1	NUM
ghmj-1070	102	38	%	%	NOUN
ghmj-1070	102	39	)	)	PUNCT
ghmj-1070	102	40	(	(	PUNCT
ghmj-1070	102	41	aini	aini	PROPN
ghmj-1070	102	42	,	,	PUNCT
ghmj-1070	102	43	wulandari	wulandari	ADJ
ghmj-1070	102	44	,	,	PUNCT
ghmj-1070	102	45	and	and	CCONJ
ghmj-1070	102	46	andajani	andajani	VERB
ghmj-1070	102	47	2019	2019	NUM
ghmj-1070	102	48	;	;	PUNCT
ghmj-1070	102	49	balzer	balzer	PROPN
ghmj-1070	102	50	et	et	PROPN
ghmj-1070	102	51	al	al	PROPN
ghmj-1070	102	52	.	.	PROPN
ghmj-1070	102	53	2018	2018	NUM
ghmj-1070	102	54	)	)	PUNCT
ghmj-1070	102	55	.	.	PUNCT
ghmj-1070	103	1	as	as	SCONJ
ghmj-1070	103	2	we	we	PRON
ghmj-1070	103	3	age	age	VERB
ghmj-1070	103	4	,	,	PUNCT
ghmj-1070	103	5	we	we	PRON
ghmj-1070	103	6	are	be	AUX
ghmj-1070	103	7	more	more	ADV
ghmj-1070	103	8	exposed	expose	VERB
ghmj-1070	103	9	to	to	ADP
ghmj-1070	103	10	hormones	hormone	NOUN
ghmj-1070	103	11	,	,	PUNCT
ghmj-1070	103	12	degenerative	degenerative	ADJ
ghmj-1070	103	13	disease	disease	NOUN
ghmj-1070	103	14	,	,	PUNCT
ghmj-1070	103	15	a	a	DET
ghmj-1070	103	16	reduce	reduce	VERB
ghmj-1070	103	17	ability	ability	NOUN
ghmj-1070	103	18	of	of	ADP
ghmj-1070	103	19	cells	cell	NOUN
ghmj-1070	103	20	to	to	PART
ghmj-1070	103	21	repair	repair	VERB
ghmj-1070	103	22	themselves	themselves	PRON
ghmj-1070	103	23	,	,	PUNCT
ghmj-1070	103	24	and	and	CCONJ
ghmj-1070	103	25	decreasing	decrease	VERB
ghmj-1070	103	26	lung	lung	NOUN
ghmj-1070	103	27	function	function	NOUN
ghmj-1070	103	28	.	.	PUNCT
ghmj-1070	104	1	the	the	DET
ghmj-1070	104	2	slowing	slowing	NOUN
ghmj-1070	104	3	of	of	ADP
ghmj-1070	104	4	cilia	cilia	NOUN
ghmj-1070	104	5	movement	movement	NOUN
ghmj-1070	104	6	is	be	AUX
ghmj-1070	104	7	one	one	NUM
ghmj-1070	104	8	of	of	ADP
ghmj-1070	104	9	the	the	DET
ghmj-1070	104	10	explanations	explanation	NOUN
ghmj-1070	104	11	for	for	ADP
ghmj-1070	104	12	a	a	DET
ghmj-1070	104	13	decrease	decrease	NOUN
ghmj-1070	104	14	in	in	ADP
ghmj-1070	104	15	lung	lung	NOUN
ghmj-1070	104	16	function	function	NOUN
ghmj-1070	104	17	.	.	PUNCT
ghmj-1070	105	1	cilia	cilia	NOUN
ghmj-1070	105	2	cleanse	cleanse	VERB
ghmj-1070	105	3	the	the	DET
ghmj-1070	105	4	lungs	lung	NOUN
ghmj-1070	105	5	from	from	ADP
ghmj-1070	105	6	particles	particle	NOUN
ghmj-1070	105	7	and	and	CCONJ
ghmj-1070	105	8	bacteria	bacteria	NOUN
ghmj-1070	105	9	.	.	PUNCT
ghmj-1070	106	1	if	if	SCONJ
ghmj-1070	106	2	the	the	DET
ghmj-1070	106	3	movement	movement	NOUN
ghmj-1070	106	4	of	of	ADP
ghmj-1070	106	5	cilia	cilia	NOUN
ghmj-1070	106	6	decreases	decrease	VERB
ghmj-1070	106	7	,	,	PUNCT
ghmj-1070	106	8	the	the	DET
ghmj-1070	106	9	lungs	lung	NOUN
ghmj-1070	106	10	become	become	VERB
ghmj-1070	106	11	susceptible	susceptible	ADJ
ghmj-1070	106	12	to	to	ADP
ghmj-1070	106	13	infection	infection	NOUN
ghmj-1070	106	14	.	.	PUNCT
ghmj-1070	107	1	the	the	DET
ghmj-1070	107	2	buildup	buildup	NOUN
ghmj-1070	107	3	of	of	ADP
ghmj-1070	107	4	unrepaired	unrepaired	ADJ
ghmj-1070	107	5	damage	damage	NOUN
ghmj-1070	107	6	caused	cause	VERB
ghmj-1070	107	7	by	by	ADP
ghmj-1070	107	8	carcinogen	carcinogen	NOUN
ghmj-1070	107	9	exposure	exposure	NOUN
ghmj-1070	107	10	,	,	PUNCT
ghmj-1070	107	11	such	such	ADJ
ghmj-1070	107	12	as	as	ADP
ghmj-1070	107	13	nicotine	nicotine	NOUN
ghmj-1070	107	14	,	,	PUNCT
ghmj-1070	107	15	the	the	DET
ghmj-1070	107	16	age	age	NOUN
ghmj-1070	107	17	related	relate	VERB
ghmj-1070	107	18	deterioration	deterioration	NOUN
ghmj-1070	107	19	in	in	ADP
ghmj-1070	107	20	the	the	DET
ghmj-1070	107	21	immune	immune	ADJ
ghmj-1070	107	22	system	system	NOUN
ghmj-1070	107	23	,	,	PUNCT
ghmj-1070	107	24	and	and	CCONJ
ghmj-1070	107	25	increased	increase	VERB
ghmj-1070	107	26	risk	risk	NOUN
ghmj-1070	107	27	of	of	ADP
ghmj-1070	107	28	lung	lung	NOUN
ghmj-1070	107	29	cancer	cancer	NOUN
ghmj-1070	107	30	as	as	ADP
ghmj-1070	107	31	people	people	NOUN
ghmj-1070	107	32	age	age	NOUN
ghmj-1070	107	33	.	.	PUNCT
ghmj-1070	108	1	the	the	DET
ghmj-1070	108	2	phrase	phrase	NOUN
ghmj-1070	108	3	“	"	PUNCT
ghmj-1070	108	4	lung	lung	NOUN
ghmj-1070	108	5	age	age	NOUN
ghmj-1070	108	6	”	"	PUNCT
ghmj-1070	108	7	(	(	PUNCT
ghmj-1070	108	8	calculated	calculate	VERB
ghmj-1070	108	9	from	from	ADP
ghmj-1070	108	10	age	age	NOUN
ghmj-1070	108	11	,	,	PUNCT
ghmj-1070	108	12	body	body	NOUN
ghmj-1070	108	13	height	height	NOUN
ghmj-1070	108	14	,	,	PUNCT
ghmj-1070	108	15	and	and	CCONJ
ghmj-1070	108	16	the	the	DET
ghmj-1070	108	17	first	first	ADJ
ghmj-1070	108	18	second	second	NOUN
ghmj-1070	108	19	of	of	ADP
ghmj-1070	108	20	forced	force	VERB
ghmj-1070	108	21	expiration	expiration	NOUN
ghmj-1070	108	22	)	)	PUNCT
ghmj-1070	108	23	has	have	AUX
ghmj-1070	108	24	demonstrated	demonstrate	VERB
ghmj-1070	108	25	to	to	PART
ghmj-1070	108	26	be	be	AUX
ghmj-1070	108	27	a	a	DET
ghmj-1070	108	28	predictor	predictor	NOUN
ghmj-1070	108	29	of	of	ADP
ghmj-1070	108	30	pulmonary	pulmonary	ADJ
ghmj-1070	108	31	obstructive	obstructive	ADJ
ghmj-1070	108	32	impairment	impairment	NOUN
ghmj-1070	108	33	and	and	CCONJ
ghmj-1070	108	34	substantially	substantially	ADV
ghmj-1070	108	35	linked	link	VERB
ghmj-1070	108	36	with	with	ADP
ghmj-1070	108	37	post	post	ADJ
ghmj-1070	108	38	-	-	ADJ
ghmj-1070	108	39	operative	operative	ADJ
ghmj-1070	108	40	breathing	breathing	NOUN
ghmj-1070	108	41	issues	issue	NOUN
ghmj-1070	108	42	and	and	CCONJ
ghmj-1070	108	43	survival	survival	NOUN
ghmj-1070	108	44	in	in	ADP
ghmj-1070	108	45	patients	patient	NOUN
ghmj-1070	108	46	with	with	ADP
ghmj-1070	108	47	lung	lung	NOUN
ghmj-1070	108	48	cancer	cancer	NOUN
ghmj-1070	108	49	(	(	PUNCT
ghmj-1070	108	50	ma	ma	PROPN
ghmj-1070	108	51	et	et	PROPN
ghmj-1070	108	52	al	al	PROPN
ghmj-1070	108	53	.	.	PROPN
ghmj-1070	108	54	2023	2023	NUM
ghmj-1070	108	55	;	;	PUNCT
ghmj-1070	108	56	pritami	pritami	NOUN
ghmj-1070	108	57	et	et	PROPN
ghmj-1070	108	58	al	al	PROPN
ghmj-1070	108	59	.	.	PROPN
ghmj-1070	108	60	2022	2022	NUM
ghmj-1070	108	61	)	)	PUNCT
ghmj-1070	108	62	.	.	PUNCT
ghmj-1070	109	1	the	the	DET
ghmj-1070	109	2	outcomes	outcome	NOUN
ghmj-1070	109	3	of	of	ADP
ghmj-1070	109	4	this	this	DET
ghmj-1070	109	5	study	study	NOUN
ghmj-1070	109	6	showed	show	VERB
ghmj-1070	109	7	that	that	SCONJ
ghmj-1070	109	8	lung	lung	NOUN
ghmj-1070	109	9	cancer	cancer	NOUN
ghmj-1070	109	10	patients	patient	NOUN
ghmj-1070	109	11	in	in	ADP
ghmj-1070	109	12	the	the	DET
ghmj-1070	109	13	cirebon	cirebon	NOUN
ghmj-1070	109	14	district	district	NOUN
ghmj-1070	109	15	are	be	AUX
ghmj-1070	109	16	more	more	ADV
ghmj-1070	109	17	likely	likely	ADJ
ghmj-1070	109	18	to	to	PART
ghmj-1070	109	19	be	be	AUX
ghmj-1070	109	20	male	male	ADJ
ghmj-1070	109	21	(	(	PUNCT
ghmj-1070	109	22	66.7	66.7	NUM
ghmj-1070	109	23	%	%	NOUN
ghmj-1070	109	24	)	)	PUNCT
ghmj-1070	109	25	than	than	ADP
ghmj-1070	109	26	female	female	ADJ
ghmj-1070	109	27	(	(	PUNCT
ghmj-1070	109	28	33.3	33.3	NUM
ghmj-1070	109	29	%	%	NOUN
ghmj-1070	109	30	)	)	PUNCT
ghmj-1070	109	31	.	.	PUNCT
ghmj-1070	110	1	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	110	2	is	be	AUX
ghmj-1070	110	3	more	more	ADV
ghmj-1070	110	4	common	common	ADJ
ghmj-1070	110	5	in	in	ADP
ghmj-1070	110	6	male	male	ADJ
ghmj-1070	110	7	(	(	PUNCT
ghmj-1070	110	8	42	42	NUM
ghmj-1070	110	9	%	%	NOUN
ghmj-1070	110	10	)	)	PUNCT
ghmj-1070	110	11	,	,	PUNCT
ghmj-1070	110	12	based	base	VERB
ghmj-1070	110	13	on	on	ADP
ghmj-1070	110	14	the	the	DET
ghmj-1070	110	15	type	type	NOUN
ghmj-1070	110	16	of	of	ADP
ghmj-1070	110	17	cancer	cancer	NOUN
ghmj-1070	110	18	cells	cell	NOUN
ghmj-1070	110	19	.	.	PUNCT
ghmj-1070	111	1	this	this	PRON
ghmj-1070	111	2	is	be	AUX
ghmj-1070	111	3	because	because	SCONJ
ghmj-1070	111	4	estrogen	estrogen	NOUN
ghmj-1070	111	5	regulates	regulate	VERB
ghmj-1070	111	6	the	the	DET
ghmj-1070	111	7	secretion	secretion	NOUN
ghmj-1070	111	8	of	of	ADP
ghmj-1070	111	9	inflammatory	inflammatory	ADJ
ghmj-1070	111	10	cytokines	cytokine	NOUN
ghmj-1070	111	11	by	by	ADP
ghmj-1070	111	12	macrophages	macrophage	NOUN
ghmj-1070	111	13	and	and	CCONJ
ghmj-1070	111	14	neutrophils	neutrophil	NOUN
ghmj-1070	111	15	,	,	PUNCT
ghmj-1070	111	16	lowering	lower	VERB
ghmj-1070	111	17	the	the	DET
ghmj-1070	111	18	risk	risk	NOUN
ghmj-1070	111	19	of	of	ADP
ghmj-1070	111	20	cancer	cancer	NOUN
ghmj-1070	111	21	in	in	ADP
ghmj-1070	111	22	female	female	NOUN
ghmj-1070	111	23	.	.	PUNCT
ghmj-1070	112	1	according	accord	VERB
ghmj-1070	112	2	to	to	ADP
ghmj-1070	112	3	who	who	PRON
ghmj-1070	112	4	,	,	PUNCT
ghmj-1070	112	5	squamous	squamous	ADJ
ghmj-1070	112	6	cell	cell	NOUN
ghmj-1070	112	7	carcinoma	carcinoma	NOUN
ghmj-1070	112	8	is	be	AUX
ghmj-1070	112	9	more	more	ADV
ghmj-1070	112	10	common	common	ADJ
ghmj-1070	112	11	in	in	ADP
ghmj-1070	112	12	male	male	NOUN
ghmj-1070	112	13	because	because	SCONJ
ghmj-1070	112	14	it	it	PRON
ghmj-1070	112	15	is	be	AUX
ghmj-1070	112	16	associated	associate	VERB
ghmj-1070	112	17	with	with	ADP
ghmj-1070	112	18	smoking	smoking	NOUN
ghmj-1070	112	19	behaviors	behavior	NOUN
ghmj-1070	112	20	,	,	PUNCT
ghmj-1070	112	21	which	which	PRON
ghmj-1070	112	22	are	be	AUX
ghmj-1070	112	23	more	more	ADV
ghmj-1070	112	24	often	often	ADV
ghmj-1070	112	25	practiced	practice	VERB
ghmj-1070	112	26	by	by	ADP
ghmj-1070	112	27	male	male	NOUN
ghmj-1070	112	28	than	than	ADP
ghmj-1070	112	29	female	female	ADJ
ghmj-1070	112	30	,	,	PUNCT
ghmj-1070	112	31	while	while	SCONJ
ghmj-1070	112	32	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	112	33	is	be	AUX
ghmj-1070	112	34	more	more	ADV
ghmj-1070	112	35	common	common	ADJ
ghmj-1070	112	36	in	in	ADP
ghmj-1070	112	37	female	female	NOUN
ghmj-1070	112	38	.	.	PUNCT
ghmj-1070	113	1	this	this	PRON
ghmj-1070	113	2	is	be	AUX
ghmj-1070	113	3	in	in	ADP
ghmj-1070	113	4	line	line	NOUN
ghmj-1070	113	5	with	with	ADP
ghmj-1070	113	6	this	this	DET
ghmj-1070	113	7	study	study	NOUN
ghmj-1070	113	8	where	where	SCONJ
ghmj-1070	113	9	squamous	squamous	ADJ
ghmj-1070	113	10	cell	cell	NOUN
ghmj-1070	113	11	carcinoma	carcinoma	NOUN
ghmj-1070	113	12	was	be	AUX
ghmj-1070	113	13	found	find	VERB
ghmj-1070	113	14	more	more	ADV
ghmj-1070	113	15	in	in	ADP
ghmj-1070	113	16	male	male	ADJ
ghmj-1070	113	17	(	(	PUNCT
ghmj-1070	113	18	15.9	15.9	NUM
ghmj-1070	113	19	%	%	NOUN
ghmj-1070	113	20	)	)	PUNCT
ghmj-1070	113	21	than	than	ADP
ghmj-1070	113	22	female	female	ADJ
ghmj-1070	113	23	(	(	PUNCT
ghmj-1070	113	24	2.9	2.9	NUM
ghmj-1070	113	25	%	%	NOUN
ghmj-1070	113	26	)	)	PUNCT
ghmj-1070	113	27	,	,	PUNCT
ghmj-1070	113	28	and	and	CCONJ
ghmj-1070	113	29	in	in	ADP
ghmj-1070	113	30	female	female	ADJ
ghmj-1070	113	31	patients	patient	NOUN
ghmj-1070	113	32	with	with	ADP
ghmj-1070	113	33	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	113	34	were	be	AUX
ghmj-1070	113	35	more	more	ADV
ghmj-1070	113	36	numerous	numerous	ADJ
ghmj-1070	113	37	than	than	ADP
ghmj-1070	113	38	other	other	ADJ
ghmj-1070	113	39	types	type	NOUN
ghmj-1070	113	40	of	of	ADP
ghmj-1070	113	41	cancer	cancer	NOUN
ghmj-1070	113	42	cells	cell	NOUN
ghmj-1070	113	43	(	(	PUNCT
ghmj-1070	113	44	27.5	27.5	NUM
ghmj-1070	113	45	%	%	NOUN
ghmj-1070	113	46	)	)	PUNCT
ghmj-1070	113	47	.	.	PUNCT
ghmj-1070	114	1	these	these	DET
ghmj-1070	114	2	findings	finding	NOUN
ghmj-1070	114	3	are	be	AUX
ghmj-1070	114	4	align	align	ADJ
ghmj-1070	114	5	with	with	ADP
ghmj-1070	114	6	those	those	PRON
ghmj-1070	114	7	of	of	ADP
ghmj-1070	114	8	the	the	DET
ghmj-1070	114	9	research	research	NOUN
ghmj-1070	114	10	conducted	conduct	VERB
ghmj-1070	114	11	by	by	ADP
ghmj-1070	114	12	putri	putri	PROPN
ghmj-1070	114	13	et	et	PROPN
ghmj-1070	114	14	al	al	PROPN
ghmj-1070	114	15	.	.	PROPN
ghmj-1070	115	1	(	(	PUNCT
ghmj-1070	115	2	2023	2023	NUM
ghmj-1070	115	3	)	)	PUNCT
ghmj-1070	115	4	which	which	PRON
ghmj-1070	115	5	was	be	AUX
ghmj-1070	115	6	conducted	conduct	VERB
ghmj-1070	115	7	at	at	ADP
ghmj-1070	115	8	dr	dr	PROPN
ghmj-1070	115	9	soedarso	soedarso	PROPN
ghmj-1070	115	10	hospital	hospital	PROPN
ghmj-1070	115	11	pontianak	pontianak	PROPN
ghmj-1070	115	12	,	,	PUNCT
ghmj-1070	115	13	with	with	ADP
ghmj-1070	115	14	82.7	82.7	NUM
ghmj-1070	115	15	%	%	NOUN
ghmj-1070	115	16	of	of	ADP
ghmj-1070	115	17	patients	patient	NOUN
ghmj-1070	115	18	were	be	AUX
ghmj-1070	115	19	male	male	ADJ
ghmj-1070	115	20	and	and	CCONJ
ghmj-1070	115	21	17.3	17.3	NUM
ghmj-1070	115	22	%	%	NOUN
ghmj-1070	115	23	were	be	AUX
ghmj-1070	115	24	female	female	ADJ
ghmj-1070	115	25	(	(	PUNCT
ghmj-1070	115	26	putri	putri	ADJ
ghmj-1070	115	27	,	,	PUNCT
ghmj-1070	115	28	pratiwi	pratiwi	NOUN
ghmj-1070	115	29	,	,	PUNCT
ghmj-1070	115	30	and	and	CCONJ
ghmj-1070	115	31	musawaris	musawaris	PROPN
ghmj-1070	115	32	2023	2023	NUM
ghmj-1070	115	33	;	;	PUNCT
ghmj-1070	115	34	travis	travis	PROPN
ghmj-1070	115	35	et	et	PROPN
ghmj-1070	115	36	al	al	PROPN
ghmj-1070	115	37	.	.	PROPN
ghmj-1070	115	38	2005	2005	NUM
ghmj-1070	115	39	;	;	PUNCT
ghmj-1070	115	40	vavalà	vavalà	NOUN
ghmj-1070	115	41	et	et	PROPN
ghmj-1070	115	42	al	al	PROPN
ghmj-1070	115	43	.	.	PROPN
ghmj-1070	115	44	2021	2021	NUM
ghmj-1070	115	45	)	)	PUNCT
ghmj-1070	115	46	.	.	PUNCT
ghmj-1070	116	1	female	female	ADJ
ghmj-1070	116	2	patients	patient	NOUN
ghmj-1070	116	3	are	be	AUX
ghmj-1070	116	4	more	more	ADV
ghmj-1070	116	5	likely	likely	ADJ
ghmj-1070	116	6	than	than	SCONJ
ghmj-1070	116	7	male	male	ADJ
ghmj-1070	116	8	patients	patient	NOUN
ghmj-1070	116	9	to	to	PART
ghmj-1070	116	10	be	be	AUX
ghmj-1070	116	11	diagnosed	diagnose	VERB
ghmj-1070	116	12	with	with	ADP
ghmj-1070	116	13	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	116	14	at	at	ADP
ghmj-1070	116	15	a	a	DET
ghmj-1070	116	16	younger	young	ADJ
ghmj-1070	116	17	age	age	NOUN
ghmj-1070	116	18	,	,	PUNCT
ghmj-1070	116	19	inherit	inherit	VERB
ghmj-1070	116	20	cancer	cancer	NOUN
ghmj-1070	116	21	from	from	ADP
ghmj-1070	116	22	their	their	PRON
ghmj-1070	116	23	families	family	NOUN
ghmj-1070	116	24	,	,	PUNCT
ghmj-1070	116	25	and	and	CCONJ
ghmj-1070	116	26	have	have	AUX
ghmj-1070	116	27	had	have	VERB
ghmj-1070	116	28	less	less	ADJ
ghmj-1070	116	29	exposure	exposure	NOUN
ghmj-1070	116	30	to	to	ADP
ghmj-1070	116	31	tobacco	tobacco	NOUN
ghmj-1070	116	32	.	.	PUNCT
ghmj-1070	117	1	smoking	smoking	NOUN
ghmj-1070	117	2	has	have	AUX
ghmj-1070	117	3	been	be	AUX
ghmj-1070	117	4	identified	identify	VERB
ghmj-1070	117	5	as	as	ADP
ghmj-1070	117	6	one	one	NUM
ghmj-1070	117	7	of	of	ADP
ghmj-1070	117	8	the	the	DET
ghmj-1070	117	9	causes	cause	NOUN
ghmj-1070	117	10	of	of	ADP
ghmj-1070	117	11	lung	lung	NOUN
ghmj-1070	117	12	cancer	cancer	NOUN
ghmj-1070	117	13	in	in	ADP
ghmj-1070	117	14	both	both	CCONJ
ghmj-1070	117	15	male	male	ADJ
ghmj-1070	117	16	and	and	CCONJ
ghmj-1070	117	17	female	female	NOUN
ghmj-1070	117	18	.	.	PUNCT
ghmj-1070	118	1	polypeptide	polypeptide	ADJ
ghmj-1070	118	2	1	1	NUM
ghmj-1070	118	3	,	,	PUNCT
ghmj-1070	118	4	family	family	NOUN
ghmj-1070	118	5	1	1	NUM
ghmj-1070	118	6	,	,	PUNCT
ghmj-1070	118	7	polymorphisms	polymorphism	NOUN
ghmj-1070	118	8	of	of	ADP
ghmj-1070	118	9	cytochrome	cytochrome	NOUN
ghmj-1070	118	10	p450	p450	NUM
ghmj-1070	118	11	,	,	PUNCT
ghmj-1070	118	12	subfamily	subfamily	ADV
ghmj-1070	118	13	a	a	PRON
ghmj-1070	118	14	that	that	PRON
ghmj-1070	118	15	can	can	AUX
ghmj-1070	118	16	impair	impair	VERB
ghmj-1070	118	17	dna	dna	PROPN
ghmj-1070	118	18	repair	repair	NOUN
ghmj-1070	118	19	,	,	PUNCT
ghmj-1070	118	20	x	x	ADJ
ghmj-1070	118	21	-	-	VERB
ghmj-1070	118	22	linked	link	VERB
ghmj-1070	118	23	gastrin	gastrin	NOUN
ghmj-1070	118	24	-	-	PUNCT
ghmj-1070	118	25	releasing	release	VERB
ghmj-1070	118	26	peptide	peptide	ADJ
ghmj-1070	118	27	receptor	receptor	NOUN
ghmj-1070	118	28	overexpression	overexpression	NOUN
ghmj-1070	118	29	,	,	PUNCT
ghmj-1070	118	30	and	and	CCONJ
ghmj-1070	118	31	p53	p53	NOUN
ghmj-1070	118	32	mutations	mutation	NOUN
ghmj-1070	118	33	are	be	AUX
ghmj-1070	118	34	among	among	ADP
ghmj-1070	118	35	the	the	DET
ghmj-1070	118	36	genetic	genetic	ADJ
ghmj-1070	118	37	variants	variant	NOUN
ghmj-1070	118	38	associated	associate	VERB
ghmj-1070	118	39	with	with	ADP
ghmj-1070	118	40	lung	lung	NOUN
ghmj-1070	118	41	cancer	cancer	NOUN
ghmj-1070	118	42	in	in	ADP
ghmj-1070	118	43	the	the	DET
ghmj-1070	118	44	non	non	ADJ
ghmj-1070	118	45	-	-	ADJ
ghmj-1070	118	46	smoking	smoking	ADJ
ghmj-1070	118	47	population	population	NOUN
ghmj-1070	118	48	.	.	PUNCT
ghmj-1070	119	1	most	most	ADJ
ghmj-1070	119	2	of	of	ADP
ghmj-1070	119	3	the	the	DET
ghmj-1070	119	4	potential	potential	ADJ
ghmj-1070	119	5	carcinogens	carcinogen	NOUN
ghmj-1070	119	6	present	present	ADJ
ghmj-1070	119	7	in	in	ADP
ghmj-1070	119	8	cigarette	cigarette	NOUN
ghmj-1070	119	9	smoke	smoke	NOUN
ghmj-1070	119	10	are	be	AUX
ghmj-1070	119	11	polycyclic	polycyclic	ADJ
ghmj-1070	119	12	hydrocarbons	hydrocarbon	NOUN
ghmj-1070	119	13	,	,	PUNCT
ghmj-1070	119	14	amino	amino	NOUN
ghmj-1070	119	15	aromatics	aromatic	NOUN
ghmj-1070	119	16	and	and	CCONJ
ghmj-1070	119	17	heavy	heavy	ADJ
ghmj-1070	119	18	metals	metal	NOUN
ghmj-1070	119	19	such	such	ADJ
ghmj-1070	119	20	as	as	ADP
ghmj-1070	119	21	nickel	nickel	NOUN
ghmj-1070	119	22	.	.	PUNCT
ghmj-1070	120	1	cigarette	cigarette	NOUN
ghmj-1070	120	2	smoking	smoking	NOUN
ghmj-1070	120	3	causes	cause	VERB
ghmj-1070	120	4	cilia	cilia	NOUN
ghmj-1070	120	5	to	to	PART
ghmj-1070	120	6	disappear	disappear	VERB
ghmj-1070	120	7	and	and	CCONJ
ghmj-1070	120	8	progression	progression	NOUN
ghmj-1070	120	9	to	to	ADP
ghmj-1070	120	10	carcinoma	carcinoma	NOUN
ghmj-1070	120	11	in	in	ADP
ghmj-1070	120	12	situ	situ	NOUN
ghmj-1070	120	13	.	.	PUNCT
ghmj-1070	121	1	a	a	DET
ghmj-1070	121	2	study	study	NOUN
ghmj-1070	121	3	accomplished	accomplish	VERB
ghmj-1070	121	4	by	by	ADP
ghmj-1070	121	5	salsabila	salsabila	PROPN
ghmj-1070	121	6	et	et	PROPN
ghmj-1070	121	7	al	al	PROPN
ghmj-1070	121	8	.	.	PROPN
ghmj-1070	121	9	(	(	PUNCT
ghmj-1070	121	10	2023	2023	NUM
ghmj-1070	121	11	)	)	PUNCT
ghmj-1070	121	12	found	find	VERB
ghmj-1070	121	13	that	that	SCONJ
ghmj-1070	121	14	patients	patient	NOUN
ghmj-1070	121	15	who	who	PRON
ghmj-1070	121	16	smoked	smoke	VERB
ghmj-1070	121	17	(	(	PUNCT
ghmj-1070	121	18	74	74	NUM
ghmj-1070	121	19	%	%	NOUN
ghmj-1070	121	20	)	)	PUNCT
ghmj-1070	121	21	were	be	AUX
ghmj-1070	121	22	more	more	ADJ
ghmj-1070	121	23	than	than	ADP
ghmj-1070	121	24	patients	patient	NOUN
ghmj-1070	121	25	who	who	PRON
ghmj-1070	121	26	did	do	AUX
ghmj-1070	121	27	not	not	PART
ghmj-1070	121	28	smoke	smoke	VERB
ghmj-1070	121	29	(	(	PUNCT
ghmj-1070	121	30	9.4	9.4	NUM
ghmj-1070	121	31	%	%	NOUN
ghmj-1070	121	32	)	)	PUNCT
ghmj-1070	121	33	.	.	PUNCT
ghmj-1070	122	1	however	however	ADV
ghmj-1070	122	2	,	,	PUNCT
ghmj-1070	122	3	this	this	DET
ghmj-1070	122	4	study	study	NOUN
ghmj-1070	122	5	discovered	discover	VERB
ghmj-1070	122	6	that	that	SCONJ
ghmj-1070	122	7	98.6	98.6	NUM
ghmj-1070	122	8	%	%	NOUN
ghmj-1070	122	9	of	of	ADP
ghmj-1070	122	10	patients	patient	NOUN
ghmj-1070	122	11	did	do	AUX
ghmj-1070	122	12	not	not	PART
ghmj-1070	122	13	have	have	VERB
ghmj-1070	122	14	information	information	NOUN
ghmj-1070	122	15	about	about	ADP
ghmj-1070	122	16	their	their	PRON
ghmj-1070	122	17	smoking	smoking	NOUN
ghmj-1070	122	18	history	history	NOUN
ghmj-1070	122	19	(	(	PUNCT
ghmj-1070	122	20	kementrian	kementrian	NOUN
ghmj-1070	122	21	kesehatan	kesehatan	PROPN
ghmj-1070	122	22	republik	republik	PROPN
ghmj-1070	122	23	indonesia	indonesia	PROPN
ghmj-1070	122	24	2018	2018	NUM
ghmj-1070	122	25	;	;	PUNCT
ghmj-1070	122	26	kusumawardani	kusumawardani	PROPN
ghmj-1070	122	27	et	et	PROPN
ghmj-1070	122	28	al	al	PROPN
ghmj-1070	122	29	.	.	PROPN
ghmj-1070	122	30	2022	2022	NUM
ghmj-1070	122	31	;	;	PUNCT
ghmj-1070	122	32	salsabila	salsabila	PROPN
ghmj-1070	122	33	,	,	PUNCT
ghmj-1070	122	34	intan	intan	PROPN
ghmj-1070	122	35	,	,	PUNCT
ghmj-1070	122	36	and	and	CCONJ
ghmj-1070	122	37	fitrina	fitrina	NOUN
ghmj-1070	122	38	2023	2023	NUM
ghmj-1070	122	39	)	)	PUNCT
ghmj-1070	122	40	.	.	PUNCT
ghmj-1070	123	1	sulaeman	sulaeman	PROPN
ghmj-1070	123	2	,	,	PUNCT
ghmj-1070	123	3	et	et	PROPN
ghmj-1070	123	4	.	.	PUNCT
ghmj-1070	124	1	al	al	PROPN
ghmj-1070	124	2	.	.	PROPN
ghmj-1070	124	3	ghmj	ghmj	PROPN
ghmj-1070	124	4	(	(	PUNCT
ghmj-1070	124	5	global	global	ADJ
ghmj-1070	124	6	health	health	PROPN
ghmj-1070	124	7	management	management	NOUN
ghmj-1070	124	8	journal	journal	PROPN
ghmj-1070	124	9	)	)	PUNCT
ghmj-1070	124	10	2024	2024	NUM
ghmj-1070	124	11	,	,	PUNCT
ghmj-1070	124	12	vol	vol	NOUN
ghmj-1070	124	13	.	.	PROPN
ghmj-1070	124	14	7	7	NUM
ghmj-1070	124	15	,	,	PUNCT
ghmj-1070	124	16	no	no	INTJ
ghmj-1070	124	17	.	.	NOUN
ghmj-1070	124	18	4	4	NUM
ghmj-1070	124	19	298	298	NUM
ghmj-1070	124	20	according	accord	VERB
ghmj-1070	124	21	to	to	ADP
ghmj-1070	124	22	data	datum	NOUN
ghmj-1070	124	23	from	from	ADP
ghmj-1070	124	24	the	the	DET
ghmj-1070	124	25	central	central	ADJ
ghmj-1070	124	26	statistics	statistic	NOUN
ghmj-1070	124	27	agency	agency	PROPN
ghmj-1070	124	28	of	of	ADP
ghmj-1070	124	29	west	west	PROPN
ghmj-1070	124	30	java	java	PROPN
ghmj-1070	124	31	province	province	PROPN
ghmj-1070	124	32	in	in	ADP
ghmj-1070	124	33	2023	2023	NUM
ghmj-1070	124	34	,	,	PUNCT
ghmj-1070	124	35	the	the	DET
ghmj-1070	124	36	percentage	percentage	NOUN
ghmj-1070	124	37	of	of	ADP
ghmj-1070	124	38	the	the	DET
ghmj-1070	124	39	population	population	NOUN
ghmj-1070	124	40	aged	age	VERB
ghmj-1070	124	41	15	15	NUM
ghmj-1070	124	42	and	and	CCONJ
ghmj-1070	124	43	up	up	ADV
ghmj-1070	124	44	who	who	PRON
ghmj-1070	124	45	smoke	smoke	VERB
ghmj-1070	124	46	in	in	ADP
ghmj-1070	124	47	cirebon	cirebon	NOUN
ghmj-1070	124	48	district	district	NOUN
ghmj-1070	124	49	in	in	ADP
ghmj-1070	124	50	15.34	15.34	NUM
ghmj-1070	124	51	%	%	NOUN
ghmj-1070	124	52	in	in	ADP
ghmj-1070	124	53	the	the	DET
ghmj-1070	124	54	age	age	NOUN
ghmj-1070	124	55	group	group	NOUN
ghmj-1070	124	56	,	,	PUNCT
ghmj-1070	124	57	24.80	24.80	NUM
ghmj-1070	124	58	%	%	NOUN
ghmj-1070	124	59	in	in	ADP
ghmj-1070	124	60	the	the	DET
ghmj-1070	124	61	age	age	NOUN
ghmj-1070	124	62	25	25	NUM
ghmj-1070	124	63	-	-	SYM
ghmj-1070	124	64	34	34	NUM
ghmj-1070	124	65	age	age	NOUN
ghmj-1070	124	66	group	group	NOUN
ghmj-1070	124	67	,	,	PUNCT
ghmj-1070	124	68	17.76	17.76	NUM
ghmj-1070	124	69	%	%	NOUN
ghmj-1070	124	70	in	in	ADP
ghmj-1070	124	71	the	the	DET
ghmj-1070	124	72	45	45	NUM
ghmj-1070	124	73	-	-	SYM
ghmj-1070	124	74	54	54	NUM
ghmj-1070	124	75	%	%	NOUN
ghmj-1070	124	76	age	age	NOUN
ghmj-1070	124	77	group	group	NOUN
ghmj-1070	124	78	,	,	PUNCT
ghmj-1070	124	79	12.37	12.37	NUM
ghmj-1070	124	80	%	%	NOUN
ghmj-1070	124	81	in	in	ADP
ghmj-1070	124	82	the	the	DET
ghmj-1070	124	83	55	55	NUM
ghmj-1070	124	84	-	-	SYM
ghmj-1070	124	85	64	64	NUM
ghmj-1070	124	86	age	age	NOUN
ghmj-1070	124	87	group	group	NOUN
ghmj-1070	124	88	,	,	PUNCT
ghmj-1070	124	89	and	and	CCONJ
ghmj-1070	124	90	6.67	6.67	NUM
ghmj-1070	124	91	%	%	NOUN
ghmj-1070	124	92	in	in	ADP
ghmj-1070	124	93	those	those	DET
ghmj-1070	124	94	over	over	ADP
ghmj-1070	124	95	65	65	NUM
ghmj-1070	124	96	age	age	NOUN
ghmj-1070	124	97	group	group	NOUN
ghmj-1070	124	98	.	.	PUNCT
ghmj-1070	125	1	the	the	DET
ghmj-1070	125	2	large	large	ADJ
ghmj-1070	125	3	number	number	NOUN
ghmj-1070	125	4	of	of	ADP
ghmj-1070	125	5	smokers	smoker	NOUN
ghmj-1070	125	6	in	in	ADP
ghmj-1070	125	7	cirebon	cirebon	NOUN
ghmj-1070	125	8	district	district	NOUN
ghmj-1070	125	9	may	may	AUX
ghmj-1070	125	10	be	be	AUX
ghmj-1070	125	11	a	a	DET
ghmj-1070	125	12	risk	risk	NOUN
ghmj-1070	125	13	factor	factor	NOUN
ghmj-1070	125	14	for	for	ADP
ghmj-1070	125	15	lung	lung	NOUN
ghmj-1070	125	16	cancer	cancer	NOUN
ghmj-1070	125	17	diagnoses	diagnosis	NOUN
ghmj-1070	125	18	,	,	PUNCT
ghmj-1070	125	19	although	although	SCONJ
ghmj-1070	125	20	the	the	DET
ghmj-1070	125	21	majority	majority	NOUN
ghmj-1070	125	22	of	of	ADP
ghmj-1070	125	23	the	the	DET
ghmj-1070	125	24	diagnosed	diagnose	VERB
ghmj-1070	125	25	patients	patient	NOUN
ghmj-1070	125	26	in	in	ADP
ghmj-1070	125	27	this	this	DET
ghmj-1070	125	28	study	study	NOUN
ghmj-1070	125	29	did	do	AUX
ghmj-1070	125	30	not	not	PART
ghmj-1070	125	31	provide	provide	VERB
ghmj-1070	125	32	smoking	smoking	NOUN
ghmj-1070	125	33	history	history	NOUN
ghmj-1070	125	34	information	information	NOUN
ghmj-1070	125	35	.	.	PUNCT
ghmj-1070	126	1	risk	risk	NOUN
ghmj-1070	126	2	factors	factor	NOUN
ghmj-1070	126	3	are	be	AUX
ghmj-1070	126	4	not	not	PART
ghmj-1070	126	5	restricted	restrict	VERB
ghmj-1070	126	6	to	to	ADP
ghmj-1070	126	7	active	active	ADJ
ghmj-1070	126	8	smokers	smoker	NOUN
ghmj-1070	126	9	.	.	PUNCT
ghmj-1070	127	1	other	other	ADJ
ghmj-1070	127	2	risk	risk	NOUN
ghmj-1070	127	3	factors	factor	NOUN
ghmj-1070	127	4	,	,	PUNCT
ghmj-1070	127	5	such	such	ADJ
ghmj-1070	127	6	as	as	ADP
ghmj-1070	127	7	second	second	ADJ
ghmj-1070	127	8	-	-	PUNCT
ghmj-1070	127	9	hand	hand	NOUN
ghmj-1070	127	10	smoke	smoke	NOUN
ghmj-1070	127	11	,	,	PUNCT
ghmj-1070	127	12	radon	radon	NOUN
ghmj-1070	127	13	exposure	exposure	NOUN
ghmj-1070	127	14	,	,	PUNCT
ghmj-1070	127	15	environmental	environmental	ADJ
ghmj-1070	127	16	exposure	exposure	NOUN
ghmj-1070	127	17	to	to	ADP
ghmj-1070	127	18	industrial	industrial	ADJ
ghmj-1070	127	19	carcinogens	carcinogen	NOUN
ghmj-1070	127	20	and	and	CCONJ
ghmj-1070	127	21	air	air	NOUN
ghmj-1070	127	22	pollution	pollution	NOUN
ghmj-1070	127	23	.	.	PUNCT
ghmj-1070	128	1	the	the	DET
ghmj-1070	128	2	most	most	ADV
ghmj-1070	128	3	well	well	ADV
ghmj-1070	128	4	-	-	PUNCT
ghmj-1070	128	5	known	know	VERB
ghmj-1070	128	6	occupational	occupational	ADJ
ghmj-1070	128	7	lung	lung	NOUN
ghmj-1070	128	8	carcinogen	carcinogen	NOUN
ghmj-1070	128	9	is	be	AUX
ghmj-1070	128	10	asbestos	asbestos	NOUN
ghmj-1070	128	11	,	,	PUNCT
ghmj-1070	128	12	which	which	PRON
ghmj-1070	128	13	is	be	AUX
ghmj-1070	128	14	frequently	frequently	ADV
ghmj-1070	128	15	found	find	VERB
ghmj-1070	128	16	in	in	ADP
ghmj-1070	128	17	building	build	VERB
ghmj-1070	128	18	materials	material	NOUN
ghmj-1070	128	19	and	and	CCONJ
ghmj-1070	128	20	vehicles	vehicle	NOUN
ghmj-1070	128	21	.	.	PUNCT
ghmj-1070	129	1	smoking	smoke	VERB
ghmj-1070	129	2	after	after	SCONJ
ghmj-1070	129	3	asbestos	asbestos	NOUN
ghmj-1070	129	4	exposure	exposure	NOUN
ghmj-1070	129	5	raises	raise	VERB
ghmj-1070	129	6	the	the	DET
ghmj-1070	129	7	risk	risk	NOUN
ghmj-1070	129	8	of	of	ADP
ghmj-1070	129	9	lung	lung	NOUN
ghmj-1070	129	10	cancer	cancer	NOUN
ghmj-1070	129	11	.	.	PUNCT
ghmj-1070	130	1	air	air	NOUN
ghmj-1070	130	2	pollution	pollution	NOUN
ghmj-1070	130	3	is	be	AUX
ghmj-1070	130	4	defined	define	VERB
ghmj-1070	130	5	as	as	ADP
ghmj-1070	130	6	air	air	NOUN
ghmj-1070	130	7	that	that	PRON
ghmj-1070	130	8	has	have	AUX
ghmj-1070	130	9	been	be	AUX
ghmj-1070	130	10	contaminated	contaminate	VERB
ghmj-1070	130	11	with	with	ADP
ghmj-1070	130	12	chemical	chemical	NOUN
ghmj-1070	130	13	,	,	PUNCT
ghmj-1070	130	14	physical	physical	ADJ
ghmj-1070	130	15	,	,	PUNCT
ghmj-1070	130	16	or	or	CCONJ
ghmj-1070	130	17	biological	biological	ADJ
ghmj-1070	130	18	elements	element	NOUN
ghmj-1070	130	19	that	that	PRON
ghmj-1070	130	20	,	,	PUNCT
ghmj-1070	130	21	when	when	SCONJ
ghmj-1070	130	22	placed	place	VERB
ghmj-1070	130	23	in	in	ADP
ghmj-1070	130	24	the	the	DET
ghmj-1070	130	25	lungs	lung	NOUN
ghmj-1070	130	26	,	,	PUNCT
ghmj-1070	130	27	might	might	AUX
ghmj-1070	130	28	initiate	initiate	VERB
ghmj-1070	130	29	the	the	DET
ghmj-1070	130	30	carcinogenesis	carcinogenesis	NOUN
ghmj-1070	130	31	process	process	NOUN
ghmj-1070	130	32	(	(	PUNCT
ghmj-1070	130	33	balzer	balzer	PROPN
ghmj-1070	130	34	et	et	PROPN
ghmj-1070	130	35	al	al	PROPN
ghmj-1070	130	36	.	.	PROPN
ghmj-1070	130	37	2018	2018	NUM
ghmj-1070	130	38	;	;	PUNCT
ghmj-1070	130	39	buana	buana	PROPN
ghmj-1070	130	40	and	and	CCONJ
ghmj-1070	130	41	agustian	agustian	PROPN
ghmj-1070	130	42	harahap	harahap	ADJ
ghmj-1070	130	43	2022	2022	NUM
ghmj-1070	130	44	)	)	PUNCT
ghmj-1070	130	45	.	.	PUNCT
ghmj-1070	131	1	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	131	2	was	be	AUX
ghmj-1070	131	3	the	the	DET
ghmj-1070	131	4	most	most	ADV
ghmj-1070	131	5	often	often	ADV
ghmj-1070	131	6	diagnosed	diagnose	VERB
ghmj-1070	131	7	cancer	cancer	NOUN
ghmj-1070	131	8	in	in	ADP
ghmj-1070	131	9	this	this	DET
ghmj-1070	131	10	study	study	NOUN
ghmj-1070	131	11	(	(	PUNCT
ghmj-1070	131	12	69.6	69.6	NUM
ghmj-1070	131	13	%	%	NOUN
ghmj-1070	131	14	)	)	PUNCT
ghmj-1070	131	15	,	,	PUNCT
ghmj-1070	131	16	followed	follow	VERB
ghmj-1070	131	17	by	by	ADP
ghmj-1070	131	18	squamous	squamous	ADJ
ghmj-1070	131	19	cell	cell	NOUN
ghmj-1070	131	20	carcinoma	carcinoma	NOUN
ghmj-1070	131	21	(	(	PUNCT
ghmj-1070	131	22	18.8	18.8	NUM
ghmj-1070	131	23	%	%	NOUN
ghmj-1070	131	24	)	)	PUNCT
ghmj-1070	131	25	.	.	PUNCT
ghmj-1070	132	1	these	these	DET
ghmj-1070	132	2	findings	finding	NOUN
ghmj-1070	132	3	align	align	VERB
ghmj-1070	132	4	with	with	ADP
ghmj-1070	132	5	the	the	DET
ghmj-1070	132	6	study	study	NOUN
ghmj-1070	132	7	accomplished	accomplish	VERB
ghmj-1070	132	8	by	by	ADP
ghmj-1070	132	9	salsabila	salsabila	PROPN
ghmj-1070	132	10	et	et	PROPN
ghmj-1070	132	11	al	al	PROPN
ghmj-1070	132	12	.	.	PROPN
ghmj-1070	132	13	(	(	PUNCT
ghmj-1070	132	14	2023	2023	NUM
ghmj-1070	132	15	)	)	PUNCT
ghmj-1070	132	16	,	,	PUNCT
ghmj-1070	132	17	who	who	PRON
ghmj-1070	132	18	found	find	VERB
ghmj-1070	132	19	that	that	SCONJ
ghmj-1070	132	20	60.4	60.4	NUM
ghmj-1070	132	21	%	%	NOUN
ghmj-1070	132	22	of	of	ADP
ghmj-1070	132	23	patients	patient	NOUN
ghmj-1070	132	24	had	have	VERB
ghmj-1070	132	25	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	132	26	and	and	CCONJ
ghmj-1070	132	27	34.9	34.9	NUM
ghmj-1070	132	28	%	%	NOUN
ghmj-1070	132	29	had	have	VERB
ghmj-1070	132	30	squamous	squamous	ADJ
ghmj-1070	132	31	cell	cell	NOUN
ghmj-1070	132	32	carcinoma	carcinoma	NOUN
ghmj-1070	132	33	.	.	PUNCT
ghmj-1070	133	1	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	133	2	spreads	spread	NOUN
ghmj-1070	133	3	mainly	mainly	ADV
ghmj-1070	133	4	through	through	ADP
ghmj-1070	133	5	lymphatic	lymphatic	ADJ
ghmj-1070	133	6	and	and	CCONJ
ghmj-1070	133	7	hematogenous	hematogenous	ADJ
ghmj-1070	133	8	pathways	pathway	NOUN
ghmj-1070	133	9	.	.	PUNCT
ghmj-1070	134	1	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	134	2	is	be	AUX
ghmj-1070	134	3	a	a	DET
ghmj-1070	134	4	type	type	NOUN
ghmj-1070	134	5	of	of	ADP
ghmj-1070	134	6	cancer	cancer	NOUN
ghmj-1070	134	7	cell	cell	NOUN
ghmj-1070	134	8	that	that	PRON
ghmj-1070	134	9	is	be	AUX
ghmj-1070	134	10	common	common	ADJ
ghmj-1070	134	11	in	in	ADP
ghmj-1070	134	12	female	female	ADJ
ghmj-1070	134	13	and	and	CCONJ
ghmj-1070	134	14	often	often	ADV
ghmj-1070	134	15	occurs	occur	VERB
ghmj-1070	134	16	in	in	ADP
ghmj-1070	134	17	patients	patient	NOUN
ghmj-1070	134	18	who	who	PRON
ghmj-1070	134	19	are	be	AUX
ghmj-1070	134	20	non	non	ADJ
ghmj-1070	134	21	-	-	NOUN
ghmj-1070	134	22	smokers	smoker	NOUN
ghmj-1070	134	23	.	.	PUNCT
ghmj-1070	135	1	whereas	whereas	ADV
ghmj-1070	135	2	,	,	PUNCT
ghmj-1070	135	3	squamous	squamous	ADJ
ghmj-1070	135	4	cell	cell	NOUN
ghmj-1070	135	5	carcinoma	carcinoma	NOUN
ghmj-1070	135	6	occurs	occur	VERB
ghmj-1070	135	7	in	in	ADP
ghmj-1070	135	8	90	90	NUM
ghmj-1070	135	9	%	%	NOUN
ghmj-1070	135	10	of	of	ADP
ghmj-1070	135	11	patients	patient	NOUN
ghmj-1070	135	12	who	who	PRON
ghmj-1070	135	13	are	be	AUX
ghmj-1070	135	14	smokers	smoker	NOUN
ghmj-1070	135	15	.	.	PUNCT
ghmj-1070	136	1	squamous	squamous	ADJ
ghmj-1070	136	2	cell	cell	NOUN
ghmj-1070	136	3	carcinoma	carcinoma	NOUN
ghmj-1070	136	4	patients	patient	NOUN
ghmj-1070	136	5	typically	typically	ADV
ghmj-1070	136	6	have	have	VERB
ghmj-1070	136	7	poor	poor	ADJ
ghmj-1070	136	8	prognosis	prognosis	NOUN
ghmj-1070	136	9	because	because	SCONJ
ghmj-1070	136	10	the	the	DET
ghmj-1070	136	11	cancer	cancer	NOUN
ghmj-1070	136	12	is	be	AUX
ghmj-1070	136	13	most	most	ADV
ghmj-1070	136	14	common	common	ADJ
ghmj-1070	136	15	in	in	ADP
ghmj-1070	136	16	smokers	smoker	NOUN
ghmj-1070	136	17	with	with	ADP
ghmj-1070	136	18	concurrent	concurrent	ADJ
ghmj-1070	136	19	diseases	disease	NOUN
ghmj-1070	136	20	such	such	ADJ
ghmj-1070	136	21	cerebral	cerebral	ADJ
ghmj-1070	136	22	infraction	infraction	NOUN
ghmj-1070	136	23	,	,	PUNCT
ghmj-1070	136	24	chronic	chronic	ADJ
ghmj-1070	136	25	obstructive	obstructive	ADJ
ghmj-1070	136	26	pulmonary	pulmonary	ADJ
ghmj-1070	136	27	disease	disease	NOUN
ghmj-1070	136	28	,	,	PUNCT
ghmj-1070	136	29	and	and	CCONJ
ghmj-1070	136	30	cardiovascular	cardiovascular	ADJ
ghmj-1070	136	31	atherosclerosis	atherosclerosis	NOUN
ghmj-1070	136	32	.	.	PUNCT
ghmj-1070	137	1	based	base	VERB
ghmj-1070	137	2	on	on	ADP
ghmj-1070	137	3	lung	lung	NOUN
ghmj-1070	137	4	cancer	cancer	NOUN
ghmj-1070	137	5	staging	staging	NOUN
ghmj-1070	137	6	,	,	PUNCT
ghmj-1070	137	7	most	most	ADJ
ghmj-1070	137	8	lung	lung	NOUN
ghmj-1070	137	9	cancer	cancer	NOUN
ghmj-1070	137	10	patients	patient	NOUN
ghmj-1070	137	11	did	do	AUX
ghmj-1070	137	12	not	not	PART
ghmj-1070	137	13	have	have	VERB
ghmj-1070	137	14	information	information	NOUN
ghmj-1070	137	15	related	relate	VERB
ghmj-1070	137	16	to	to	ADP
ghmj-1070	137	17	staging	stage	VERB
ghmj-1070	137	18	(	(	PUNCT
ghmj-1070	137	19	89.9	89.9	NUM
ghmj-1070	137	20	%	%	NOUN
ghmj-1070	137	21	)	)	PUNCT
ghmj-1070	137	22	.	.	PUNCT
ghmj-1070	138	1	however	however	ADV
ghmj-1070	138	2	,	,	PUNCT
ghmj-1070	138	3	according	accord	VERB
ghmj-1070	138	4	to	to	ADP
ghmj-1070	138	5	the	the	DET
ghmj-1070	138	6	study	study	NOUN
ghmj-1070	138	7	’s	’s	PART
ghmj-1070	138	8	findings	finding	NOUN
ghmj-1070	138	9	,	,	PUNCT
ghmj-1070	138	10	there	there	PRON
ghmj-1070	138	11	are	be	VERB
ghmj-1070	138	12	4	4	NUM
ghmj-1070	138	13	patients	patient	NOUN
ghmj-1070	138	14	with	with	ADP
ghmj-1070	138	15	stage	stage	NOUN
ghmj-1070	138	16	4	4	NUM
ghmj-1070	138	17	lung	lung	NOUN
ghmj-1070	138	18	cancer	cancer	NOUN
ghmj-1070	138	19	.	.	PUNCT
ghmj-1070	139	1	the	the	DET
ghmj-1070	139	2	therapy	therapy	NOUN
ghmj-1070	139	3	of	of	ADP
ghmj-1070	139	4	choice	choice	NOUN
ghmj-1070	139	5	in	in	ADP
ghmj-1070	139	6	patients	patient	NOUN
ghmj-1070	139	7	with	with	ADP
ghmj-1070	139	8	staging	stage	VERB
ghmj-1070	139	9	4	4	NUM
ghmj-1070	139	10	is	be	AUX
ghmj-1070	139	11	chemotherapy	chemotherapy	NOUN
ghmj-1070	139	12	palliative	palliative	NOUN
ghmj-1070	139	13	,	,	PUNCT
ghmj-1070	139	14	radiotherapy	radiotherapy	NOUN
ghmj-1070	139	15	palliative	palliative	NOUN
ghmj-1070	139	16	,	,	PUNCT
ghmj-1070	139	17	targeted	target	VERB
ghmj-1070	139	18	therapy	therapy	NOUN
ghmj-1070	139	19	,	,	PUNCT
ghmj-1070	139	20	immunotherapy	immunotherapy	NOUN
ghmj-1070	139	21	,	,	PUNCT
ghmj-1070	139	22	interdisciplinary	interdisciplinary	ADJ
ghmj-1070	139	23	team	team	NOUN
ghmj-1070	139	24	,	,	PUNCT
ghmj-1070	139	25	and	and	CCONJ
ghmj-1070	139	26	comprehensive	comprehensive	ADJ
ghmj-1070	139	27	palliative	palliative	ADJ
ghmj-1070	139	28	care	care	NOUN
ghmj-1070	139	29	(	(	PUNCT
ghmj-1070	139	30	asmara	asmara	PROPN
ghmj-1070	139	31	et	et	PROPN
ghmj-1070	139	32	al	al	PROPN
ghmj-1070	139	33	.	.	PROPN
ghmj-1070	139	34	2023	2023	NUM
ghmj-1070	139	35	;	;	PUNCT
ghmj-1070	139	36	kawase	kawase	PROPN
ghmj-1070	139	37	et	et	PROPN
ghmj-1070	139	38	al	al	PROPN
ghmj-1070	139	39	.	.	PROPN
ghmj-1070	139	40	2012	2012	NUM
ghmj-1070	139	41	;	;	PUNCT
ghmj-1070	139	42	salsabila	salsabila	PROPN
ghmj-1070	139	43	et	et	PROPN
ghmj-1070	139	44	al	al	PROPN
ghmj-1070	139	45	.	.	PROPN
ghmj-1070	139	46	2023	2023	NUM
ghmj-1070	139	47	;	;	PUNCT
ghmj-1070	139	48	travis	travis	PROPN
ghmj-1070	139	49	et	et	PROPN
ghmj-1070	139	50	al	al	PROPN
ghmj-1070	139	51	.	.	PROPN
ghmj-1070	139	52	2005	2005	NUM
ghmj-1070	139	53	)	)	PUNCT
ghmj-1070	139	54	.	.	PUNCT
ghmj-1070	140	1	this	this	DET
ghmj-1070	140	2	research	research	NOUN
ghmj-1070	140	3	has	have	VERB
ghmj-1070	140	4	several	several	ADJ
ghmj-1070	140	5	limitations	limitation	NOUN
ghmj-1070	140	6	such	such	ADJ
ghmj-1070	140	7	as	as	ADP
ghmj-1070	140	8	limitations	limitation	NOUN
ghmj-1070	140	9	in	in	ADP
ghmj-1070	140	10	research	research	NOUN
ghmj-1070	140	11	time	time	NOUN
ghmj-1070	140	12	and	and	CCONJ
ghmj-1070	140	13	many	many	ADJ
ghmj-1070	140	14	of	of	ADP
ghmj-1070	140	15	the	the	DET
ghmj-1070	140	16	data	datum	NOUN
ghmj-1070	140	17	needed	need	VERB
ghmj-1070	140	18	by	by	ADP
ghmj-1070	140	19	researchers	researcher	NOUN
ghmj-1070	140	20	are	be	AUX
ghmj-1070	140	21	incomplete	incomplete	ADJ
ghmj-1070	140	22	in	in	ADP
ghmj-1070	140	23	medical	medical	ADJ
ghmj-1070	140	24	records	record	NOUN
ghmj-1070	140	25	,	,	PUNCT
ghmj-1070	140	26	such	such	ADJ
ghmj-1070	140	27	as	as	ADP
ghmj-1070	140	28	occupation	occupation	NOUN
ghmj-1070	140	29	,	,	PUNCT
ghmj-1070	140	30	smoking	smoking	NOUN
ghmj-1070	140	31	history	history	NOUN
ghmj-1070	140	32	,	,	PUNCT
ghmj-1070	140	33	family	family	NOUN
ghmj-1070	140	34	history	history	NOUN
ghmj-1070	140	35	,	,	PUNCT
ghmj-1070	140	36	and	and	CCONJ
ghmj-1070	140	37	staging	staging	NOUN
ghmj-1070	140	38	.	.	PUNCT
ghmj-1070	141	1	further	further	ADJ
ghmj-1070	141	2	research	research	NOUN
ghmj-1070	141	3	is	be	AUX
ghmj-1070	141	4	expected	expect	VERB
ghmj-1070	141	5	to	to	PART
ghmj-1070	141	6	fill	fill	VERB
ghmj-1070	141	7	inadequacies	inadequacy	NOUN
ghmj-1070	141	8	in	in	ADP
ghmj-1070	141	9	smoking	smoking	NOUN
ghmj-1070	141	10	and	and	CCONJ
ghmj-1070	141	11	family	family	NOUN
ghmj-1070	141	12	history	history	NOUN
ghmj-1070	141	13	data	datum	NOUN
ghmj-1070	141	14	,	,	PUNCT
ghmj-1070	141	15	as	as	ADV
ghmj-1070	141	16	well	well	ADV
ghmj-1070	141	17	as	as	ADP
ghmj-1070	141	18	research	research	NOUN
ghmj-1070	141	19	specific	specific	ADJ
ghmj-1070	141	20	lung	lung	NOUN
ghmj-1070	141	21	cancer	cancer	NOUN
ghmj-1070	141	22	risk	risk	NOUN
ghmj-1070	141	23	factors	factor	NOUN
ghmj-1070	141	24	and	and	CCONJ
ghmj-1070	141	25	analyze	analyze	VERB
ghmj-1070	141	26	lung	lung	NOUN
ghmj-1070	141	27	cancer	cancer	NOUN
ghmj-1070	141	28	progression	progression	NOUN
ghmj-1070	141	29	and	and	CCONJ
ghmj-1070	141	30	outcomes	outcome	NOUN
ghmj-1070	141	31	based	base	VERB
ghmj-1070	141	32	on	on	ADP
ghmj-1070	141	33	histopathological	histopathological	ADJ
ghmj-1070	141	34	types	type	NOUN
ghmj-1070	141	35	and	and	CCONJ
ghmj-1070	141	36	stages	stage	NOUN
ghmj-1070	141	37	.	.	PUNCT
ghmj-1070	142	1	5	5	X
ghmj-1070	142	2	.	.	X
ghmj-1070	142	3	conclusion	conclusion	NOUN
ghmj-1070	142	4	in	in	ADP
ghmj-1070	142	5	conclusion	conclusion	NOUN
ghmj-1070	142	6	,	,	PUNCT
ghmj-1070	142	7	most	most	ADJ
ghmj-1070	142	8	lung	lung	NOUN
ghmj-1070	142	9	cancer	cancer	NOUN
ghmj-1070	142	10	patients	patient	NOUN
ghmj-1070	142	11	were	be	AUX
ghmj-1070	142	12	age	age	NOUN
ghmj-1070	142	13	46	46	NUM
ghmj-1070	142	14	-	-	SYM
ghmj-1070	142	15	70	70	NUM
ghmj-1070	142	16	years	year	NOUN
ghmj-1070	142	17	.	.	PUNCT
ghmj-1070	143	1	the	the	DET
ghmj-1070	143	2	analysis	analysis	NOUN
ghmj-1070	143	3	showed	show	VERB
ghmj-1070	143	4	that	that	SCONJ
ghmj-1070	143	5	male	male	ADJ
ghmj-1070	143	6	incidence	incidence	NOUN
ghmj-1070	143	7	in	in	ADP
ghmj-1070	143	8	lung	lung	NOUN
ghmj-1070	143	9	cancer	cancer	NOUN
ghmj-1070	143	10	patients	patient	NOUN
ghmj-1070	143	11	were	be	AUX
ghmj-1070	143	12	higher	high	ADJ
ghmj-1070	143	13	.	.	PUNCT
ghmj-1070	144	1	based	base	VERB
ghmj-1070	144	2	on	on	ADP
ghmj-1070	144	3	histopathological	histopathological	ADJ
ghmj-1070	144	4	,	,	PUNCT
ghmj-1070	144	5	adenocarcinoma	adenocarcinoma	PROPN
ghmj-1070	144	6	was	be	AUX
ghmj-1070	144	7	the	the	DET
ghmj-1070	144	8	most	most	ADV
ghmj-1070	144	9	prevalent	prevalent	ADJ
ghmj-1070	144	10	cancer	cancer	NOUN
ghmj-1070	144	11	cell	cell	NOUN
ghmj-1070	144	12	type	type	NOUN
ghmj-1070	144	13	.	.	PUNCT
ghmj-1070	145	1	related	relate	VERB
ghmj-1070	145	2	to	to	ADP
ghmj-1070	145	3	occupational	occupational	ADJ
ghmj-1070	145	4	data	datum	NOUN
ghmj-1070	145	5	,	,	PUNCT
ghmj-1070	145	6	smoking	smoking	NOUN
ghmj-1070	145	7	history	history	NOUN
ghmj-1070	145	8	,	,	PUNCT
ghmj-1070	145	9	family	family	NOUN
ghmj-1070	145	10	history	history	NOUN
ghmj-1070	145	11	,	,	PUNCT
ghmj-1070	145	12	and	and	CCONJ
ghmj-1070	145	13	staging	staging	NOUN
ghmj-1070	145	14	could	could	AUX
ghmj-1070	145	15	not	not	PART
ghmj-1070	145	16	be	be	AUX
ghmj-1070	145	17	concluded	conclude	VERB
ghmj-1070	145	18	because	because	SCONJ
ghmj-1070	145	19	they	they	PRON
ghmj-1070	145	20	were	be	AUX
ghmj-1070	145	21	not	not	PART
ghmj-1070	145	22	included	include	VERB
ghmj-1070	145	23	in	in	ADP
ghmj-1070	145	24	the	the	DET
ghmj-1070	145	25	medical	medical	ADJ
ghmj-1070	145	26	record	record	NOUN
ghmj-1070	145	27	.	.	PUNCT
ghmj-1070	146	1	further	further	ADJ
ghmj-1070	146	2	research	research	NOUN
ghmj-1070	146	3	is	be	AUX
ghmj-1070	146	4	expected	expect	VERB
ghmj-1070	146	5	to	to	PART
ghmj-1070	146	6	fill	fill	VERB
ghmj-1070	146	7	inadequacies	inadequacy	NOUN
ghmj-1070	146	8	in	in	ADP
ghmj-1070	146	9	smoking	smoking	NOUN
ghmj-1070	146	10	and	and	CCONJ
ghmj-1070	146	11	family	family	NOUN
ghmj-1070	146	12	history	history	NOUN
ghmj-1070	146	13	data	datum	NOUN
ghmj-1070	146	14	,	,	PUNCT
ghmj-1070	146	15	as	as	ADV
ghmj-1070	146	16	well	well	ADV
ghmj-1070	146	17	as	as	ADP
ghmj-1070	146	18	research	research	NOUN
ghmj-1070	146	19	specific	specific	ADJ
ghmj-1070	146	20	lung	lung	NOUN
ghmj-1070	146	21	cancer	cancer	NOUN
ghmj-1070	146	22	risk	risk	NOUN
ghmj-1070	146	23	factors	factor	NOUN
ghmj-1070	146	24	and	and	CCONJ
ghmj-1070	146	25	analyze	analyze	VERB
ghmj-1070	146	26	lung	lung	NOUN
ghmj-1070	146	27	cancer	cancer	NOUN
ghmj-1070	146	28	progression	progression	NOUN
ghmj-1070	146	29	and	and	CCONJ
ghmj-1070	146	30	outcomes	outcome	NOUN
ghmj-1070	146	31	based	base	VERB
ghmj-1070	146	32	on	on	ADP
ghmj-1070	146	33	histopathological	histopathological	ADJ
ghmj-1070	146	34	types	type	NOUN
ghmj-1070	146	35	and	and	CCONJ
ghmj-1070	146	36	stages	stage	NOUN
ghmj-1070	146	37	.	.	PUNCT
ghmj-1070	147	1	conflict	conflict	NOUN
ghmj-1070	147	2	of	of	ADP
ghmj-1070	147	3	interest	interest	NOUN
ghmj-1070	147	4	there	there	PRON
ghmj-1070	147	5	is	be	VERB
ghmj-1070	147	6	no	no	DET
ghmj-1070	147	7	potential	potential	ADJ
ghmj-1070	147	8	conflict	conflict	NOUN
ghmj-1070	147	9	of	of	ADP
ghmj-1070	147	10	interest	interest	NOUN
ghmj-1070	147	11	.	.	PUNCT
ghmj-1070	148	1	references	reference	NOUN
ghmj-1070	148	2	aini	aini	PROPN
ghmj-1070	148	3	,	,	PUNCT
ghmj-1070	148	4	sita	sita	PROPN
ghmj-1070	148	5	ro'yul	ro'yul	PROPN
ghmj-1070	148	6	,	,	PUNCT
ghmj-1070	148	7	laksmi	laksmi	PROPN
ghmj-1070	148	8	wulandari	wulandari	X
ghmj-1070	148	9	,	,	PUNCT
ghmj-1070	148	10	and	and	CCONJ
ghmj-1070	148	11	susilowati	susilowati	NOUN
ghmj-1070	148	12	andajani	andajani	NOUN
ghmj-1070	148	13	.	.	PUNCT
ghmj-1070	148	14	2019	2019	NUM
ghmj-1070	148	15	.	.	PUNCT
ghmj-1070	149	1	"	"	PUNCT
ghmj-1070	149	2	lung	lung	NOUN
ghmj-1070	149	3	cancer	cancer	NOUN
ghmj-1070	149	4	patients	patient	NOUN
ghmj-1070	149	5	'	'	PART
ghmj-1070	149	6	profile	profile	NOUN
ghmj-1070	149	7	in	in	ADP
ghmj-1070	149	8	dr	dr	PROPN
ghmj-1070	149	9	soetomo	soetomo	PROPN
ghmj-1070	149	10	general	general	PROPN
ghmj-1070	149	11	hospital	hospital	PROPN
ghmj-1070	149	12	surabaya	surabaya	PROPN
ghmj-1070	149	13	2016	2016	NUM
ghmj-1070	149	14	2017	2017	NUM
ghmj-1070	149	15	:	:	PUNCT
ghmj-1070	149	16	newest	new	ADJ
ghmj-1070	149	17	report	report	NOUN
ghmj-1070	149	18	.	.	PUNCT
ghmj-1070	149	19	"	"	PUNCT
ghmj-1070	150	1	juxta	juxta	PROPN
ghmj-1070	150	2	:	:	PUNCT
ghmj-1070	150	3	jurnal	jurnal	ADJ
ghmj-1070	150	4	ilmiah	ilmiah	PROPN
ghmj-1070	150	5	mahasiswa	mahasiswa	PROPN
ghmj-1070	150	6	kedokteran	kedokteran	VERB
ghmj-1070	150	7	universitas	universita	NOUN
ghmj-1070	150	8	airlangga	airlangga	PROPN
ghmj-1070	150	9	10(1):44	10(1):44	PROPN
ghmj-1070	150	10	.	.	PUNCT
ghmj-1070	151	1	https://doi.org/10.20473/juxta.v10i12019.44-47	https://doi.org/10.20473/juxta.v10i12019.44-47	PROPN
ghmj-1070	151	2	american	american	ADJ
ghmj-1070	151	3	cancer	cancer	NOUN
ghmj-1070	151	4	society	society	NOUN
ghmj-1070	151	5	.	.	PUNCT
ghmj-1070	152	1	2023	2023	NUM
ghmj-1070	152	2	.	.	PUNCT
ghmj-1070	153	1	cancer	cancer	NOUN
ghmj-1070	153	2	facts	fact	NOUN
ghmj-1070	153	3	&	&	CCONJ
ghmj-1070	153	4	figures	figure	NOUN
ghmj-1070	153	5	2023	2023	NUM
ghmj-1070	153	6	:	:	PUNCT
ghmj-1070	153	7	special	special	ADJ
ghmj-1070	153	8	section	section	NOUN
ghmj-1070	153	9	on	on	ADP
ghmj-1070	153	10	lung	lung	NOUN
ghmj-1070	153	11	cancer	cancer	NOUN
ghmj-1070	153	12	.	.	PUNCT
ghmj-1070	154	1	american	american	ADJ
ghmj-1070	154	2	cancer	cancer	NOUN
ghmj-1070	154	3	society	society	NOUN
ghmj-1070	154	4	.	.	PUNCT
ghmj-1070	155	1	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annualcancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annualcancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	PROPN
ghmj-1070	155	2	.	.	PUNCT
ghmj-1070	156	1	https://doi.org/10.20473/juxta.v10i12019.44-47	https://doi.org/10.20473/juxta.v10i12019.44-47	PROPN
ghmj-1070	156	2	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	PROPN
ghmj-1070	156	3	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cff-special-section-lung-cancer.pdf	NOUN
ghmj-1070	156	4	sulaeman	sulaeman	NOUN
ghmj-1070	156	5	,	,	PUNCT
ghmj-1070	156	6	et	et	PROPN
ghmj-1070	156	7	.	.	PUNCT
ghmj-1070	157	1	al	al	PROPN
ghmj-1070	157	2	.	.	PROPN
ghmj-1070	157	3	ghmj	ghmj	PROPN
ghmj-1070	157	4	(	(	PUNCT
ghmj-1070	157	5	global	global	ADJ
ghmj-1070	157	6	health	health	PROPN
ghmj-1070	157	7	management	management	NOUN
ghmj-1070	157	8	journal	journal	PROPN
ghmj-1070	157	9	)	)	PUNCT
ghmj-1070	157	10	2024	2024	NUM
ghmj-1070	157	11	,	,	PUNCT
ghmj-1070	157	12	vol	vol	NOUN
ghmj-1070	157	13	.	.	PROPN
ghmj-1070	157	14	7	7	NUM
ghmj-1070	157	15	,	,	PUNCT
ghmj-1070	157	16	no	no	INTJ
ghmj-1070	157	17	.	.	NOUN
ghmj-1070	157	18	4	4	NUM
ghmj-1070	157	19	299	299	NUM
ghmj-1070	157	20	asmara	asmara	ADJ
ghmj-1070	157	21	,	,	PUNCT
ghmj-1070	157	22	oke	oke	PROPN
ghmj-1070	157	23	dimas	dimas	PROPN
ghmj-1070	157	24	,	,	PUNCT
ghmj-1070	157	25	eric	eric	PROPN
ghmj-1070	157	26	daniel	daniel	PROPN
ghmj-1070	157	27	tenda	tenda	PROPN
ghmj-1070	157	28	,	,	PUNCT
ghmj-1070	157	29	gurmeet	gurmeet	VERB
ghmj-1070	157	30	singh	singh	PROPN
ghmj-1070	157	31	,	,	PUNCT
ghmj-1070	157	32	ceva	ceva	PROPN
ghmj-1070	157	33	wicaksono	wicaksono	PROPN
ghmj-1070	157	34	pitoyo	pitoyo	PROPN
ghmj-1070	157	35	,	,	PUNCT
ghmj-1070	157	36	cleopas	cleopa	VERB
ghmj-1070	157	37	martin	martin	PROPN
ghmj-1070	157	38	rumende	rumende	PROPN
ghmj-1070	157	39	,	,	PUNCT
ghmj-1070	157	40	wulyo	wulyo	ADJ
ghmj-1070	157	41	rajabto	rajabto	PROPN
ghmj-1070	157	42	,	,	PUNCT
ghmj-1070	157	43	nur	nur	VERB
ghmj-1070	157	44	rahmi	rahmi	PROPN
ghmj-1070	157	45	ananda	ananda	PROPN
ghmj-1070	157	46	,	,	PUNCT
ghmj-1070	157	47	ika	ika	PROPN
ghmj-1070	157	48	trisnawati	trisnawati	PROPN
ghmj-1070	157	49	,	,	PUNCT
ghmj-1070	157	50	eko	eko	PROPN
ghmj-1070	157	51	budiyono	budiyono	PROPN
ghmj-1070	157	52	,	,	PUNCT
ghmj-1070	157	53	harik	harik	PROPN
ghmj-1070	157	54	firman	firman	PROPN
ghmj-1070	157	55	thahadian	thahadian	PROPN
ghmj-1070	157	56	,	,	PUNCT
ghmj-1070	157	57	e.	e.	PROPN
ghmj-1070	157	58	christiaan	christiaan	PROPN
ghmj-1070	157	59	boerma	boerma	PROPN
ghmj-1070	157	60	,	,	PUNCT
ghmj-1070	157	61	achmad	achmad	PROPN
ghmj-1070	157	62	faisal	faisal	PROPN
ghmj-1070	157	63	,	,	PUNCT
ghmj-1070	157	64	david	david	PROPN
ghmj-1070	157	65	hutagaol	hutagaol	PROPN
ghmj-1070	157	66	,	,	PUNCT
ghmj-1070	157	67	wuryantoro	wuryantoro	PROPN
ghmj-1070	157	68	soeharto	soeharto	PROPN
ghmj-1070	157	69	,	,	PUNCT
ghmj-1070	157	70	fahmi	fahmi	PROPN
ghmj-1070	157	71	radityamurti	radityamurti	PROPN
ghmj-1070	157	72	,	,	PUNCT
ghmj-1070	157	73	erika	erika	PROPN
ghmj-1070	157	74	marfiani	marfiani	PROPN
ghmj-1070	157	75	,	,	PUNCT
ghmj-1070	157	76	pradana	pradana	PROPN
ghmj-1070	157	77	zaky	zaky	PROPN
ghmj-1070	157	78	romadhon	romadhon	PROPN
ghmj-1070	157	79	,	,	PUNCT
ghmj-1070	157	80	fathur	fathur	ADJ
ghmj-1070	157	81	nur	nur	VERB
ghmj-1070	157	82	kholis	kholis	PROPN
ghmj-1070	157	83	,	,	PUNCT
ghmj-1070	157	84	hendarsyah	hendarsyah	NOUN
ghmj-1070	157	85	suryadinata	suryadinata	NOUN
ghmj-1070	157	86	,	,	PUNCT
ghmj-1070	157	87	arto	arto	PROPN
ghmj-1070	157	88	yuwono	yuwono	PROPN
ghmj-1070	157	89	soeroto	soeroto	PROPN
ghmj-1070	157	90	,	,	PUNCT
ghmj-1070	157	91	soehartati	soehartati	PROPN
ghmj-1070	157	92	a.	a.	NOUN
ghmj-1070	157	93	gondhowiardjo	gondhowiardjo	PROPN
ghmj-1070	157	94	,	,	PUNCT
ghmj-1070	157	95	and	and	CCONJ
ghmj-1070	157	96	wouter	wouter	PROPN
ghmj-1070	157	97	h.	h.	PROPN
ghmj-1070	157	98	van	van	PROPN
ghmj-1070	157	99	geffen	geffen	PROPN
ghmj-1070	157	100	.	.	PUNCT
ghmj-1070	158	1	2023	2023	NUM
ghmj-1070	158	2	.	.	PUNCT
ghmj-1070	159	1	"	"	PUNCT
ghmj-1070	159	2	lung	lung	NOUN
ghmj-1070	159	3	cancer	cancer	NOUN
ghmj-1070	159	4	in	in	ADP
ghmj-1070	159	5	indonesia	indonesia	PROPN
ghmj-1070	159	6	.	.	PUNCT
ghmj-1070	159	7	"	"	PUNCT
ghmj-1070	160	1	journal	journal	PROPN
ghmj-1070	160	2	of	of	ADP
ghmj-1070	160	3	thoracic	thoracic	NOUN
ghmj-1070	160	4	oncology	oncology	NOUN
ghmj-1070	160	5	18(9):1134	18(9):1134	NUM
ghmj-1070	160	6	-	-	SYM
ghmj-1070	160	7	45	45	NUM
ghmj-1070	160	8	.	.	PUNCT
ghmj-1070	161	1	https://doi.org/10.1016/j.jtho.2023.06.010	https://doi.org/10.1016/j.jtho.2023.06.010	PROPN
ghmj-1070	161	2	balzer	balzer	PROPN
ghmj-1070	161	3	,	,	PUNCT
ghmj-1070	161	4	ben	ben	PROPN
ghmj-1070	161	5	w.	w.	PROPN
ghmj-1070	161	6	r.	r.	PROPN
ghmj-1070	161	7	,	,	PUNCT
ghmj-1070	161	8	christine	christine	PROPN
ghmj-1070	161	9	loo	loo	PROPN
ghmj-1070	161	10	,	,	PUNCT
ghmj-1070	161	11	craig	craig	PROPN
ghmj-1070	161	12	r.	r.	PROPN
ghmj-1070	161	13	lewis	lewis	PROPN
ghmj-1070	161	14	,	,	PUNCT
ghmj-1070	161	15	toby	toby	PROPN
ghmj-1070	161	16	n.	n.	PROPN
ghmj-1070	161	17	trahair	trahair	PROPN
ghmj-1070	161	18	,	,	PUNCT
ghmj-1070	161	19	and	and	CCONJ
ghmj-1070	161	20	antoinette	antoinette	PROPN
ghmj-1070	161	21	c.	c.	PROPN
ghmj-1070	161	22	anazodo	anazodo	PROPN
ghmj-1070	161	23	.	.	PUNCT
ghmj-1070	162	1	2018	2018	NUM
ghmj-1070	162	2	.	.	PUNCT
ghmj-1070	163	1	"	"	PUNCT
ghmj-1070	163	2	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	163	3	of	of	ADP
ghmj-1070	163	4	the	the	DET
ghmj-1070	163	5	lung	lung	NOUN
ghmj-1070	163	6	in	in	ADP
ghmj-1070	163	7	childhood	childhood	NOUN
ghmj-1070	163	8	and	and	CCONJ
ghmj-1070	163	9	adolescence	adolescence	NOUN
ghmj-1070	163	10	:	:	PUNCT
ghmj-1070	163	11	a	a	DET
ghmj-1070	163	12	systematic	systematic	ADJ
ghmj-1070	163	13	review	review	NOUN
ghmj-1070	163	14	.	.	PUNCT
ghmj-1070	163	15	"	"	PUNCT
ghmj-1070	164	1	journal	journal	NOUN
ghmj-1070	164	2	of	of	ADP
ghmj-1070	164	3	thoracic	thoracic	NOUN
ghmj-1070	164	4	oncology	oncology	NOUN
ghmj-1070	164	5	13(12):183241	13(12):183241	NUM
ghmj-1070	164	6	.	.	PUNCT
ghmj-1070	165	1	https://doi.org/10.1016/j.jtho.2018.08.2020	https://doi.org/10.1016/j.jtho.2018.08.2020	PROPN
ghmj-1070	165	2	buana	buana	PROPN
ghmj-1070	165	3	,	,	PUNCT
ghmj-1070	165	4	indra	indra	PROPN
ghmj-1070	165	5	,	,	PUNCT
ghmj-1070	165	6	and	and	CCONJ
ghmj-1070	165	7	dwi	dwi	PROPN
ghmj-1070	165	8	agustian	agustian	PROPN
ghmj-1070	165	9	harahap	harahap	PROPN
ghmj-1070	165	10	.	.	PUNCT
ghmj-1070	166	1	2022	2022	NUM
ghmj-1070	166	2	.	.	PUNCT
ghmj-1070	167	1	asbestos	asbestos	NOUN
ghmj-1070	167	2	,	,	PUNCT
ghmj-1070	167	3	radon	radon	PROPN
ghmj-1070	167	4	dan	dan	PROPN
ghmj-1070	167	5	polusi	polusi	PROPN
ghmj-1070	167	6	udara	udara	PROPN
ghmj-1070	167	7	sebagai	sebagai	PROPN
ghmj-1070	167	8	faktor	faktor	PROPN
ghmj-1070	167	9	resiko	resiko	PROPN
ghmj-1070	167	10	kanker	kanker	PROPN
ghmj-1070	167	11	paru	paru	PROPN
ghmj-1070	167	12	pada	pada	PROPN
ghmj-1070	167	13	perempuan	perempuan	PROPN
ghmj-1070	167	14	bukan	bukan	PROPN
ghmj-1070	167	15	perokok	perokok	PROPN
ghmj-1070	167	16	.	.	PUNCT
ghmj-1070	168	1	vol	vol	NOUN
ghmj-1070	168	2	.	.	PROPN
ghmj-1070	169	1	8	8	NUM
ghmj-1070	169	2	.	.	PUNCT
ghmj-1070	170	1	https://doi.org/10.29103/averrous.v8i1.7088	https://doi.org/10.29103/averrous.v8i1.7088	PROPN
ghmj-1070	170	2	ferlay	ferlay	PROPN
ghmj-1070	170	3	j	j	PROPN
ghmj-1070	170	4	,	,	PUNCT
ghmj-1070	170	5	ervik	ervik	PROPN
ghmj-1070	170	6	m	m	PROPN
ghmj-1070	170	7	,	,	PUNCT
ghmj-1070	170	8	lam	lam	PROPN
ghmj-1070	170	9	f	f	PROPN
ghmj-1070	170	10	,	,	PUNCT
ghmj-1070	170	11	laversanne	laversanne	PROPN
ghmj-1070	170	12	m	m	PROPN
ghmj-1070	170	13	,	,	PUNCT
ghmj-1070	170	14	colombet	colombet	PROPN
ghmj-1070	170	15	m	m	PROPN
ghmj-1070	170	16	,	,	PUNCT
ghmj-1070	170	17	mery	mery	PROPN
ghmj-1070	170	18	l	l	PROPN
ghmj-1070	170	19	,	,	PUNCT
ghmj-1070	170	20	piñeros	piñeros	PROPN
ghmj-1070	170	21	m	m	PROPN
ghmj-1070	170	22	,	,	PUNCT
ghmj-1070	170	23	znaor	znaor	PROPN
ghmj-1070	170	24	a	a	X
ghmj-1070	170	25	,	,	PUNCT
ghmj-1070	170	26	soerjomataram	soerjomataram	PROPN
ghmj-1070	170	27	i	i	PROPN
ghmj-1070	170	28	,	,	PUNCT
ghmj-1070	170	29	bray	bray	PROPN
ghmj-1070	170	30	f	f	PROPN
ghmj-1070	170	31	(	(	PUNCT
ghmj-1070	170	32	2024	2024	NUM
ghmj-1070	170	33	)	)	PUNCT
ghmj-1070	170	34	.	.	PUNCT
ghmj-1070	171	1	global	global	ADJ
ghmj-1070	171	2	cancer	cancer	NOUN
ghmj-1070	171	3	observatory	observatory	NOUN
ghmj-1070	171	4	:	:	PUNCT
ghmj-1070	171	5	cancer	cancer	NOUN
ghmj-1070	171	6	today	today	NOUN
ghmj-1070	171	7	.	.	PUNCT
ghmj-1070	172	1	lyon	lyon	PROPN
ghmj-1070	172	2	,	,	PUNCT
ghmj-1070	172	3	france	france	PROPN
ghmj-1070	172	4	:	:	PUNCT
ghmj-1070	172	5	international	international	ADJ
ghmj-1070	172	6	agency	agency	NOUN
ghmj-1070	172	7	for	for	ADP
ghmj-1070	172	8	research	research	NOUN
ghmj-1070	172	9	on	on	ADP
ghmj-1070	172	10	cancer	cancer	NOUN
ghmj-1070	172	11	.	.	PUNCT
ghmj-1070	173	1	available	available	ADJ
ghmj-1070	173	2	from	from	ADP
ghmj-1070	173	3	:	:	PUNCT
ghmj-1070	173	4	https://gco.iarc.who.int/today	https://gco.iarc.who.int/today	PROPN
ghmj-1070	173	5	.	.	PUNCT
ghmj-1070	174	1	kawase	kawase	PROPN
ghmj-1070	174	2	,	,	PUNCT
ghmj-1070	174	3	akikazu	akikazu	NOUN
ghmj-1070	174	4	,	,	PUNCT
ghmj-1070	174	5	junji	junji	PROPN
ghmj-1070	174	6	yoshida	yoshida	PROPN
ghmj-1070	174	7	,	,	PUNCT
ghmj-1070	174	8	genichiro	genichiro	PROPN
ghmj-1070	174	9	ishii	ishii	PROPN
ghmj-1070	174	10	,	,	PUNCT
ghmj-1070	174	11	masayuki	masayuki	PROPN
ghmj-1070	174	12	nakao	nakao	PROPN
ghmj-1070	174	13	,	,	PUNCT
ghmj-1070	174	14	keiju	keiju	NOUN
ghmj-1070	174	15	aokage	aokage	NOUN
ghmj-1070	174	16	,	,	PUNCT
ghmj-1070	174	17	tomoyuki	tomoyuki	PROPN
ghmj-1070	174	18	hishida	hishida	PROPN
ghmj-1070	174	19	,	,	PUNCT
ghmj-1070	174	20	mitsuyo	mitsuyo	PROPN
ghmj-1070	174	21	nishimura	nishimura	PROPN
ghmj-1070	174	22	,	,	PUNCT
ghmj-1070	174	23	and	and	CCONJ
ghmj-1070	174	24	kanji	kanji	X
ghmj-1070	174	25	nagai	nagai	PROPN
ghmj-1070	174	26	.	.	PROPN
ghmj-1070	174	27	2012	2012	NUM
ghmj-1070	174	28	.	.	PUNCT
ghmj-1070	175	1	"	"	PUNCT
ghmj-1070	175	2	differences	difference	NOUN
ghmj-1070	175	3	between	between	ADP
ghmj-1070	175	4	squamous	squamous	ADJ
ghmj-1070	175	5	cell	cell	NOUN
ghmj-1070	175	6	carcinoma	carcinoma	NOUN
ghmj-1070	175	7	and	and	CCONJ
ghmj-1070	175	8	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	175	9	of	of	ADP
ghmj-1070	175	10	the	the	DET
ghmj-1070	175	11	lung	lung	NOUN
ghmj-1070	175	12	:	:	PUNCT
ghmj-1070	175	13	are	be	AUX
ghmj-1070	175	14	adenocarcinoma	adenocarcinoma	ADJ
ghmj-1070	175	15	and	and	CCONJ
ghmj-1070	175	16	squamous	squamous	ADJ
ghmj-1070	175	17	cell	cell	NOUN
ghmj-1070	175	18	carcinoma	carcinoma	NOUN
ghmj-1070	175	19	prognostically	prognostically	ADV
ghmj-1070	175	20	equal	equal	ADJ
ghmj-1070	175	21	?	?	PUNCT
ghmj-1070	175	22	"	"	PUNCT
ghmj-1070	175	23	japanese	japanese	ADJ
ghmj-1070	175	24	journal	journal	NOUN
ghmj-1070	175	25	of	of	ADP
ghmj-1070	175	26	clinical	clinical	ADJ
ghmj-1070	175	27	oncology	oncology	NOUN
ghmj-1070	175	28	42(3):189	42(3):189	PROPN
ghmj-1070	175	29	-	-	PUNCT
ghmj-1070	175	30	95	95	NUM
ghmj-1070	175	31	.	.	PUNCT
ghmj-1070	176	1	https://doi.org/10.1093/jjco/hyr188	https://doi.org/10.1093/jjco/hyr188	ADJ
ghmj-1070	176	2	kementrian	kementrian	NOUN
ghmj-1070	176	3	kesehatan	kesehatan	PROPN
ghmj-1070	176	4	republik	republik	PROPN
ghmj-1070	176	5	indonesia	indonesia	PROPN
ghmj-1070	176	6	.	.	PROPN
ghmj-1070	177	1	2018	2018	NUM
ghmj-1070	177	2	.	.	PUNCT
ghmj-1070	178	1	pedoman	pedoman	NOUN
ghmj-1070	178	2	pengendalian	pengendalian	ADJ
ghmj-1070	178	3	faktor	faktor	PROPN
ghmj-1070	178	4	risiko	risiko	PROPN
ghmj-1070	178	5	kanker	kanker	PROPN
ghmj-1070	178	6	paru	paru	PROPN
ghmj-1070	178	7	.	.	PUNCT
ghmj-1070	179	1	jakarta	jakarta	PROPN
ghmj-1070	179	2	.	.	PUNCT
ghmj-1070	180	1	kementrian	kementrian	PROPN
ghmj-1070	180	2	kesehatan	kesehatan	PROPN
ghmj-1070	180	3	republik	republik	PROPN
ghmj-1070	180	4	indonesia	indonesia	PROPN
ghmj-1070	180	5	.	.	PROPN
ghmj-1070	181	1	2019	2019	NUM
ghmj-1070	181	2	.	.	PUNCT
ghmj-1070	182	1	laporan	laporan	ADJ
ghmj-1070	182	2	nasional	nasional	ADJ
ghmj-1070	182	3	riskesdas	riskesda	NOUN
ghmj-1070	182	4	2018	2018	NUM
ghmj-1070	182	5	.	.	PUNCT
ghmj-1070	183	1	jakarta	jakarta	PROPN
ghmj-1070	183	2	:	:	PUNCT
ghmj-1070	183	3	lembagapenerbitbadanpenelitiandanpengembangankesehatan	lembagapenerbitbadanpenelitiandanpengembangankesehatan	PROPN
ghmj-1070	183	4	.	.	PUNCT
ghmj-1070	184	1	kusumawardani	kusumawardani	PROPN
ghmj-1070	184	2	,	,	PUNCT
ghmj-1070	184	3	ida	ida	PROPN
ghmj-1070	184	4	ayu	ayu	PROPN
ghmj-1070	184	5	jasminarti	jasminarti	PROPN
ghmj-1070	184	6	dwi	dwi	PROPN
ghmj-1070	184	7	,	,	PUNCT
ghmj-1070	184	8	luh	luh	PROPN
ghmj-1070	184	9	komang	komang	PROPN
ghmj-1070	184	10	ayu	ayu	PROPN
ghmj-1070	184	11	widhiaty	widhiaty	PROPN
ghmj-1070	184	12	karang	karang	PROPN
ghmj-1070	184	13	,	,	PUNCT
ghmj-1070	184	14	ni	ni	PROPN
ghmj-1070	184	15	wayan	wayan	PROPN
ghmj-1070	184	16	candrawati	candrawati	PROPN
ghmj-1070	184	17	,	,	PUNCT
ghmj-1070	184	18	herman	herman	PROPN
ghmj-1070	184	19	saputra	saputra	PROPN
ghmj-1070	184	20	,	,	PUNCT
ghmj-1070	184	21	ni	ni	PROPN
ghmj-1070	184	22	putu	putu	PROPN
ghmj-1070	184	23	sriwidyani	sriwidyani	PROPN
ghmj-1070	184	24	,	,	PUNCT
ghmj-1070	184	25	and	and	CCONJ
ghmj-1070	184	26	nornazirah	nornazirah	PROPN
ghmj-1070	184	27	binti	binti	PROPN
ghmj-1070	184	28	azizan	azizan	PROPN
ghmj-1070	184	29	.	.	PUNCT
ghmj-1070	185	1	2022	2022	NUM
ghmj-1070	185	2	.	.	PUNCT
ghmj-1070	186	1	"	"	PUNCT
ghmj-1070	186	2	risk	risk	NOUN
ghmj-1070	186	3	factors	factor	NOUN
ghmj-1070	186	4	and	and	CCONJ
ghmj-1070	186	5	challenging	challenging	ADJ
ghmj-1070	186	6	management	management	NOUN
ghmj-1070	186	7	of	of	ADP
ghmj-1070	186	8	lung	lung	NOUN
ghmj-1070	186	9	adenocarcinoma	adenocarcinoma	NOUN
ghmj-1070	186	10	in	in	ADP
ghmj-1070	186	11	young	young	ADJ
ghmj-1070	186	12	adult	adult	NOUN
ghmj-1070	186	13	women	woman	NOUN
ghmj-1070	186	14	:	:	PUNCT
ghmj-1070	186	15	case	case	NOUN
ghmj-1070	186	16	series	series	NOUN
ghmj-1070	186	17	.	.	PUNCT
ghmj-1070	186	18	"	"	PUNCT
ghmj-1070	187	1	jurnal	jurnal	ADJ
ghmj-1070	187	2	respirasi	respirasi	NOUN
ghmj-1070	187	3	8(2):94	8(2):94	NUM
ghmj-1070	187	4	-	-	SYM
ghmj-1070	187	5	98	98	NUM
ghmj-1070	187	6	.	.	PUNCT
ghmj-1070	188	1	https://doi.org/10.20473/jr.v8-i.2.2022.94-98	https://doi.org/10.20473/jr.v8-i.2.2022.94-98	PROPN
ghmj-1070	188	2	ma	ma	PROPN
ghmj-1070	188	3	,	,	PUNCT
ghmj-1070	188	4	zhimin	zhimin	PROPN
ghmj-1070	188	5	,	,	PUNCT
ghmj-1070	188	6	chen	chen	PROPN
ghmj-1070	188	7	zhu	zhu	PROPN
ghmj-1070	188	8	,	,	PUNCT
ghmj-1070	188	9	hui	hui	PROPN
ghmj-1070	188	10	wang	wang	PROPN
ghmj-1070	188	11	,	,	PUNCT
ghmj-1070	188	12	mengmeng	mengmeng	PROPN
ghmj-1070	188	13	ji	ji	PROPN
ghmj-1070	188	14	,	,	PUNCT
ghmj-1070	188	15	yanqian	yanqian	PROPN
ghmj-1070	188	16	huang	huang	PROPN
ghmj-1070	188	17	,	,	PUNCT
ghmj-1070	188	18	xiaoxia	xiaoxia	PROPN
ghmj-1070	188	19	wei	wei	PROPN
ghmj-1070	188	20	,	,	PUNCT
ghmj-1070	188	21	jing	jing	PROPN
ghmj-1070	188	22	zhang	zhang	PROPN
ghmj-1070	188	23	,	,	PUNCT
ghmj-1070	188	24	yuzhuo	yuzhuo	PROPN
ghmj-1070	188	25	wang	wang	PROPN
ghmj-1070	188	26	,	,	PUNCT
ghmj-1070	188	27	rong	rong	PROPN
ghmj-1070	188	28	yin	yin	PROPN
ghmj-1070	188	29	,	,	PUNCT
ghmj-1070	188	30	juncheng	juncheng	PROPN
ghmj-1070	188	31	dai	dai	PROPN
ghmj-1070	188	32	,	,	PUNCT
ghmj-1070	188	33	lin	lin	PROPN
ghmj-1070	188	34	xu	xu	PROPN
ghmj-1070	188	35	,	,	PUNCT
ghmj-1070	188	36	hongxia	hongxia	PROPN
ghmj-1070	188	37	ma	ma	PROPN
ghmj-1070	188	38	,	,	PUNCT
ghmj-1070	188	39	zhibin	zhibin	PROPN
ghmj-1070	188	40	hu	hu	PROPN
ghmj-1070	188	41	,	,	PUNCT
ghmj-1070	188	42	guangfu	guangfu	PROPN
ghmj-1070	188	43	jin	jin	PROPN
ghmj-1070	188	44	,	,	PUNCT
ghmj-1070	188	45	meng	meng	PROPN
ghmj-1070	188	46	zhu	zhu	PROPN
ghmj-1070	188	47	,	,	PUNCT
ghmj-1070	188	48	and	and	CCONJ
ghmj-1070	188	49	hongbing	hongbe	VERB
ghmj-1070	188	50	shen	shen	PROPN
ghmj-1070	188	51	.	.	PUNCT
ghmj-1070	189	1	2023	2023	NUM
ghmj-1070	189	2	.	.	PUNCT
ghmj-1070	190	1	"	"	PUNCT
ghmj-1070	190	2	association	association	NOUN
ghmj-1070	190	3	between	between	ADP
ghmj-1070	190	4	biological	biological	ADJ
ghmj-1070	190	5	aging	aging	NOUN
ghmj-1070	190	6	and	and	CCONJ
ghmj-1070	190	7	lung	lung	NOUN
ghmj-1070	190	8	cancer	cancer	NOUN
ghmj-1070	190	9	risk	risk	NOUN
ghmj-1070	190	10	:	:	PUNCT
ghmj-1070	190	11	cohort	cohort	NOUN
ghmj-1070	190	12	study	study	NOUN
ghmj-1070	190	13	and	and	CCONJ
ghmj-1070	190	14	mendelian	mendelian	ADJ
ghmj-1070	190	15	randomization	randomization	NOUN
ghmj-1070	190	16	analysis	analysis	NOUN
ghmj-1070	190	17	.	.	PUNCT
ghmj-1070	190	18	"	"	PUNCT
ghmj-1070	191	1	iscience	iscience	NOUN
ghmj-1070	191	2	26(3	26(3	NUM
ghmj-1070	191	3	)	)	PUNCT
ghmj-1070	191	4	.	.	PUNCT
ghmj-1070	192	1	https://doi.org/10.1016/j.isci.2023.106018	https://doi.org/10.1016/j.isci.2023.106018	PROPN
ghmj-1070	192	2	nicholson	nicholson	PROPN
ghmj-1070	192	3	,	,	PUNCT
ghmj-1070	192	4	andrew	andrew	PROPN
ghmj-1070	192	5	g.	g.	PROPN
ghmj-1070	192	6	,	,	PUNCT
ghmj-1070	192	7	ming	ming	PROPN
ghmj-1070	192	8	s.	s.	PROPN
ghmj-1070	192	9	tsao	tsao	PROPN
ghmj-1070	192	10	,	,	PUNCT
ghmj-1070	192	11	mary	mary	PROPN
ghmj-1070	192	12	beth	beth	PROPN
ghmj-1070	192	13	beasley	beasley	PROPN
ghmj-1070	192	14	,	,	PUNCT
ghmj-1070	192	15	alain	alain	PROPN
ghmj-1070	192	16	c.	c.	PROPN
ghmj-1070	192	17	borczuk	borczuk	PROPN
ghmj-1070	192	18	,	,	PUNCT
ghmj-1070	192	19	elisabeth	elisabeth	PROPN
ghmj-1070	192	20	brambilla	brambilla	PROPN
ghmj-1070	192	21	,	,	PUNCT
ghmj-1070	192	22	wendy	wendy	PROPN
ghmj-1070	192	23	a.	a.	PROPN
ghmj-1070	192	24	cooper	cooper	PROPN
ghmj-1070	192	25	,	,	PUNCT
ghmj-1070	192	26	sanja	sanja	PROPN
ghmj-1070	192	27	dacic	dacic	PROPN
ghmj-1070	192	28	,	,	PUNCT
ghmj-1070	192	29	deepali	deepali	PROPN
ghmj-1070	192	30	jain	jain	PROPN
ghmj-1070	192	31	,	,	PUNCT
ghmj-1070	192	32	keith	keith	PROPN
ghmj-1070	192	33	m.	m.	PROPN
ghmj-1070	192	34	kerr	kerr	PROPN
ghmj-1070	192	35	,	,	PUNCT
ghmj-1070	192	36	sylvie	sylvie	PROPN
ghmj-1070	192	37	lantuejoul	lantuejoul	PROPN
ghmj-1070	192	38	,	,	PUNCT
ghmj-1070	192	39	masayuki	masayuki	PROPN
ghmj-1070	192	40	noguchi	noguchi	PROPN
ghmj-1070	192	41	,	,	PUNCT
ghmj-1070	192	42	mauro	mauro	PROPN
ghmj-1070	192	43	papotti	papotti	PROPN
ghmj-1070	192	44	,	,	PUNCT
ghmj-1070	192	45	natasha	natasha	PROPN
ghmj-1070	192	46	rekhtman	rekhtman	PROPN
ghmj-1070	192	47	,	,	PUNCT
ghmj-1070	192	48	giorgio	giorgio	PROPN
ghmj-1070	192	49	scagliotti	scagliotti	PROPN
ghmj-1070	192	50	,	,	PUNCT
ghmj-1070	192	51	paul	paul	PROPN
ghmj-1070	192	52	van	van	PROPN
ghmj-1070	192	53	schil	schil	PROPN
ghmj-1070	192	54	,	,	PUNCT
ghmj-1070	192	55	lynette	lynette	PROPN
ghmj-1070	192	56	sholl	sholl	PROPN
ghmj-1070	192	57	,	,	PUNCT
ghmj-1070	192	58	yasushi	yasushi	PROPN
ghmj-1070	192	59	yatabe	yatabe	PROPN
ghmj-1070	192	60	,	,	PUNCT
ghmj-1070	192	61	akihiko	akihiko	PROPN
ghmj-1070	192	62	yoshida	yoshida	PROPN
ghmj-1070	192	63	,	,	PUNCT
ghmj-1070	192	64	and	and	CCONJ
ghmj-1070	192	65	william	william	PROPN
ghmj-1070	192	66	d.	d.	PROPN
ghmj-1070	192	67	travis	travis	PROPN
ghmj-1070	192	68	.	.	PROPN
ghmj-1070	192	69	2022	2022	NUM
ghmj-1070	192	70	.	.	PUNCT
ghmj-1070	193	1	"	"	PUNCT
ghmj-1070	193	2	the	the	DET
ghmj-1070	193	3	2021	2021	NUM
ghmj-1070	193	4	who	who	PRON
ghmj-1070	193	5	classification	classification	NOUN
ghmj-1070	193	6	of	of	ADP
ghmj-1070	193	7	lung	lung	NOUN
ghmj-1070	193	8	tumors	tumor	NOUN
ghmj-1070	193	9	:	:	PUNCT
ghmj-1070	193	10	impact	impact	NOUN
ghmj-1070	193	11	of	of	ADP
ghmj-1070	193	12	advances	advance	NOUN
ghmj-1070	193	13	since	since	SCONJ
ghmj-1070	193	14	2015	2015	NUM
ghmj-1070	193	15	.	.	PUNCT
ghmj-1070	193	16	"	"	PUNCT
ghmj-1070	194	1	journal	journal	NOUN
ghmj-1070	194	2	of	of	ADP
ghmj-1070	194	3	thoracic	thoracic	NOUN
ghmj-1070	194	4	oncology	oncology	NOUN
ghmj-1070	194	5	17(3):362	17(3):362	PROPN
ghmj-1070	194	6	-	-	PUNCT
ghmj-1070	194	7	87	87	NUM
ghmj-1070	194	8	.	.	PUNCT
ghmj-1070	195	1	https://doi.org/10.1016/j.jtho.2021.11.003	https://doi.org/10.1016/j.jtho.2021.11.003	PROPN
ghmj-1070	195	2	pritami	pritami	NOUN
ghmj-1070	195	3	,	,	PUNCT
ghmj-1070	195	4	aldiesa	aldiesa	PROPN
ghmj-1070	195	5	ade	ade	PROPN
ghmj-1070	195	6	,	,	PUNCT
ghmj-1070	195	7	retno	retno	PROPN
ghmj-1070	195	8	ariza	ariza	PROPN
ghmj-1070	195	9	,	,	PUNCT
ghmj-1070	195	10	soeprihatini	soeprihatini	PROPN
ghmj-1070	195	11	soemarwoto	soemarwoto	NOUN
ghmj-1070	195	12	,	,	PUNCT
ghmj-1070	195	13	risal	risal	NOUN
ghmj-1070	195	14	wintoko|	wintoko|	NOUN
ghmj-1070	195	15	,	,	PUNCT
ghmj-1070	195	16	faktor	faktor	NOUN
ghmj-1070	195	17	risiko	risiko	NOUN
ghmj-1070	195	18	,	,	PUNCT
ghmj-1070	195	19	kanker	kanker	NOUN
ghmj-1070	195	20	paru	paru	NOUN
ghmj-1070	195	21	,	,	PUNCT
ghmj-1070	195	22	and	and	CCONJ
ghmj-1070	195	23	risal	risal	ADJ
ghmj-1070	195	24	wintoko	wintoko	NOUN
ghmj-1070	195	25	.	.	PUNCT
ghmj-1070	196	1	2022	2022	NUM
ghmj-1070	196	2	.	.	PUNCT
ghmj-1070	197	1	faktor	faktor	PROPN
ghmj-1070	197	2	risiko	risiko	PROPN
ghmj-1070	197	3	kanker	kanker	PROPN
ghmj-1070	197	4	paru	paru	PROPN
ghmj-1070	197	5	:	:	PUNCT
ghmj-1070	197	6	tinjauan	tinjauan	PROPN
ghmj-1070	197	7	pustaka	pustaka	PROPN
ghmj-1070	197	8	.	.	PUNCT
ghmj-1070	198	1	lampung	lampung	PROPN
ghmj-1070	198	2	.	.	PUNCT
ghmj-1070	199	1	putri	putri	ADJ
ghmj-1070	199	2	,	,	PUNCT
ghmj-1070	199	3	agusriani	agusriani	PROPN
ghmj-1070	199	4	,	,	PUNCT
ghmj-1070	199	5	sari	sari	ADJ
ghmj-1070	199	6	eka	eka	PROPN
ghmj-1070	199	7	pratiwi	pratiwi	NOUN
ghmj-1070	199	8	,	,	PUNCT
ghmj-1070	199	9	and	and	CCONJ
ghmj-1070	199	10	risa	risa	PROPN
ghmj-1070	199	11	febriana	febriana	PROPN
ghmj-1070	199	12	musawaris	musawaris	PROPN
ghmj-1070	199	13	.	.	PUNCT
ghmj-1070	199	14	2023	2023	NUM
ghmj-1070	199	15	.	.	PUNCT
ghmj-1070	200	1	"	"	PUNCT
ghmj-1070	200	2	characteristics	characteristic	NOUN
ghmj-1070	200	3	of	of	ADP
ghmj-1070	200	4	lung	lung	NOUN
ghmj-1070	200	5	cancer	cancer	NOUN
ghmj-1070	200	6	patients	patient	NOUN
ghmj-1070	200	7	at	at	ADP
ghmj-1070	200	8	dr	dr	PROPN
ghmj-1070	200	9	.	.	PROPN
ghmj-1070	200	10	soedarso	soedarso	PROPN
ghmj-1070	200	11	hospital	hospital	NOUN
ghmj-1070	200	12	pontianak	pontianak	PROPN
ghmj-1070	200	13	from	from	ADP
ghmj-1070	200	14	2017	2017	NUM
ghmj-1070	200	15	to	to	ADP
ghmj-1070	200	16	2019	2019	NUM
ghmj-1070	200	17	.	.	PUNCT
ghmj-1070	200	18	"	"	PUNCT
ghmj-1070	201	1	indonesian	indonesian	ADJ
ghmj-1070	201	2	journal	journal	PROPN
ghmj-1070	201	3	of	of	ADP
ghmj-1070	201	4	cancer	cancer	NOUN
ghmj-1070	201	5	17(2):101	17(2):101	NUM
ghmj-1070	201	6	.	.	PUNCT
ghmj-1070	202	1	https://doi.org/10.33371/ijoc.v17i2.950	https://doi.org/10.33371/ijoc.v17i2.950	PROPN
ghmj-1070	202	2	salsabila	salsabila	PROPN
ghmj-1070	202	3	,	,	PUNCT
ghmj-1070	202	4	syifa	syifa	PROPN
ghmj-1070	202	5	,	,	PUNCT
ghmj-1070	202	6	shinta	shinta	PROPN
ghmj-1070	202	7	ayu	ayu	PROPN
ghmj-1070	202	8	intan	intan	PROPN
ghmj-1070	202	9	,	,	PUNCT
ghmj-1070	202	10	and	and	CCONJ
ghmj-1070	202	11	dewi	dewi	PROPN
ghmj-1070	202	12	wahyu	wahyu	PROPN
ghmj-1070	202	13	fitrina	fitrina	PROPN
ghmj-1070	202	14	.	.	PUNCT
ghmj-1070	202	15	2023	2023	NUM
ghmj-1070	202	16	.	.	PUNCT
ghmj-1070	203	1	"	"	PUNCT
ghmj-1070	203	2	gambaran	gambaran	NOUN
ghmj-1070	203	3	tipe	tipe	PROPN
ghmj-1070	203	4	sel	sel	PROPN
ghmj-1070	203	5	kanker	kanker	PROPN
ghmj-1070	203	6	paru	paru	PROPN
ghmj-1070	203	7	berdasarkan	berdasarkan	PROPN
ghmj-1070	203	8	usia	usia	PROPN
ghmj-1070	203	9	,	,	PUNCT
ghmj-1070	203	10	jenis	jenis	PROPN
ghmj-1070	203	11	kelamin	kelamin	PROPN
ghmj-1070	203	12	,	,	PUNCT
ghmj-1070	203	13	dan	dan	PROPN
ghmj-1070	203	14	paparan	paparan	PROPN
ghmj-1070	203	15	rokok	rokok	PROPN
ghmj-1070	203	16	di	di	PROPN
ghmj-1070	203	17	rsup	rsup	PROPN
ghmj-1070	203	18	dr	dr	PROPN
ghmj-1070	203	19	.	.	PROPN
ghmj-1070	203	20	m.	m.	PROPN
ghmj-1070	203	21	djamil	djamil	PROPN
ghmj-1070	203	22	padang	padang	PROPN
ghmj-1070	203	23	tahun	tahun	PROPN
ghmj-1070	203	24	2018	2018	NUM
ghmj-1070	203	25	-	-	SYM
ghmj-1070	203	26	2020	2020	NUM
ghmj-1070	203	27	.	.	PUNCT
ghmj-1070	203	28	"	"	PUNCT
ghmj-1070	204	1	jurnal	jurnal	ADJ
ghmj-1070	204	2	ilmu	ilmu	PROPN
ghmj-1070	204	3	kesehatan	kesehatan	PROPN
ghmj-1070	204	4	indonesia	indonesia	PROPN
ghmj-1070	204	5	4(4):281	4(4):281	PROPN
ghmj-1070	204	6	-	-	SYM
ghmj-1070	204	7	88	88	NUM
ghmj-1070	204	8	.	.	PUNCT
ghmj-1070	205	1	https://doi.org/10.25077/jikesi.v4i4.1118	https://doi.org/10.25077/jikesi.v4i4.1118	PROPN
ghmj-1070	205	2	travis	travis	PROPN
ghmj-1070	205	3	,	,	PUNCT
ghmj-1070	205	4	william	william	PROPN
ghmj-1070	205	5	d.	d.	PROPN
ghmj-1070	205	6	..	..	PROPN
ghmj-1070	205	7	,	,	PUNCT
ghmj-1070	205	8	elizabeth	elizabeth	PROPN
ghmj-1070	205	9	.	.	PUNCT
ghmj-1070	205	10	brambilla	brambilla	PROPN
ghmj-1070	205	11	,	,	PUNCT
ghmj-1070	205	12	and	and	CCONJ
ghmj-1070	205	13	h.	h.	PROPN
ghmj-1070	205	14	konrad	konrad	PROPN
ghmj-1070	205	15	.	.	PUNCT
ghmj-1070	206	1	muller	muller	PROPN
ghmj-1070	206	2	-	-	PUNCT
ghmj-1070	206	3	hermelink	hermelink	PROPN
ghmj-1070	206	4	.	.	PUNCT
ghmj-1070	207	1	2005	2005	NUM
ghmj-1070	207	2	.	.	PUNCT
ghmj-1070	208	1	world	world	PROPN
ghmj-1070	208	2	health	health	PROPN
ghmj-1070	208	3	organization	organization	PROPN
ghmj-1070	208	4	classification	classification	NOUN
ghmj-1070	208	5	of	of	ADP
ghmj-1070	208	6	tumours	tumours	PROPN
ghmj-1070	208	7	 	 	SPACE
ghmj-1070	208	8	:	:	PUNCT
ghmj-1070	208	9	pathology	pathology	NOUN
ghmj-1070	208	10	and	and	CCONJ
ghmj-1070	208	11	genetics	genetic	NOUN
ghmj-1070	208	12	of	of	ADP
ghmj-1070	208	13	tumours	tumour	NOUN
ghmj-1070	208	14	of	of	ADP
ghmj-1070	208	15	the	the	DET
ghmj-1070	208	16	lung	lung	NOUN
ghmj-1070	208	17	,	,	PUNCT
ghmj-1070	208	18	pleura	pleura	NOUN
ghmj-1070	208	19	,	,	PUNCT
ghmj-1070	208	20	thymus	thymus	VERB
ghmj-1070	208	21	and	and	CCONJ
ghmj-1070	208	22	heart	heart	NOUN
ghmj-1070	208	23	.	.	PUNCT
ghmj-1070	209	1	iarc	iarc	NOUN
ghmj-1070	209	2	publications	publication	NOUN
ghmj-1070	209	3	.	.	PUNCT
ghmj-1070	210	1	vavalà	vavalà	NOUN
ghmj-1070	210	2	,	,	PUNCT
ghmj-1070	210	3	tiziana	tiziana	NOUN
ghmj-1070	210	4	,	,	PUNCT
ghmj-1070	210	5	annamaria	annamaria	PROPN
ghmj-1070	210	6	catino	catino	PROPN
ghmj-1070	210	7	,	,	PUNCT
ghmj-1070	210	8	pamela	pamela	PROPN
ghmj-1070	210	9	pizzutilo	pizzutilo	PROPN
ghmj-1070	210	10	,	,	PUNCT
ghmj-1070	210	11	vito	vito	PROPN
ghmj-1070	210	12	longo	longo	PROPN
ghmj-1070	210	13	,	,	PUNCT
ghmj-1070	210	14	and	and	CCONJ
ghmj-1070	210	15	domenico	domenico	PROPN
ghmj-1070	210	16	galetta	galetta	PROPN
ghmj-1070	210	17	.	.	PUNCT
ghmj-1070	210	18	2021	2021	NUM
ghmj-1070	210	19	.	.	PUNCT
ghmj-1070	211	1	"	"	PUNCT
ghmj-1070	211	2	gender	gender	NOUN
ghmj-1070	211	3	differences	difference	NOUN
ghmj-1070	211	4	and	and	CCONJ
ghmj-1070	211	5	immunotherapy	immunotherapy	NOUN
ghmj-1070	211	6	outcome	outcome	NOUN
ghmj-1070	211	7	in	in	ADP
ghmj-1070	211	8	advanced	advanced	ADJ
ghmj-1070	211	9	lung	lung	NOUN
ghmj-1070	211	10	cancer	cancer	NOUN
ghmj-1070	211	11	.	.	PUNCT
ghmj-1070	211	12	"	"	PUNCT
ghmj-1070	212	1	international	international	ADJ
ghmj-1070	212	2	journal	journal	NOUN
ghmj-1070	212	3	of	of	ADP
ghmj-1070	212	4	molecular	molecular	ADJ
ghmj-1070	212	5	sciences	science	NOUN
ghmj-1070	212	6	22(21	22(21	NUM
ghmj-1070	212	7	)	)	PUNCT
ghmj-1070	212	8	.	.	PUNCT
ghmj-1070	213	1	https://doi.org/10.3390/ijms222111942	https://doi.org/10.3390/ijms222111942	NOUN
ghmj-1070	213	2	cite	cite	VERB
ghmj-1070	213	3	this	this	DET
ghmj-1070	213	4	article	article	NOUN
ghmj-1070	213	5	as	as	ADP
ghmj-1070	213	6	:	:	PUNCT
ghmj-1070	213	7	sulaeman	sulaeman	PROPN
ghmj-1070	213	8	,	,	PUNCT
ghmj-1070	213	9	s.	s.	PROPN
ghmj-1070	213	10	p.	p.	PROPN
ghmj-1070	213	11	,	,	PUNCT
ghmj-1070	213	12	fitrie	fitrie	PROPN
ghmj-1070	213	13	,	,	PUNCT
ghmj-1070	213	14	a.	a.	NOUN
ghmj-1070	213	15	a.	a.	PROPN
ghmj-1070	213	16	,	,	PUNCT
ghmj-1070	213	17	&	&	CCONJ
ghmj-1070	213	18	sedayu	sedayu	PROPN
ghmj-1070	213	19	,	,	PUNCT
ghmj-1070	213	20	s.	s.	PROPN
ghmj-1070	213	21	(	(	PUNCT
ghmj-1070	213	22	2024	2024	NUM
ghmj-1070	213	23	)	)	PUNCT
ghmj-1070	213	24	.	.	PUNCT
ghmj-1070	214	1	demographics	demographic	NOUN
ghmj-1070	214	2	and	and	CCONJ
ghmj-1070	214	3	histopathological	histopathological	ADJ
ghmj-1070	214	4	characteristics	characteristic	NOUN
ghmj-1070	214	5	of	of	ADP
ghmj-1070	214	6	lung	lung	NOUN
ghmj-1070	214	7	cancer	cancer	NOUN
ghmj-1070	214	8	patients	patient	NOUN
ghmj-1070	214	9	in	in	ADP
ghmj-1070	214	10	cirebon	cirebon	PROPN
ghmj-1070	214	11	district	district	PROPN
ghmj-1070	214	12	,	,	PUNCT
ghmj-1070	214	13	indonesia	indonesia	PROPN
ghmj-1070	214	14	(	(	PUNCT
ghmj-1070	214	15	2021	2021	NUM
ghmj-1070	214	16	-	-	SYM
ghmj-1070	214	17	2023	2023	NUM
ghmj-1070	214	18	)	)	PUNCT
ghmj-1070	214	19	.	.	PUNCT
ghmj-1070	215	1	ghmj	ghmj	PROPN
ghmj-1070	215	2	(	(	PUNCT
ghmj-1070	215	3	global	global	ADJ
ghmj-1070	215	4	health	health	PROPN
ghmj-1070	215	5	management	management	NOUN
ghmj-1070	215	6	journal	journal	PROPN
ghmj-1070	215	7	)	)	PUNCT
ghmj-1070	215	8	,	,	PUNCT
ghmj-1070	215	9	7(4	7(4	NUM
ghmj-1070	215	10	)	)	PUNCT
ghmj-1070	215	11	,	,	PUNCT
ghmj-1070	215	12	293	293	NUM
ghmj-1070	215	13	–	–	PUNCT
ghmj-1070	215	14	299	299	NUM
ghmj-1070	215	15	.	.	PUNCT
ghmj-1070	215	16	https://doi.org/10.35898/ghmj-741070	https://doi.org/10.35898/ghmj-741070	PROPN
ghmj-1070	215	17	https://doi.org/10.1016/j.jtho.2023.06.010	https://doi.org/10.1016/j.jtho.2023.06.010	PROPN
ghmj-1070	215	18	https://doi.org/10.1016/j.jtho.2018.08.2020	https://doi.org/10.1016/j.jtho.2018.08.2020	NOUN
ghmj-1070	215	19	https://doi.org/10.29103/averrous.v8i1.7088	https://doi.org/10.29103/averrous.v8i1.7088	ADJ
ghmj-1070	215	20	https://gco.iarc.who.int/today	https://gco.iarc.who.int/today	PROPN
ghmj-1070	215	21	https://doi.org/10.1093/jjco/hyr188	https://doi.org/10.1093/jjco/hyr188	ADJ
ghmj-1070	215	22	https://doi.org/10.20473/jr.v8-i.2.2022.94-98	https://doi.org/10.20473/jr.v8-i.2.2022.94-98	PROPN
ghmj-1070	215	23	https://doi.org/10.1016/j.isci.2023.106018	https://doi.org/10.1016/j.isci.2023.106018	PROPN
ghmj-1070	215	24	https://doi.org/10.1016/j.jtho.2021.11.003	https://doi.org/10.1016/j.jtho.2021.11.003	PROPN
ghmj-1070	215	25	https://doi.org/10.33371/ijoc.v17i2.950	https://doi.org/10.33371/ijoc.v17i2.950	NOUN
ghmj-1070	215	26	https://doi.org/10.25077/jikesi.v4i4.1118	https://doi.org/10.25077/jikesi.v4i4.1118	VERB
ghmj-1070	215	27	https://doi.org/10.3390/ijms222111942	https://doi.org/10.3390/ijms222111942	NOUN
ghmj-1070	215	28	https://doi.org/10.35898/ghmj-741070	https://doi.org/10.35898/ghmj-741070	VERB